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Abstract
The in vivo antioxidant activity of a dose of green tea which could realistically be achieved 
by habitual consumption of green tea beverage has been investigated in animals and 
humans.
Initially methods for the analysis of biomarkers of oxidative damage in animals were set up 
and validated. Apparatus for the measurement of ethane exhalation was reactivated and 
the role of the gastrointestinal flora in ethane production investigated. There was no 
significant difference in ethane production between conventional and germ-free Lister 
Hooded rats fed either LAD 1 animal diet or a semi-synthetic diets containing 5 % fish oil. 
Ethane production from germ-free rats fed a semi-synthetic diet containing maize oil was 
significantly greater than that from conventional animals fed the same diet. The 
gastrointestinal flora was therefore discounted as a significant source of ethane production 
in rats fed such diets. A method was also developed for the measurement of plasma and 
urinary malondialdehyde.
Using these biomarkers the in vivo antioxidant activity of green tea was investigated in 
conventional and vitamin E-deficient Lister Hooded rats fed fish oil and maize oil diets 
similar to those used when investigating the role of the gastrointestinal flora in ethane 
production. All three biomarkers were significantly greater in animals fed the fish oil diet 
compared with animals fed the maize oil diet. Plasma malondialdehyde in conventional 
anim als fed either diet, fish oil or maize oil, was significantly lower in animals provided 
with green tea beverage compared with animals maintained on normal drinking water. 
Addition of green tea extract to plasma samples immediately prior to development of the 
malondialdehyde-diethylthiobarbituric acid complex had no effect on their 
malondialdehyde content.
Urinary malondialdehyde excretion from animals fed the tocopherol-stripped maize oil diet 
from weaning was significantly greater than that from animals weaned onto a similar maize 
oil diet containing a-tocopherol. Plasma malondialdehyde and ethane exhalation were not 
significantly affected by vitamin E status in animals fed the maize oil diets. Ethane 
exhalation and urinary malondialdehyde excretion from vitamin E-deficient animals fed the 
vitamin E-deficient fish oil diet were significantly greater than that from conventional
anim ais fed a fish oil diet replete in vitamin E. This may have been a reflection of dietary 
peroxidation as well as the deficient nature of the animals. There was no evidence to 
suggest that green tea had antioxidant activity in the vitamin E-deficient animals.
Following the animal studies the methodology for ethane and malondialdehyde analysis 
was transferred to humans. The in vivo antioxidant activity of green tea was then 
investigated in ostensibly health men aged 40-60 years. The study was conducted in 
smokers and non-smokers given a fish oil supplement in an attempt to increase antioxidant 
requirements.
Prior to supplementation, ethane exhalation and urinary malondialdehyde excretion were 
significantly greater from smokers. Plasma malondialdehyde was not significantly affected 
by smoking status. Similarly, there was no significant difference in baseline levels of 
plasma protein carbonyls and lymphocyte DNA oxidation between smokers and non- 
smokers. Plasma antioxidant nutrients were also measured and were found to be 
consistently lower in smokers, with the exception of y-tocopherol which was lower in non- 
smokers. There was, however, considerable inter-individual variability in plasma 
antioxidant nutrient concentrations and differences between smokers and non-smokers did 
not reach statistical significance.
Fish oil supplementation increased plasma and urinary levels of malondialdehyde without 
affecting ethane exhalation in both groups, smokers and non-smokers. The magnitude of 
this effect was greater in smokers. Plasma protein carbonyls also increased in response to 
fish oil supplementation, although there was no change in lymphocyte DNA oxidation. 
Plasma concentrations of a-tocopherol and carotenoids were not significantly affected by 
fish oil supplementation in smokers and non-smokers. Fish oil supplementation did, 
however, result in a significant reduction in non-smokers’ plasma y-tocopherol. Plasma 
triglycerides also decreased during the study, an observation suggestive of compliance 
with the requested consumption of fish oil capsules. With the exception of plasma retinol, 
none of the biomarkers selected were significantly affected by green tea.
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Chapter 1
Introduction
1
1. Exposure to reactive oxygen species
Free radicals are defined as chemical species capable of independent existence with one 
or more unpaired electrons and as such they can be highly reactive. Together with 
some non-radical oxygen-centred species such as hydrogen peroxide, ozone and singlet 
oxygen they constitute reactive oxygen species (ROS) which are capable of damaging 
DNA, proteins and lipids. Ground state molecular oxygen has two unpaired electrons 
in degenerate n antibonding orbitals and is therefore a free radical. Hund’s rule states 
that when two electrons fill degenerate orbitals they have the same spin. The unpaired 
electrons in ground state molecular oxygen are therefore of parallel spin which imparts 
spin restriction on its reactions with non-radicals and makes it poorly reactive. It does, 
however, accept electrons singly and reacts rapidly with carbon-centred free radicals. 
Successive one electron reductions of molecular oxygen yield superoxide radical (0 2_), 
hydrogen peroxide (H^Og), hydroxyl radical ( OH) and water [1]. The intermediates in 
this process, especially the hydroxyl radical, are much more reactive than ground state 
molecular oxygen and are capable of damaging biological molecules.
[1] 0 2 »  0 2- -» 1 %  OH + ELjO -» KjO
The reduction of oxygen to water by NADH and FADH^ is, however, an energetically 
favourable process. This is the driving force of oxidative phosphorylation in the 
mitochondrial electron transport chain and therefore the basis of energy generation in
not, however, appear to be 100 % efficient and leakage of some electrons onto oxygen 
appears inevitable. Reactive oxygen species are also intentionally produced in vivo and 
are an integral part of some biological processes such as the phagocytic burst. Thus, 
although exposure of self tissue to ROS is generally undesirable it is at the same time 
an unavoidable consequence of oxidative metabolism.
1.1. Endogenous sources of reactive oxygen species
1.1.1. Superoxide. It has been estimated that the average human consumes 250 g of 
oxygen per day and that 2-5 % of this is converted to superoxide. Ames et al. (1993)
e' e" +2Ht e- +H+
aerobic organisms. This and other biological processes involving electron transfer do
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have calculated that each cell in the human body is exposed to 1010 molecules of 
superoxide per day. Potential in vivo sources of superoxide include:
(1) leakage of electrons from the mitochondrial electron transport chain. It has been 
estimated from in vitro studies that 1-2 % of the electrons passing down the 
respiratory chain leak onto oxygen. In vivo the degree of electron leakage might be 
significantly lower than this (Frei, 1994). Proposed sites of electron leakage include 
ubiquinone (Forman and Boveris, 1982) and cytochrome b. Reactive oxygen species 
do not, however, appear to be released from cytochrome oxidase (Wilkstrom and 
Morgan, 1992);
(2) autooxidation of haemoglobin (Misra and Fridovich, 1972). Up to 3 % of 
oxyhaemaglobin undergoes autooxidation each day;
(3) leakage of electrons from NADPH cytochrome P450 reductase (Halliwell and 
Gutteridge, 1989). Uncoupling of cytochrome P450 may also result in the formation of 
reactive oxygen species (Gibson and Skett, 1986);
(4) autooxidation of compounds such as flavins, quinones and ascorbic acid.
Despite inactivating some enzymes including catalases and peroxidases (Fridovich, 
1989; Wilkstrom and Morgan, 1992) and components of the mitochondrial electron 
transport chain (Zhang et a l, 1990) superoxide is poorly reactive compared with other 
oxygen-centred free radicals. It cannot, for example, abstract hydrogen atoms from 
R-H bonds with a bond dissociation energy (BDE) greater than 66 kcal mol'1 
(Chaudiere, 1994) and accordingly cannot initiate lipid peroxidation. The toxicity of 
superoxide is therefore generally considered to be due to its role in the formation of 
more reactive species. It reacts rapidly with nitric oxide to form the non-radical 
peroxynitrite (Stamler et a l, 1992). Superoxide can also be transformed to singlet 
oxygen (Wefers and Seis, 1983). In 1934 Haber and Weiss first proposed the 
production of hydroxyl radicals from the reductive cleavage of hydrogen peroxide by 
superoxide [2].
[2] n1o2 + 0 2‘ -» 0 2 + OH- + OH
Although the rate of the Haber-Weiss reaction in aqueous solution was later shown to 
be negligible the formation of hydroxyl radical is still considered a central feature of
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superoxide toxicity. The transition metal ion-catalysed reduction of hydrogen peroxide 
is much more rapid. This is termed the Fenton reaction [3].
[3] H A  + Fe2+ -» OH- + OH + Fe3+
Superoxide can stimulate the Fenton reaction by reducing the oxidized transition metal 
ion, recycling it for further reaction with hydrogen peroxide. Given the amount of 
superoxide present in cells (lO"12 M ) compared with other reducing agents such as 
glutathione, ascorbic acid and NADPH, which are present at concentrations several 
orders of magnitude greater than that of superoxide, its role in reducing transition 
metal ions in vivo has been questioned. Superoxide may also release ferrous iron from 
the storage protein ferritin, supplying the transition metal catalyst required for the 
Fenton reaction. This may be a significant factor in its toxicity given the stringent 
limitation of free transition metals in vivo. Dismutation of superoxide to hydrogen, 
peroxide providing substrate for the Fenton reaction, also occurs rapidly in vivo.
In addition to catalysing the Fenton reaction it has been suggested that superoxide- 
mediated oxidation of iron and copper to Cu3+ and Fe4+ could occur if the redox 
potential of the Cu3+/Cu2+ and Fe4+/Fe3+ couples was lowered by ligation (Czapski et 
al, 1988). Both Cu3+ and Fe4+ are highly oxidizing species.
1.1.2. Hydroperoxyl radical. The conjugated acid of superoxide, the hydroperoxyl 
radical, has a greater oxidation potential than superoxide. In vitro it has been shown to 
abstract hydrogen atoms from bis-allylic methylene groups and initiate lipid 
peroxidation of polyunsaturated fatty acids (PUFA) with a rate constant of IxlO3 M-1 
S"1 (Bielski, 1983). Its formation is, however, pH dependent. At physiological pH it has 
been estimated that only 1 % of superoxide is in this form. The significance of the 
hydroperoxyl radical might be greater in local areas of low pH such as activated 
phagocytes and in the phagocytic vacuole. Its formation does not, however, require a 
transition metal catalyst.
1.1.3. Hydrogen peroxide. Dismutation of superoxide to hydrogen peroxide and 
oxygen occurs at pH 7-2 with a rate constant of 3-8xl05 M"1 s-1 and is accelerated by 
the ubiquitous enzyme superoxide dismutase. The concentrations of hydrogen peroxide 
have been estimated at 10'9 mol/1 and 10-25 pmol/1 in liver and eye respectively. 
Although hydrogen peroxide is not a particularly reactive species it does impair energy 
homeostasis through inhibition of mitochondrial ADP phosphorylation and the
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glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. These effects do, 
however, only occur at concentrations considerably higher than those estimated in vivo 
(Hyslop et a l, 1988).
1.1.4. Hydroxyl radical. The hydroxyl radical is a highly oxidizing species (E° 2-31) 
which can be formed from homolytic fission of covalent bonds in water on exposure to 
background radiation and by the Fenton reaction [3]. It is highly reactive and can only 
difiuse 5-10 molecular orbitals before it reacts with cellular components (Cadenas, 
1989). Hydroxyl radicals will therefore react at or near their site of formation. DNA 
and cellular membranes are both polyanionic structures to which metal cations would 
adhere (Fridovich, 1989). Site-specific hydroxyl radical damage to these important 
cellular components could therefore take place. In addition to hydroxyl radicals higher 
oxidation states of transition metal ions such as ferryl iron may also result from the 
reaction of decompartmentalised haem proteins such as haemoglobin and myoglobin 
with hydrogen peroxide (Sutton and Winterboum, 1989; Turner et a l, 1991). These 
have been suggested to be the main oxidizing species in systems containing myoglobin 
or haemoglobin at low concentrations of hydrogen peroxide (Harel, 1988).
1.1.5. Singlet oxygen. Input of 94 kJ mol-1 into ground state molecular oxygen 
produces the first excited state of singlet oxygen in which one of the unpaired electrons 
changes its spin and pairs with the other in its antibonding orbital. Input of a larger 
amount of energy (157 kJ mol-1) produces a second more excited state of singlet 
oxygen which, because of its extremely short half-life, is not biologically relevant. 
Singlet oxygen is more reactive than ground state oxygen and is, for example, capable 
of reacting with PUFA to form lipid hydroperoxides. Proposed sources of singlet 
oxygen include the reaction of superoxide with glutathione (Wefers and Seis, 1983), 
reaction of hydrogen peroxide with hypochlorous acid (Cadenas, 1989) and peroxyl 
radical recombination reactions (Gardner, 1989). It is also formed by photosensitising 
agents which absorb fight, enter a higher electronic excitation state, and transfer energy 
to oxygen. It has been suggested that substances found in the human body which might 
do this include porphyrins and the bile pigment bilirubin.
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1.2. Reactive oxygen species as useful molecules
Further to originating as accidental by-products of oxidative metabolism ROS are 
emerging as intentionally produced species which have specific biological functions in, 
for example, the immune system and bioregulation. Activation of phagocytic cells 
results in the respiratory burst and production of ROS responsible for destroying 
engulfed microorganisms. The plasma membrane-bound enzyme NADPH oxidase and 
the haemporotein myeloperoxidase catalyse the reduction of oxygen to superoxide and 
the production of hypochlorous acid from chloride ions and hydrogen peroxide 
respectively. Superoxide reacts with hypochlorous acid to give a strong oxidant, 
possibly the hydroxyl radical, while the reaction of hydrogen peroxide with 
hypochlorous acid generates singlet oxygen. Thus a potent cocktail of ROS is 
generated deliberately. Reaction of superoxide with an albumin-bound factor also 
produces a strong neutrophil chemotactic factor important in neutrophil-mediated 
inflammatory events (Petrone et cd., 1980).
Other cell types such as lymphocytes (Maly, 1990), fibroblasts (Murrell et a l, 1990) 
and vascular endothelial cells (Halliwell, 1993) have also been shown to produce 
superoxide. In this instance it may be involved in intercellular signal transduction and 
regulation of cell growth. Indeed both superoxide and hydrogen peroxide have been 
shown to stimulate growth in a variety of mammalian cells in vitro (Burdon, 1994). 
Hydrogen peroxide has also been proposed as a regulator of thyroid hormone 
production through controlling the activity of the enzyme thyroid peroxidase (Dupuy 
e ta l, 1991).
Nitric oxide is another free radical implicated in bioregulation and immunological 
defence. It is produced by cells including endothelial cells, platelets and activated 
macrophages and neutrophils (Efibbs et a l, 1988; Moncada et a l, 1991). Proposed 
regulatory actions include regulation of vascular tone, (Halliwell, 1993), platelet 
aggregation and hormone secretion from the adrenal gland as well as possible actions 
in the central nervous system (Moncada et a l, 1991). Nitric oxide has also been 
proposed as an effector of macrophage toxicity against tumour cells and 
microorganisms that are too large to be phagocytosed. Other cells including 
endothelial cells also synthesise nitric oxide in response to activation by cytokines and 
it has been suggested as a general non-specific host defence response.
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Lipid peroxidation is also deliberately carried out in vivo by lipoxygenase and 
cyclooxygenase enzymes. These enzymes insert one and two molecules of oxygen into 
C20 fatty acids at specific points to form leukotrienes and prostanoids respectively 
(Yamamoto, 1991). Lipid peroxidation may also be involved in regulating enzymes 
such as adenylate cyclase in synaptic membranes (Baba et al., 1981).
1.3. Exogenous sources of reactive oxygen species
Exogenous sources of ROS which may be of significance include air pollution and 
lifestyle factors such as alcohol consumption and smoking.
1.3.1. Ozone. Although it performs an essential fimction in the upper atmosphere 
ozone is a highly oxidizing pollutant in the urban environment. It reacts with biological 
molecules including the amino acids methionine and cysteine and the antioxidants uric 
acid and ascorbic acid to form singlet oxygen (Kanofsky and Sima, 1991). Free 
radicals have also been implicated as intermediates in its toxicity (Morgan and Wenzel, 
1985).
1.3.2. Nitrogen dioxide. Nitrogen dioxide is a free radical produced from vehicle 
exhausts and the combustion of biological material. It can initiate lipid peroxidation 
through both addition to PUFA double bonds or hydrogen abstraction. Below 1000 
ppm hydrogen abstraction is the predominant reaction (Pryor and Lightsey, 1981).
1.3.3. Tobacco smoke. It has been estimated that cigarette smoke contains more than 
1015 carbon- and oxygen-centred free radicals per puff (Pryor and Stone, 1993). 
Despite their short lifetimes high concentrations of free radicals are maintained in 
smoke for more than 10 minutes. These free radicals do not therefore originate in the 
frame, but appear to be produced in a steady state by the slow oxidation of nitric oxide, 
present in smoke at up to 300 ppm, to nitrogen dioxide which then reacts with 
unsaturated compounds to form free radicals (Church and Pryor, 1985). Each cigarette 
smoked also deposits up to 20 mg of tar in the lungs which is washed by the 
pulmonary fluids. The principal radical in tar has been identified as a 
quinone/hydroquinone complex capable of reducing molecular oxygen to superoxide.
1.3.4. Ethanol metabolism. It has been suggested that the activity of alcohol 
dehydrogenase and aldehyde dehydrogenase is accompanied by formation of ROS
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(Bondy, 1992). Ethanol is also known to induce mixed function oxidase enzymes in the 
liver, specifically P4502E1. Uncoupling of this isoform of P450 has been reported to 
produce significant amounts of hydrogen peroxide. Binding of acetaldehyde to 
microsomal mixed function oxidase to form a stable product with impaired properties 
could therefore be a further source of ROS. Acetaldehyde may also convert xanthine 
dehydrogenase to xanthine oxidase and release bound iron, possibly through 
superoxide formation.
2. Damage to biomolecules by reactive oxygen species
Reactive oxygen species are capable of damaging cellular components including 
proteins, lipids and DNA. The most commonly used biomarkers office radical damage 
in humans and animals are lipid peroxidation products. The lipid peroxidation process 
will therefore be briefly reviewed.
2.1. Lipid peroxidation
The lipid peroxidation process was elucidated in detail by Farmer and co-workers in 
the 1940s. A large number of lipid degradation products are formed, some of which 
are toxic. Hie initial step in lipid peroxidation is hydrogen abstraction which can be 
initiated by any species of sufficient reactivity. Free radicals such as the hydroxyl 
radical are capable of initiation [4].
[4] LH + OH -> L* + HgO
The BDE of the C-H bonds from mono-allylic and bis-allylic methylene groups are 88 
kcal mol'1 and 75 kcal mol*1 respectively (Gardner, 1989). Hydrogen abstraction from 
bis-allylic methylene groups, to afford a pentadienyl radical, is thus more energetically 
favourable and polyunsaturated fatty acids are more susceptible to lipid peroxidation 
than saturates and monounsaturates.
Following hydrogen abstraction molecular rearrangement occurs to form a conjugated 
diene structure which characteristic absorption in the range 230-235 nm Possible 
reactions of the conjugated diene include homogenic dimérisation [5] and reaction with 
other membrane components such as proteins. In aerobic organisms a highly probable
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reaction is with molecular oxygen to form a peroxyl radical [6]. This reaction occurs 
readily since there is no spin restriction on the reaction of molecular oxygen with 
carbon-centred radicals.
[5] L + L” »  LL'
[6] L + 0 2 »  LOO*
In the presence of a good hydrogen donor such as another PUFA the peroxyl radical 
can abstract a hydrogen atom to form a lipid hydroperoxide and another carbon- 
centred free radical. This is referred to as the propagating reaction of lipid peroxidation
[7]. A single initiating event can therefore result in conversion of a large number of 
fatty acid side chains to lipid hydroperoxides without the continued presence of the 
initiating species. The length of this chain reaction will depend on factors including the 
ratio of lipid to protein in the membrane and the concentration of chain breaking 
antioxidants. Singlet oxygen (10 2) can also react with PUFA to form lipid 
hydroperoxides [8].
[7] LOO* + L'H -> LOOK + L*'
[8] LH + i0 2 -» LOOK
In competition with hydrogen abstraction are p-scission and cyclisation reactions. 
Through p-scission both the position of oxidation and the geometry of the diene 
conjugate can rearrange. Peroxyl radicals with a double bond located p-y to the carbon 
bearing the peroxyl group can cyclise to form cyclic peroxides. Decomposition of 
cyclic peroxides was proposed as a mechanism of malondialdehyde (MDA) formation 
from PUFA by Dahle et a l (1962). This proposal was, however, later criticised since 
only lipids containing three or more double bonds give appreciable amounts of 
thiobarbituric acid (TBA)-reactive material. Dienoic PUFA can also form cyclic 
peroxides and would therefore be expected to produce MDA. These findings led Pryor 
et al. (1976) to propose a mechanism in which MDA is formed from the 
decomposition of bicyclic endoperoxides (figure 1, page 12). Although dienoic PUFA 
might be able to form a bicyclic endoperoxide structure the radical so produced is 
much less stable than that produced by PUFA with 3 or more double bonds. 
Accordingly a very much smaller yield of the bicyclic endoperoxide is observed from 
dienoic PUFA. More recently other lipid peroxidation products have been identified as
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sources of MDA. These include monocyclic hydroperoxy epidioxides, 1,2- 
dihydroperoxides, 1,4-dihydroperoxides and monohydroperoxides. The yield of MDA 
from these is however only 5 %, IT  %, 0-2 % and 1 % respectively (Frankel and Neff; 
1983).
Other proposed reactions of peroxyl radicals include serial cyclisation for PUFA with 
four or more double bonds, combination to form a peroxide-linked dimer and oxygen 
[9], combination to form a tetraoxide which decomposes into a molecule each of 
alcohol, ketone and singlet oxygen through the Russell mechanism [10] and 
intermolecular addition to olefinic carbons in other PUFA molecules. Reaction with 
other membrane components is also a possibility. .
[9] LOO* + LOO*' -» LOOL* + 0 2
Peroxyl radicals can be regenerated from lipid hydroperoxides in a transition metal 
catalysed reaction [11]. Oxidation of hydroperoxides is, however, a relatively 
unfavourable reaction. The O-H bond has a BDE of approximately 90 kcal mol"1. Its 
one electron oxidative cleavage requires a strong oxidant with a reduction potential 
greater than that of the LOO /LOOH couple (E0' IV). Most ferric complexes do not 
fulfil this requirement. Ferric iron is therefore an inefficient catalyst of this reaction.
[11] LOOH +Fe3+ -» LOO + Fe2+ + H+
The reductive cleavage of lipid hydroperoxides to alkoxyl radicals in a Fenton type
reaction is, however, a more energetically favourable process [12]. The 
LOOHZLO’couple has a reduction potential of approximately 2V and is therefore 
highly oxidizing. Reactions of Fe2+ with hydroperoxides are therefore rapid.
[12] LOOH + Fe2+ -» LO + Fe3+ + OH“
Although not as great as that of the hydroxyl radical, alkoxyl radicals still have
considerable oxidizing power, greater than that of peroxyl radicals. Weakly bonded
L
[10] 2 ^CHOO -»
l /
L
XCHOH + 
LZ
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hydrogens such as those in PUFA are easily abstracted by alkoxyl radicals to form a 
stronger LO-H bond. Other reactions of the alkoxyl radical do, however, appear more 
competitive than hydrogen abstraction. Reaction with other alkoxyl radicals to form 
ether-linked dinners [13] and intramolecular rearrangement to afford an epoxyallylic 
radical are other possible reactions. Epoxyallylic radicals can combine with other 
available radicals or react with oxygen to form the corresponding hydroperoxyl radical. 
Further reactions of this produce a range of products.
[13] LO + L'O* -» LOOL'
Beta-scission of alkoxyl radicals results in the formation of a carbonyl compound and a 
carbon-centred radical. In the case of n-3 fatty acids such as eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) p-scission of the alkoxyl radical formed by 
hydrogen abstraction from C16 and CIS respectively results in formation of ethyl 
radicals. Hydrogen abstraction by this radical produces the hydrocarbon gas ethane. 
Production of ethane from the n-3 fatty acid EPA is illustrated in figure 1.
It can now be seen that lipid peroxidation of PUFA is a highly complicated process 
giving rise to a multitude of products. The relative proportions of each will depend on 
factors including the hydrogen atom-donating capacity of the local environment, 
oxygen concentration and the presence of transition metal ions.
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Figure 1. Formation of malondialdehyde and ethane from 
eicosapentaenoic acid
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3. Endogenous defences against oxidative damage
Antioxidants have been defined as substances which can delay or prevent oxidation of 
a substrate when they are present in small amounts relative to the amount of the 
substrate. In vivo protection against ROS can be considered on several levels:
(1) physical restriction of free radical intermediates of oxidative metabolism, an 
example of which is the tight binding of reduced oxygen by cytochrome oxidase 
(Wilkstrom and Morgan, 1992);
(2) rapid removal of any ROS that are inappropriately formed;
(3) minimising exposure to highly reactive free radicals through sequestration of 
transition metal ions in catalytically inactive forms;
(4) limitation of free radical damage through chain breaking antioxidants.
The focus of this section will be on antioxidant defence mechanisms responsible for 
neutralising ROS and sequestering transition metal ions since these are mechanisms 
through which green tea may reduce oxidative damage.
3.1. Enzymes
3.1.1. Superoxide dismutase. This is a ubiquitous enzyme which accelerates the 
spontaneous dismutation of superoxide to hydrogen peroxide and water [14].
[14] 202- + 2H+ H A  + 0 2
There are two forms of superoxide dismutase in mammals, a copper/zinc enzyme and a 
manganese-containing enzyme, both of which are highly specific for superoxide as 
substrate. Studies of rat liver showed the copper/zinc enzyme to be mainly in the 
cytosol with some possibly located between mitochondrial membranes. An 
extracellular form has also been isolated which appears to be associated with 
endothelial cell surfaces. The manganese-containing enzyme is found in the 
mitochondrial matrix and possibly outside the mitochondria in humans. The rate 
constant for the spontaneous dismutation of superoxide is 5xl05 M-1 s_1 at pH 7-4
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(Fridovich, 1989). That of the enzyme catalysed reaction is ~2.4xl09 M_1 s-1 and ~1.5x 
109 M'1 s'1 for the copper/zinc and manganese enzymes respectively. While the rate 
constant for the uncatalysed reaction is strongly dependent on pH that of the 
copper/zinc enzyme purified from bovine erythrocytes is less dependent on pH 
between pH 5*3 and 9 5.
The mechanism of action of the copper/zinc enzyme appears to be through alternate 
oxidation and reduction of the copper ion with the zinc stabilising the enzyme. The 
redox potential of the copper Cu2+/Cu+ couple is approximately 0-3-0-4V. This is 
midway between the redox potential of the 0 2/0 2' and 0 2‘/H20 2 couples (-0 33V and 
0 89V respectively), making the following reaction sequence feasible.
[15] Cu2+ + 0 2- -» Cu+ + 0 2
[16] Cu+ + 0 2- + 2H+ Cu2+ + H2O2
In the case of the manganese enzyme, changes in valence also appear to occur during 
the catalytic activity of the enzyme.
3.1.2. Catalase. This is a second dismutase which catalyses the dismutation of 
hydrogen peroxide to water and oxygen. It is made up of four subunits, each with a 
haem group at its active site. High concentrations are found in erythrocytes with lower 
levels in brain, heart and skeletal muscle, located primarily in peroxisomes.
[17] 2 ^ 0 ,  »  2H2O + 0 2
The reaction is thought to proceed via the formation of an intermediary ferryl complex 
(compound I) when ferric haem donates two electrons to hydrogen peroxide. Ferric 
haem is then regenerated by reaction with a further molecule of hydrogen peroxide. 
Individuals deficient in catalase show no deleterious physical consequences. The 
significance of catalase in the dismutation of hydrogen peroxide and its importance in 
antioxidant protection has therefore been questioned. It might, however, be of greater 
significance if the cytosolic concentration of hydrogen peroxide increases since 
glutathione peroxidase functions efficiently only at low concentrations of hydrogen 
peroxide (Diplock, 1994). Hydrogen peroxide can cross cell membranes and under 
such conditions could diffuse into peroxisomes.
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3.1.3. Glutathione peroxidase. This is a selenium-dependent enzyme found at high 
activity in the liver with lower activity in heart, lung and muscle. It is made up of 4 
subunits, each of which contains selenium at the active site in a seleneocysteine 
residue. It catalyses the reduction of hydrogen peroxide to water [18] and organic 
hydroperoxides to the corresponding alcohol.
[18] H A  + 2 GSH »  2H^O + GSSG
The catalytic mechanism of the enzyme is complex and does not appear to be fully 
understood. The specificity for glutathione (GSH) as reducing substrate is absolute but 
it will act on hydrogen peroxide and a wide range of lipid hydroperoxides. Its activity 
appears greatest towards hydrogen peroxide.
3.1.4. Phospholipid glutathione peroxidase. Like glutathione peroxidase this is a 
selenium-containing enzyme catalysing the reduction of peroxides. However, unlike 
glutathione peroxidase it is not specific for glutathione as reducing substrate and does 
not require prior hydrolysis of membrane phospholipid hydroperoxides by 
phospholipase Aj before reduction can take place (Thomas et a l, 1990). It can 
therefore reduce lipid hydroperoxides in membranes and has been shown to be strongly 
synergistic with vitamin E in vitro (Maiorino, 1989). Not surprisingly its activity 
towards lipid hydroperoxides is greater than that of glutathione peroxidase while its 
activity towards hydrogen peroxide is lower (Ursini et a l , 1985).
3.1.5. Selenium-independent glutathione peroxidase. Rat liver has been shown to 
possess a small amount of selenium-independent glutathione peroxidase activity 
(Mehlert and Diplock, 1985). This activity appears to be associated with glutathione S- 
transferases and is active towards lipid hydroperoxides but not hydrogen peroxide 
(Lawrence and Burk, 1976).
3.1.6. Glutathione reductase. Although it is not an antioxidant enzyme, glutathione 
reductase is, nonetheless, important in maintaining the reducing capacity of the cell. It 
catalyses the reduction of oxidized glutathione (GSSG) by NADPH [19].
[19] GSSG + NADPH + H+ 2GSH + NADI»
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3.2. Small molecules
3.2.1. cc-tocopherol. This is the most biologically active form of vitamin E and is the 
major chain breaking antioxidant in cellular membranes. It is incoiporated into cellular 
membranes by a specific carrier and displays optimal activity for peroxyl radicals 
(Murphy and Maris, 1981). The rate constants for hydroperoxyl radical reaction with 
a-tocopherol and PUFA in the phospholipid bilayer have been estimated at 4-3 xlO3 
M"1 s-1 and 36 M*1 s-1 respectively (Barclay et a l, 1989). The a-tocopheroxy radical 
formed on hydrogen donation is resonance stabilised and reacts with PUFA with a rate 
constant of 0-024 M-1 S"1 (Ingold et a l, 1993). Alpha-tocopherol is therefore an 
effective inhibitor of lipid peroxidation. It is, however, present at a concentration of 
less than one molecule per 1-2000 membrane phospholipids (Packer, 1992). Further 
oxidation of the a-tocopheroxyl radical gives a-tocopheryl quinone in which the 
chromai ring opens. While a-tocopherol can be regenerated from the a-tocopheroxy 
radical this is not the case for the quinone. There are, however, only small amounts of 
the quinone in animal tissue and the turnover of a-tocopherol is quite small. In vivo 
regeneration of a-tocopherol from a-tocopheroxyl radicals may therefore take place. 
Mechanism have been proposed which involve reduction by other antioxidants 
including vitamin C and glutathione.
3.2.2. (3-carotene. Beta-carotene is an efficient quencher of singlet oxygen, both 
dissipating the energy without chemical change and reacting with it in a process in 
which it is destroyed. It is also highly reactive towards peroxyl radicals
L Burton and Ingold (1984) proposed a 
mechanism in which a peroxyl radical combines with the conjugated system of 13- 
carotene to form a resonance-stabilised carbon-centred free radical. They also state 
that vitamin E is an efficient antioxidant at high oxygen concentrations. By placing 
these two antioxidants at different points in the membrane antioxidant protection may 
therefore be optimised.
3.2.3. Ubiquinol-10. Ubiquinol-10 is a lipid-soluble component of the mitochondrial 
electron transport chain which has been shown to inhibit lipid peroxidation both in 
vitro and in vivo. Frei et al (1990) found it to be equal to a-tocopherol in preventing 
lipid peroxidation in liposomal membranes when present at a concentration similar to 
that found in human tissue. It is found in all membranes in eukaryotic cells, primarily in 
the central plane of the lipid bilayer. The redox-active chromai moiety of a-tocopherol 
is located near the bilayer surface (Perly et a l, 1985). Ubiquinol-10 may therefore
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complement the antioxidant activity of a-tocopherol in biological membranes. It has 
been shown to spare a-tocopherol when both were present in the same liposomal 
membrane, possibly through regeneration of a-tocopherol from the a  -tocopheroxyl 
radical (Frei et al, 1990). Although it does not appear to be regenerated by ascorbic 
acid ubiquinol-10 can be recycled by the mitochondrial electron transport chain. Its 
regeneration is therefore independent of the postulated antioxidant cascade.
3.2.4. Ascorbic acid (vitamin C). In contrast to most other mammals, humans cannot 
synthesise ascorbic acid and must obtain it from the diet. It is, nonetheless, an 
important source of water-soluble reducing power. It can react with aqueous radicals 
such as superoxide, hydroperoxyl and hydroxyl radicals. It is also an efficient quencher 
of singlet oxygen. The one-electron oxidation of ascorbic acid gives the semi- 
dehydroascorbate radical which on further oxidation gives dehydroascorbate. 
Regeneration of ascorbic acid can occur through several routes. Dehydroascorbate can 
be reduced back to ascorbic acid by glutathione, possibly in an enzyme catalysed 
reaction (Winkler et al., 1994). Semi-dehydroascorbate can also be reduced to 
ascorbate by the enzyme semi-dehydroascorbate reductase (Dihberto et a l, 1982). 
Dismutation of semi-dehydroascorbate to ascorbic acid and dehydroascorbate acid is a 
further means of regeneration.
In addition to scavenging aqueous free radicals, an important biological function of 
ascorbic acid might be regeneration of a-tocopherol through an interaction at the 
lipid/cytosol interface. This has been shown to occur in chemical solution and has been 
suggested to occur in vitro in erythrocyte membranes (van den Berg et a l, 1990). 
Conflicting reports exist regarding any interaction between ascorbic acid and a- 
tocopherol in vivo (Burton et a l, 1990; Igarashi et a l, 1991).
3.2.5. Glutathione. The importance of glutathione as reducing substrate for 
glutathione peroxidase enzymes has already been discussed. In addition to this it can 
scavenge free radicals such as superoxide and quench singlet oxygen. Glutathione has 
also been shown to regenerate a-tocopherol in platelet homogenates, possibly via an 
enzyme catalysed reaction (Chan, 1993). Taken with its ability to reduce 
dehydroascofbic acid to ascorbic acid its role as an integral part of the antioxidant 
defence system can be seen. Glutathione is, however, not all good news since its 
reaction with superoxide has been proposed as a source of singlet oxygen.
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3.2.6. Uric acid. Uric acid is generated by the oxidation of purines and is present at 
concentrations of up to 0 5 mM in plasma since humans lack the enzyme required to 
oxidize it further. It is a powerful scavenger of singlet oxygen and peroxyl radicals and 
has been shown to protect red blood cells from peroxidative damage and lysis (Ames et 
al, 1981). Scavenging activity against hypochlorous acid and inhibition of ozone- 
induced degradation of nucleic acid bases has also been observed (Grootveld and 
Halliwell, 1987). Uric acid also forms complexes with ferric iron, decreasing its 
oxidizing potential and inhibiting iron-catalysed ascorbate oxidation and lipid 
peroxidation (Davies et al., 1986).
3.3. Transition metal biochemistry
Humans are exposed to both reduced oxygen species and transition metal ions. 
Preventing any interaction between these is essential if formation of the highly
oxidizing hydroxyl and alkoxyl radical is to be avoided. ___
since free transition metal ions 
are . catalytically active. Minimising their availability is therefore an important 
component of the antioxidant defence system The presence of free iron in plasma is 
prevented by the iron transport protein transferrin, present at T2-2-0 mg/ml This is 
usually only 30 % saturated and can therefore bind any free iron. Iron bound to 
transferrin cannot participate in the Fenton reaction or catalyse the decomposition of 
lipid hydroperoxides (Halliwell et a l, 1988). The potential of the iron storage protein 
ferritin to form oxygen radicals is also minimal (Singh, 1994). The availability of free 
copper is limited by the protein ceruloplasmin. Albumin also has specific binding sites 
for Cu2+ ions, some of which become less available for reaction on binding (Halliwell,
1988). Some are, however, still accessible and can catalyse the Fenton reaction. Any 
hydroxyl radicals formed appear to react at the site of formation, namely albumin, and 
are not released into solution. In this regard albumin can be considered a sacrificial 
antioxidant, protecting other more essential biological components. Ceruloplasmin also 
has ferroxidase activity oxidizing ferrous iron and reducing oxygen to water without 
releasing reduced forms of oxygen. It can also scavenge superoxide (Monterio et a l,
1989).
Although the availability of transition metals may be limited in plasma, intracellular 
exposure to free transition metals might be unavoidable between their release from 
storage or transport proteins and incorporation into metalloproteins. The existence of a 
low molecular weight pool of iron bound to ligands such as ATP, AMP and citrate has
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been proposed. Of the proposed ligands, citrate appears to be the most catalytically 
active (Baker and GeboM, 1986). Indeed complexes of ferric iron with ATP and citrate 
have been shown to reduce hydrogen peroxide (Puppo, 1992). The size and existence 
of this iron pool does, however, appear a matter of speculation.
The availability of free transition metal ions may increase during oxidative stress. 
Radicals with a redox potential lower than that of ferric iron in the central core of 
ferritin (-0-23 V) have been shown to catalyse its reduction and release (Montinerio et 
al, 1989). This includes superoxide which at physiological pH releases ferrous iron 
from ferritin with a rate constant of 2xl06M"1 S’1 (Buettner, 1987). Indeed ferritin has 
been shown to catalyse lipid peroxidation in the presence of oxygen radicals (Roster 
and Slee, 1986). Transferrin and lactoferrin do not, however, generate hydroxyl 
radicals from hydrogen peroxide and superoxide unless a strong chelating agent is 
present (Amoma and Halliwell, 1987).
4. Biomarkers of damage caused by reactive oxygen species
To investigate the in vivo antioxidant activity of green tea, reliable biomarkers of ROS 
damage are required. Measurement of lipid peroxidation products has been and 
remains the most commonly used method of assessing oxidative damage in humans and 
animals and will be the main focus of this section.
Several different lipid peroxidation products are currently available for this purpose. 
This is, however, indicative of the fret that no single product is universally accepted as 
ideal The methodology used to measure a particular lipid peroxidation product can 
also vary considerably. Baseline values for the same product measured in healthy 
humans using slightly different methods may vary by as much as a factor of 10. 
Relating lipid peroxidation to biological damage can also be difficult. For example, 
smoking has been shown to increase oxidative damage measured by pentane 
exhalation. In the same study other assays of lipid peroxidation were, however, 
uneffected by smoking (Allard et a l, 1994a). When assessing biological damage by 
ROS, measurement of as many biomarkers as possible is therefore desirable. Assays for 
oxidative damage to proteins and DNA are now available. The use of these in 
combination with lipid peroxidation products should facilitate a more meaningful 
assessment of in vivo free radical damage.
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Lipid peroxidation products commonly used in in vivo investigations include 
conjugated dienes, the hydrocarbon gases ethane and pentane and the aldehyde 4- 
hydroxylnonenal. Perhaps the most commonly used biomarker of oxidative damage is, 
however, the thiobarbituric acid reactive substance (TEARS) assay. This is a simple 
procedure which measures both preformed MDA and that formed from the 
decomposition of lipid hydroperoxides during the assay. The measurement of TEARS 
in biological samples is, however, heavily criticised. Pryor et a l (1976) postulated that 
MDA is formed by the decomposition of bicyclic endoperoxides. The TEARS value 
will therefore encompass prostaglandin endoperoxides such as prostaglandin G2 
(PGG2) and prostaglandin Hg (PG ty. Malondialdehyde is also produced in the 
synthesis of the prostanoids thromboxane A  ^ and hydroxy-5,8,10-heptadecatrienoic 
acid from PGH^ (Janero, 1990). Equimolar amounts of each of these are produced in a 
reaction catalysed by thromboxane synthase. Degradation of a variety of non-lipid 
biomolecules including proteins, bile pigments nucleic acids and carbohydrates has also 
been suggested to yield MDA. Many other compounds will react with TEA to form 
adducts which absorb at or very near to the same wavelength as the genuine TBA- 
MDA adduct. Apart from these biological considerations the assay itself is also 
problematic. The composition of the sample in addition to its content of lipid peroxides 
and MDA can have a considerable affect on its TEARS value. Results are also 
dependent on the reaction conditions and detection method used.
The measurement of conjugated dienes in human material is another relatively simple 
procedure which has received criticism. Compounds present in biological material such 
as haem proteins, purines and pyrimidines also absorb UV light and create a high 
background. The compound octadeca-9(c/s)l l(/ra/zs)-dienoic acid, an isomer of 
linoleic acid, has been found to be responsible for most of the UV-absorbing material 
in human samples (Dormandy and Wickens, 1987). Peroxidation of biological 
membranes would be expected to produce carbon-centred radicals from several fatty 
acids, not only linoleic add. Thompson and Smith (1985) suggested that octadeca- 
9(c/s)ll(/r<ms)-dienoic acid may come from the diet and bacterial metabolism rather 
than in vivo lipid peroxidation.
TTie measurement of ethane and pentane is also not without criticism Ethane, and to a 
greater extent, pentane are both metabolised by the liver. Any changes in metabolism 
will therefore alter exhalation independent of production. The use of this parameter has 
also been criticised because of possible interference from alkanes produced by the 
gastrointestinal flora. The low levels of alkanes in human breath in relation to
20
atmospheric air mean that strict collection and concentration procedures are required 
prior to analysis. Alkane analysis can therefore be time consuming and expensive.
More recently the measurement of prostaglandin F2-like compounds (F2 isoprostanes) 
formed by the action of free radicals rather than cyclooxygenase activity has been 
proposed as a biomarker of lipid peroxidation in biological fluids (Morrow et al, 
1990b). Potential problems associated with this assay include relatively high 
background levels present in plasma and urine and differentiating free radical-derived 
compounds from prostaglandin F2 metabolites of cyclooxygenase (Morrow and 
Roberts, 1991).
A general point to consider when measuring lipid peroxidation in biological fluids, 
particularly plasma, is that peroxidation of lipids present in the sample may occur 
during handling and storage. Both the TEARS value and F2 isoprostane concentration 
(Morrow et a l, 1990a) in plasma increase on storage. Analysis of these biomarkers 
must therefore be carried out as soon as possible after sample collection. From a purely 
practical point of view measurement of alkanes in breath is therefore advantageous 
since, providing adequate storage procedures are observed, sample analysis does not 
have to be carried out directly after collection.
5. Reactive oxygen species, antioxidants and disease
5.1. Reactive oxygen species in disease
Despite the antioxidant defence system present in the human body some damage to 
biomolecules appears to be an inevitable consequence of exposure to ROS. Indeed it 
has been estimated that there are 10,000 oxidative modifications on the DNA of each 
human cell per day (Ames et a l, 1993). Enzymes exist to repair this damage but are 
not 100 % efficient and oxidative DNA lesions accumulate with age (Fraga et a l,
1990). Similarly, oxidatively modified proteins also accumulate with age (Oliver et a l, 
1986; Stadtman, 1992). A recent review by Gutteridge (1993) fists over 100 diseases 
and chemical toxicities in which free radicals have been implicated. Not surprisingly 
these include some age-related diseases. Free radicals have even been implicated in the 
ageing process itself (Harman, 1981). Caution must, however, be exercised when ROS 
damage is detected before it is implicated as the causative agent in a disease. Reactive 
oxygen species may arise secondarily to tissue damage and cellular disruption resulting
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from the primary lesion. Thus, although they may contribute to the disease pathology 
they are not necessarily the causative agent. Reactive oxygen species are, however, 
implicated as a causative agent in some conditions including emphysema and 
atherosclerosis. Reactive oxygen species have also been implicated in cancer related to 
chronic infection. While of obvious benefit in the short term, products of phagocytic 
cells are also capable of damaging DNA (Weitzman and Stossel, 1981; Weitberg et a l, 
1983). This has been estimated to contribute to one third of the world’s cancers (Ames 
et a l, 1993). Examples of infection-related cancer include hepatocellular carcinoma in 
hepatitis sufferers and stomach cancer associated with Helicobacter pylori infection. In 
addition to a role in these chronic conditions ROS have also been implicated in acute 
cellular damage in reperfusion injury following ischaemia.
It can now be seen that formation of ROS is an ongoing and unavoidable process and 
that some biological damage appears an inevitable consequence of this. Any imbalance 
in the oxidant/antioxidant ratio in favour of the oxidant, a condition termed "oxidative 
stress", could therefore increase biological damage with pathological consequences. 
Conversely enhancement of antioxidant defences could have health benefits. A 
potential benefit for antioxidants in acute medicine is in the reduction of reperfusion 
injury following ischaemia. In this situation the iron chelator desferrioxamine (Singh 
and Hider, 1994) and the antioxidant enzymes superoxide dismutase and catalase 
(McCord, 1985) have been shown to reduce injury and maintain organ function 
respectively. Desferrioxamine has also been shown to enhance the viability of 
transplanted tissue. Certain fiavonoids may be of significant benefit in ameliorating 
reperfusion injury since not only have they been shown to scavenge free radicals and 
sequester transition metal ions but they also inhibit xanthine oxidase. These same 
fiavonoids have, however, also been shown to be mutagenic (Robak and Gryglewski, 
1988).
In ostensibly healthy individuals ROS damage does not appear to be life threatening in 
the short term, rather it appears to be associated with degenerative diseases such as 
cancer and heart disease. These are two of the principal causes of death in elderly 
people. The most significant health benefits of antioxidants might therefore be seen in 
the long term in prevention of these diseases. This is of course of even greater 
significance for individuals chronically exposed to ROS through smoking or chronic 
infection. The potential benefit of antioxidants is illustrated in studies which have 
shown that dietary supplementation with antioxidants increases the life-span of mice
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and rats (Harman, 1981). It has also been the subject of epidemiological investigation 
and a more limited number of intervention trials in humans.
5.2. Evidence for the health benefits of antioxidant nutrients
5.2.1. Epidemiology. The status of an individual’s antioxidant defences can, at least in 
part, be investigated by measuring dietary intake and plasma levels of antioxidant 
nutrients. This possibility has resulted in a large number of observational 
epidemiological studies investigating any association between these nutrients and 
cancer development (reviewed by Byers and Perry, 1992; Comstock et a l, 1992; Burr 
1994). Although not entirely consistent, the majority of these studies suggest that 
individuals with a higher intake of vitamin C, vitamin E and P-carotene are at a 
reduced risk of developing cancer compared with individuals with a lower intake.
The results of two large scale population studies investigating the relationship between 
dietary intake of antioxidant nutrients and coronary disease have also been published 
recently. The Health Professionals Follow-up Study is a prospective study of nearly 
40,000 men aged 40 to 75 years (Rimm et a l, 1993). After a 4-year follow-up period 
those in the highest quintiles of total dietary vitamin E and p-carotene intake (including 
supplements) had an age-adjusted relative risk of coronary disease of 0 59 and 0 71 
respectively compared with men in the lowest quintile of intake. After adjustment for 
use of other antioxidants no protective eftect of vitamin C was seen. The Nurses 
Health Study is a similar study of 90,000 female nurses (Stampfer et a l, 1993). 
Women in the highest quintile of vitamin E intake had a relative risk of coronary 
disease of 0-66 compared with women in the lowest intake group after adjustment for 
age and smoking.
Correlations between antioxidant nutrients and cataract development have been 
reviewed by Christen (1994). The results of these studies appear mixed. A decreased 
risk of cataract formation may be associated with certain nutrients and not with others 
in one study while in another study the protective and ineffective nutrients might be 
reversed. In other studies antioxidant nutrients have been found to be a risk factor for 
cataract development. The number of studies investigating this is, however, small.
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5.2.2. Intervention trials. Observational epidemiological studies are inherently 
vulnerable to confounding factors. Individuals with a higher intake of antioxidant 
nutrients may differ from those with lower intakes in a number of ways that are 
predictive of disease. They might, for example, be generally more health conscious and 
take more exercise or smoke less. Although many of these factors can be controlled for 
the possibility that unidentified dietary or lifestyle factors associated with dietary intake 
of antioxidant nutrients could at least be contributing to any protective effect seen 
cannot be ruled out. For example, although fruit and vegetables are, supplements aside, 
the principal dietary sources of vitamin C and P-carotene they also contain a variety of 
other compounds in addition to these nutrients. Difficulty in accurately ascertaining 
dietary intake of antioxidant nutrients is a further possible limitation. This is essential in 
order to estimate relative risk for different intake levels. The results of the Health 
professionals study are, however, consistent with a role for vitamin E rather than 
dietary factors associated with its intake in preventing coronary artery disease. 
Individuals taking specific vitamin E supplements had a multivariate relative risk of 
coronary disease of 0-75 compared with non-supplement users. Similarly, the relative 
risk of coronary heart disease was lower in women who took multi-vitamins or specific 
vitamin E supplements compared with non-supplement users in the Nurses Health 
Study. Confounding lifestyle factors associated with supplement use cannot, however, 
be ruled out.
Even if antioxidant nutrients are responsible for any protective effect seen their 
mechanism of action might not be solely due to their radical scavenging properties. 
V itamin C can inhibit endogenous formation of carcinogenic nitrosamines and 
nitrosamides in the stomach by reducing nitrite (Mirvish, 1994). Vitamin C and 
carotenoids might also enhance the immune system, reducing cancer risk by enhancing 
tumour surveillance (Byers and Perry, 1992).
Confounding variables can be minimised in intervention trials in which volunteers are 
given supplements of the antioxidant nutrients suggested from observational studies to 
have a protective effect. Intervention trials are, however, not without their limitations. 
They are, for example, generally conducted over a fraction of the human lifetime while 
cancer may take many years to develop. The protective effect of antioxidant nutrients 
may also depend on their aggregate action. Supplementation with a single antioxidant 
nutrient may therefore be ineffective.
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The results of two large scale intervention studies have been published recently. Blot et 
al (1993) investigated the effect of combinations of nutrients in nearly 30,000 adults 
(40—69 years) from T.irman county China. This is an area with one of the world’s 
highest rates of oesophageal cancer and whose residents have low blood levels of 
several micronutrients including retinol, vitamin C, vitamin E and p-carotene compared 
with western standards. Daily supplementation with a combination of a-tocopherol (30 
mg), p-carotene (15 mg) and selenium (50 jig) for 5lA years reduced overall mortality 
by 9 % and that from oesophageal cancer by 10 %. This effect was, however, not seen 
with other combinations of micronutrients, one of which included vitamin C. In a study 
of 29,133 male Finnish smokers supplementation with a-tocopherol for 5-8 years had 
no significant effect on lung cancer development (a-tocopherol Study Group, 1994). 
In the same study the incidence of lung cancer was 18 % higher in volunteers 
supplemented with P-carotene. Beta-carotene was also associated with an increased 
incidence of ischaemic heart disease. The benefit of antioxidant supplementation in well 
nourished individuals, even in those exposed to increased levels of free radicals 
through smoking, is therefore, at present, unproved. Indeed the results of the Finnish 
smokers trial suggest that P-carotene may increase cancer in smokers. Ongoing studies 
such as the P-carotene and retinol efficacy trial (CARET) (Omenn et a l, 1994) 
investigating the efficacy of P-carotene and retinol in lung cancer prevention in 
smokers and men with extensive occupational exposure to asbestos will help to clarify 
this.
6. Antioxidant activity of the antioxidants
Data from observational epidemiological studies suggest that antioxidant nutrients 
present in the diet may be protective against degenerative diseases. Although this is a 
highly plausible explanation for the suggested health benefits of fruit and vegetables it 
is by no means the only one and it would be an over-interpretation of the results to 
attribute the effects seen solely to these nutrients. Supplementation studies allow us to 
be more firm in our assignment of the protective effect to specific nutrients. These 
studies are, however, far fewer in number and are by no means conclusive in their 
results. By design, as many subjects are enrolled as is practically possible, often at 
multiple centres. Measurement of biomarkers of ROS damage is therefore generally 
not a practical proposition.
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A number of smaller-short term supplementation studies have been conducted in which 
ROS damage has been defined as the primary end point. Dixon et al (1994) found that 
feeding a low carotene diet to "normal" (defined here as ostensibly healthy individuals 
with no apparent nutrient insufficiency and no recorded lifestyle factors associated with 
oxidative stress) women for 68 days caused a five-fold increase in plasma TEARS and 
increased the susceptibility of low density lipoprotein (LDL) to oxidation. After a 
further 28 days re-feeding (3-carotene (15 mg/day) plasma TEARS returned to 
baseline. Supplementation at this level did not, however, reduce plasma TEARS below 
baseline values. Allard et a l (1994a) found that supplementation with 20 mg 13- 
carotene for 4 weeks resulted in a statistically significant reduction in lipid peroxidation 
in smokers but not non-smokers. Gottlieb et al (1993) also found that 
supplementation with very high levels of p-carotene significantly reduced lipid 
peroxidation. This study was, however, carried out in individuals fed a carotene-ftee 
diet for two weeks prior to P-carotene supplementation. As a result of this they were 
deficient in p-carotene at the start of the supplementation period. The results of this 
study do not therefore tell us the effect of p-carotene supplementation on lipid 
peroxidation in normal individuals replete in P-carotene. Winklhofer-Roob et al 
(1995) investigated the effect of p-carotene supplementation on lipid peroxidation in 
cystic fibrosis patients. Compared with healthy controls, patients were severely 
deficient in p-carotene and had significantly higher plasma TEARS. Supplementation 
with 0 5 mg/kg p-carotene for 3 months normalised both plasma TEARS and plasma 
p-carotene. Interestingly this effect was seen despite the fact that patients were all long 
term users of vitamin E supplements and had plasma a-tocopherol levels not 
significantly different from the controls. Taken together these studies indicate that p- 
carotene supplementation reduces lipid peroxidation in individuals suffering from p- 
carotene deficiency or exposure to free radicals but appears ineffective in reducing lipid 
peroxidation below baseline values measured in normal individuals.
A similar effect has been observed for other antioxidant nutrients. In men with low 
antioxidant nutrient status supplementation with a combination of a-tocopherol, p- 
carotene, vitamin C and selenium for 5 months significantly decreased serum lipid 
peroxides, an effect which appeared greatest in smokers (Salonen et a l, 1991). 
Conversely supplementation of normal individuals with a combination of P-carotene, 
vitamin C and a-tocopherol for 6 months had no significant effect on uninduced LDL 
TEARS, despite causing a significant increase in the concentration of all three nutrients 
(Abbey ef a/., 1993).
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Antioxidant nutrients have also been shown to attenuate lipid peroxidation associated 
with increased oxidant load. Vitamin E has been shown to decrease pentane exhalation 
measured in smokers after overnight abstention ftom smoking (Hoshino et a l, 1990). 
Similarly, supplementation with vitamin C or vitamin E for 4 weeks nullified the 
increase in plasma and LDL TBARS seen after smoking 5-7 cigarettes over a 90 
minute period (Karats et a l, 1990). Vitamin E has also been shown to counteract the 
increase in lipid peroxidation seen on giving fish oils to smokers and non-smokers 
(Haglund et a l, 1991; Karats et a l, 1991). A combination of antioxidant nutrients 
given at a high dose for 3 months significantly reduced pentane exhalation and serum 
TBARS measured in non-smoking young men after vigorous physical exercise (Kanter 
et a l, 1993). Daily supplementation with a-tocopherol acetate for 4 weeks has also 
been shown to attenuate exercise-induced lipid peroxidation (Sumida et a l, 1989).
A limited number of studies have also shown antioxidant supplementation to reduce 
lipid peroxidation in normal individuals. Daily supplementation with a-tocopherol for 
10 days significantly reduced pentane exhalation (Lemoyne et a l, 1987). In a 
subsequent study by the same group supplementation with a-tocopherol acetate was 
again found to decrease pentane exhalation in healthy volunteers (Van Gossum et a l, 
1988a). Unfortunately the authors did not state the smoking status of the subjects used 
in either of these studies. The reported levels of pentane exhalation were, however, 
consistent with those found in non-smokers in a subsequent study by the same group 
(Hoshino et a l, 1990).
The ability of antioxidant supplementation to reduce lipid peroxidation has thus been 
demonstrated in individuals subject to mild oxidative stress, be it through nutrient 
insufficiency, fish oil supplementation, smoking or vigorous physical exercise. The 
capacity of antioxidant supplementation to reduce lipid peroxidation in individuals 
replete in antioxidant nutrients and not exposed to any of the other factors listed above 
is, however, less clearly demonstrated. One could take the view that over the course of 
evolution the human body has developed an antioxidant defence system adequate to 
deal with basal ROS production in individuals not suffering ftom disease or exposed to 
other risk factors associated with ROS. Healthy individuals might therefore have no 
need for additional antioxidants which would explain the apparent non-effect of 
antioxidant nutrients seen in some studies. Some ROS damage does, however, appear 
to slip through the in vivo defence and repair system, comprehensive though it may be, 
to cause biological damage. Indeed Harman (1981) even suggests a role for ftee 
radical damage to DNA in evolution. Increasing the activity of either specific or non­
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specific antioxidant defence mechanisms could thus be of benefit, even to normal 
healthy individuals. Antioxidant supplementation might therefore have a slight effect in 
normal individuals which is too small to be detected by the assays commonly used to 
monitor oxidative damage. Over the course of a lifetime such a small undetectable 
reduction in oxidative damage could be significant in protecting against degenerative 
diseases. From the practical point of view it does, however, appear prudent to impose 
a mild oxidative stress, preferably in combination with antioxidant nutrient deficiency, 
when investigating the in vivo antioxidant activity of a compound or dietary 
component, fix this regard smokers appear an ideal study group since they are both 
deficient in antioxidant nutrients and exposed to free radicals from cigarette smoke and 
tar and the pro-inflammatory effects of smoking.
7. Fruit, vegetables and disease prevention
A recent review by Block et al (1992) summarises studies investigating the possibility 
of a negative association between fruit and vegetable consumption and cancer 
development. Out of the 156 studies reviewed, 128 reported fruit and vegetables to be 
protective against a range of cancers including those of the respiratory and digestive 
tracts, breast and bladder. Only four studies found an increased risk of cancer 
associated with fruit and vegetable intake. For most cancer sites individuals with the 
lowest intake of fruit and vegetables experienced approximately twice the risk of 
cancer development compared with those in the highest intake group. Declining heart 
disease in the United States has also been associated with increasing fruit and vegetable 
consumption.
Although fruits and vegetables are, supplements aside, the principal dietary sources of 
vitamin C and p-carotene (Byers and Perry, 1992) they also contain a mixture of other 
nutrient and non-nutrient compounds. A study by Wu et al (1987) of colorectal cancer 
in a cohort of 11,888 men and women is suggestive of beneficial effects of other 
components of fruit and vegetables in addition to antioxidant nutrients. A significant 
inverse association between dietary vitamin C (excluding supplements) and cancer risk 
was observed. However, neither vitamin C from supplements or total vitamin C, 
accounting for diet and supplements, showed the same protective effect. Other 
components of fruit and vegetables could therefore contribute to the protective effects 
attributed to antioxidant nutrients in the studies reviewed in section 5.2.1 and to those 
seen for fruits and vegetables themselves in the studies reviewed by Block et al
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(1992). One such group of compounds of current interest are the fiavonoids. In the 
current climate of intense interest in the antioxidant nutrients it is important not to lose 
site of this and the benefit of eating a diet rich in finit and vegetables in addition to 
simply taking vitamin pills.
7.1. Fiavonoids
Fiavonoids are a diverse subgroup of polyphenolic non-nutrient compounds which are 
widespread throughout the plant kingdom Concentrations in plant cells often exceed 1 
mM while human consumption has been estimated at 1 g/day of mixed fiavonoids 
(Middleton, 1984). Proposed functions within the plant include:
(1) a signal for pollinating insects for the intensely coloured flavonols and 
anthocyanidins in flower petals;
(2) feeding repellants for the astringent flavanols and condensed tannins;
(3) scavenging of superoxide for the flavonols kaempferol and quercetin (Bors and 
Saran, 1987).
Fiavonoids, with their strong absorption in the 300-400 nm UV region may also act as 
light filters and protect chloroplasts and other cellular components ftom UV damage 
(Caldwell et al. 1983).
Interest in the biological activity of dietary fiavonoids was stimulated in the late 1930s 
with the discovery of their vitamin C-sparing and anti-scurvy properties which gave 
rise to the short-lived proposal of vitamin P. Since then fiavonoids have been attributed 
a variety of physiological effects including anti-inflammatory, anti-allergic and anti- 
haemorrhagic activities (Havsteen, 1983; Middleton, 1984). Recently, intake of 
fiavonoids has been associated with a decreased risk of death from coronary heart 
disease and a lower incidence of myocardial infarction in elderly men (Hertog, 1993). 
The underlying biochemical mechanisms behind the proposed biological actions of 
fiavonoids may be complex. However, with the recognition of the harmful effects of 
ROS their well known antioxidant properties are of particular interest. These along 
with other possible mechanisms through which fiavonoids could protect against 
degenerative diseases will be briefly discussed. Since the focus of the work described in
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this thesis is on green tea, which is a rich source of flavan-3-ols (catechins), emphasis 
will be placed on the properties of catechins in relation to other well studied 
fiavonoids, most particularly quercetin.
7.1.1. Radical scavenging activity. Fiavonoids have been shown to possess radical 
scavenging activity against a variety of free radicals. Husain et a l (1987) found the 
flavonols quercetin and myricetin to be the most efficient flavonoid scavengers of 
hydroxyl radicals, showing activity greater than that of (+)-catechin. Scavenging 
activity was directly related to the number of hydroxyl groups substituted in the B ring 
with substitution at C-31 of particular importance. The presence of a carbonyl function 
at C-4 was also suggested as an important structural feature. Quercetin and myricetin 
have also been shown to be the most effective flavonoid scavengers of superoxide, 
again having greater activity than (+)-catechin (Robak and Gryglewski, 1988). Sichel 
et al (1991) also found quercetin to be the most effective flavonoid scavenger of 
superoxide. The presence of hydroxyl groups in the B ring was found to be essential 
for this activity. The introduction of an OH group at position 3 also increased 
scavenger activity. Fiavonoids have also been shown to inhibit air oxidation of linoleic 
acid in aqueous media (Torel et a l, 1986). The proposed mechanism was through 
hydrogen atom donation to peroxyl radicals. Although Bors et al (1990) suggest that 
scavenging against specific radicals in the studies of Torel et a l (1986), Husain et al 
(1987) and Robak and Gryglewski (1988) may be an overinteipretation of the results 
these studies do, nevertheless, demonstrate the radical scavenging activity of 
fiavonoids and the importance of hydroxyl groups in this activity. In agreement with 
this Cotelle et a l (1992) also concluded that the presence of a catechol structure in the 
B ring is responsible for radical scavenging activity.
The antioxidant activity of a compound is a function of the reactivity of the secondary 
radical formed on reaction with the primary radical as well as its radical scavenging 
properties and concentration. A highly reactive secondary radical will propagate rather 
than terminate a chain reaction. In a study of 15 structurally different fiavonoids Bors 
and Saran (1987) found rapid formation of flavonoid aroxyl radicals on reaction with 
azide. The relative stability of these radicals was however, found to vary considerably. 
Substances with a catechol structure on the B ring were found to form the most stable 
radicals. Accordingly (+)-catechin formed a relatively stable radical.
Fiavonoids have also been shown to quench singlet oxygen (Sorata et a l, 1984). The 
presence of a C2-C3 double bond and 3-hydroxyl group appears to be a key factor in
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chemical reactivity with singlet oxygen. Fiavonoids with a catechol structure on the B 
ring are the most efficient physical quenchers. Out of the 13 fiavonoids studied, 
including flavonols, flavones and flavanones, (+)-catechin was found to be the most 
efficient quencher of singlet oxygen while at the same time being chemically inert 
towards it (Toumaire et al., 1993).
These studies demonstrate the capacity of fiavonoids to neutralise ROS in vitro and the 
importance of B ring hydroxyl groups in this activity. If  flaovnoids were to display 
such activity in vivo the significance of an estimated dietary intake of 1 g can be seen. 
This and other biological properties of fiavonoids will depend on their bioavailability 
(see section 7.1.5).
7.1.2. Effect on enzymes. In addition to scavenging free radicals fiavonoids may also 
reduce ROS damage through modulating the activity of certain enzymes. Quercetin 
and morin have been shown to inhibit neutrophil NADPH oxidase in a broken cell 
assay (Tauber et a i, 1984). Unlike morin, quercetin also inhibited oxygen consumption 
in whole cells. This activity may be related to the relative hydrophobicity and the 
degree to which they permeate the cell membrane. Quercetin has also been shown to 
inhibit neutrophil myeloperoxidase and scavenge hypochlorous acid (Pincemail et a l, 
1988). If it were to occur in vivo this anti-inflammatoiy activity could be of benefit to 
individuals such as smokers suffering from chronic inflammation.
Quercetin is also an inhibitor of lipoxygenase-dependent oxidation of linoleic acid in 
vitro. Reduction of the free radical intermediates generated by the enzyme rather than 
direct inhibition of the enzymes or its reaction with substrate has been suggested to 
account for this activity (Takahama, 1985). Laughton et a l (1991) also demonstrated 
that in vitro enzymic lipid peroxidation was inhibited by a range of fiavonoids. The 
majority of the fiavonoids tested were found to be selective inhibitors of either 
cyclooxygenase or lipoxygenase. They suggested that inhibition was not simply due to 
interception of radicals generated at the active site of the enzyme.
Fiavonoids including the flavonols quercetin and myricetin have been shown to inhibit 
mitochondrial respiration and to induce a respiratory burst with concomitant formation 
of ROS (Hodnick et a l, 1986). Catechins were, however, ineffective on both accounts.
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7.1.3. Pro-oxidant activity. The antioxidant activity of a compound may depend on 
the experimental conditions under which the investigation is carried out as well as its 
own intrinsic properties. For example, while ascorbic acid is universally recognised as 
an antioxidant it has also been shown to have pro-oxidant activity in the presence of 
transition metal ions. The same appears be true for fiavonoids. Laughton et al (1989) 
found that addition of quercetin and myricetin to a reaction mixture containing Fe3+- 
EDTA and hydrogen peroxide caused an approximately six-fold increase in hydroxyl 
radical formation. The mechanism proposed was one in which oxidation of the phenol 
produced superoxide which reduced the Fe3+-EDTA complex, recycling catalytic iron 
for the Fenton reaction. When EDTA was replaced with more physiologically relevant 
ligands such as citrate or ADP no increase in hydroxyl radical production was seen. 
Puppo (1992) also found fiavonoids to enhance hydroxyl radical formation from 
hydrogen peroxide in the presence of Fe3+-EDTA. Again the fiavonoids tested had no 
effect on hydroxyl radical generation when complexes of ferric iron with ATP or 
citrate were used. Puppo pointed out the critical importance of flavonoid oxidation and 
reinforced Laughton’s theory that the fiavonoids act by redox-cycling the iron. Canada 
et al. (1990) also demonstrated autooxidation of quercetin and production of ROS.
In addition to redox cycling iron, plant phenols have been shown to release iron from 
ferritin, a property which correlated with their reduction potential (Boyer et a l, 1988). 
Thus not only do fiavonoids have the potential to stimulate the Fenton reaction but 
they may also release the iron catalyst required.
The results of these studies demonstrate that fiavonoids have both antioxidant and pro­
oxidant character in vitro, depending on the experimental conditions employed, and 
cannot simply be classed as antioxidants. Their ability to behave as pro-oxidants in vivo 
will depend on the presence of endogenous iron chelators with redox properties similar 
to that of EDTA. In this regard Laughton et a l (1989) noted that some fiavonoids 
accelerate the oxidative modification of human low density lipoprotein and this 
possibility cannot be ruled out.
7.1.4. Mutagenicity and carcinogenicity. In addition to possessing radical 
scavenging activity some fiavonoids have been shown to be mutagenic in the Ames test 
(Brown, 1980). Most notably quercetin, one of the most biologically active fiavonoids 
with the greatest radical scavenging activity, also appears to be the most potent 
flavonoid mutagen. The presence of the fiavonol structure appears to be a basic
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requirement for mutagenesis. Fiavonol aglycones are mutagenic while the 
corresponding glycosides are not. (+)-Catechin does not possess the fiavonol structure 
and accordingly dose not display mutagenicity when tested in several Salmonella 
strains (Brown, 1980).
Concurrent with reports of the direct mutagenesis of quercetin and other flavonols are 
studies which show these same flavonols inhibit the mutagenesis of benzo[a]pyrene 
(Das et a l, 1994). Inhibition of monooxygenase-dependent activation or interaction 
with the ultimate mutagen have both been suggested.
Despite the in vitro mutagenicity of quercetin, studies investigating its in vivo 
carcinogenicity are predominantly negative. Morino et al (1982) found that quercetin 
and the quercetin glycoside rutin were not carcinogenic when given to golden hamsters 
at up to 10 % of the diet for 2 years. Similarly quercetin has been reported to be non- 
carcinogenic in ddy mice, strain A mice and ACI rats (Das et a l, 1994). Pamukcu et 
al ( 1980) have, however, found quercetin to be a rat intestinal and bladder carcinogen 
when given as 0-1 % of the diet for approximately 1 year. Flavonols have also been 
shown to inhibit chemically induced carcinogenesis. Dietary quercetin has been shown 
to inhibit the induction of mammary cancer by either 7 ,12-dimethylbenz[a]anthracene 
(DMBA) or À-nitrosomethylurea (NMU) in rats (Verma et a l, 1988). Topical 
application of quercetin also inhibited 12-(9-tetradecanoylphorbol-12-acetate (TPA)- 
induced skin tumour promotion, possibly through inhibition of lipoxygenase (Kato et 
al, 1983). In vitro quercetin has been shown to induce quinone reductase (De Long et 
al, 1986). Inactivation of the ultimate carcinogen could therefore contribute to this 
activity.
It can now be seen that quercetin and other flavonols may be directly mutagenic and 
carcinogenic and at the same time capable of inhibiting chemically induced mutagenesis 
and carcinogenesis. In this regard all fiavonoids do not appear the same. Catechins 
appear to lack any direct mutagenic activity. They are, however, potent inhibitors of 
chemical carcinogens (see section 8.2).
7.1.5. Bioavailability. The in vivo biological activity of fiavonoids will depend on 
their absorption from the gastrointestinal tract and presence in the body in a 
biologically active form Oral administration of 4 g quercetin to humans resulted in no 
detectable quercetin in plasma and no quercetin or quercetin conjugates in the urine at 
least 24 hours after ingestion (Gugler et a l, 1975). It was concluded that less than 1 %
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of the dose was absorbed from the gastrointestinal tract. This does not rule out the 
possibility of absorption of intestinal breakdown products of quercetin.
The pharmacokinetics of (+)-catechin metabolism in man have been studied by Hackett 
et al (1983). Following a single dose of 2 g of 14C radiolabelled (+)-catechin an 
average of 55 % of the dose was excreted in the urine, 90 % of this within the first 24 
hours. Only a fraction of the dose, typically O 2 %, was excreted unchanged. The 
principal metabolites in urine were (+)-catechin glucuronide and the glucuronide and 
sulphate conjugates of 3'-omethyl-(+)-catechin, collectively accounting for 75 % of 
the urine radioactivity. These metabolites are also extensively excreted in bile after oral 
administration of 14C-(+)-catechin to rats. Indeed 34 % of an orally administered dose 
of 40 mg/kg (+)-catechin was excreted by this route within 24 hours in the rat (Shaw 
and Griffiths, 1980). Absorption by humans might therefore have been greater than the 
55 % estimated from urinary excretion alone. Moreover, a greater percentage 
absorption might be expected from a smaller, more dilute dose such as that obtained 
from green tea beverage. Even if this is not the case it can be seen that a significant 
percentage of orally ingested (+)-catechin is absorbed.
Unchanged (+)-catechin was detectable in plasma for up to 24 hours after dosing in the 
study of Hackett et a l (1983). At its peak, 3 hours after administration, it accounted 
for only 12 % of the total plasma radioactivity, corresponding to a (+)-catechin 
concentration of 15 pg/mL The in vivo antioxidant activity of (+)-catechin might 
therefore depend predominantly on the activity of its metabolites rather than the parent 
compound. Over 75 % of the urinary metabolites were conjugates of (+)-catechin and 
3'-0-methyl-(+)-catechin. Méthylation at the 3' hydroxyl group accounted for 
approximately two thirds of the total metabolites. This hydroxyl group appears 
important for the radical scavenging activity of fiavonoids. The in vivo radical 
scavenging activity of (+)-catechin might therefore be less than that predicted from in 
vitro assays. Similarly, if the total number of hydroxyl groups is an important 
determinant of radical scavenging activity, glucuronide and sulphate conjugation may 
also reduce the anticipated antioxidant activity. The overall effect of metabolism will 
depend on the significance of radical scavenging in relation to other possible 
antioxidant properties and the effect of conjugation on these properties. Although 
méthylation of the 3' hydroxyl group may decrease radical scavenging activity it will 
also decrease hydrophilicity. Metabolism may therefore enhance cellular uptake and 
any possible protection of cell membranes.
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The study of Hackett et al. (1983) also illustrates the inter-individual variability in (+)- 
catechin metabolism Although the pharmacokinetics of excretion were similar between 
the three volunteers used there was a large degree of variability in the percentage 
absorption, estimated by urinary excretion. This may indicate that the actual dose 
absorbed, and thus the antioxidant activity, varied considerably between individuals. It 
may, however, also be explained by differences in the proportion excreted in the bile 
and urine.
7.2. Other biologically-active plant components
In addition to fiavonoids, foods contain several other components which may possess 
anticarcinogenic activity (Wattenberg, 1983). Cruciferous vegetables such as broccoli 
have been identified as a rich source of phase II enzyme inducers (Prochaska et a l, 
1992). Zhang et a l (1992) have isolated the isothiocyanate sulforaphane as a major, 
and very potent, inducer of quinone reductase and glutathione ^-transferase from 
broccoli. Cabbage and other cruciferous vegetables also contain dithiolthiones which 
have been shown to induce glutathione ^-transferase and quinone reductase in various 
rodent tissues (Ansher et a l, 1986). Other phenolic compounds, such as the phenolic 
acids cafifeic and chlorogenic acid, and other non-fiavonoid phenols, such as curcumin 
from turmeric have been shown to possess antioxidant activity (Larson, 1988).
8. Biological significance of green tea
It can be seen that catechins appear to be biologically available antioxidants which do 
not show the harmful effects in vitro of some other fiavonoids. Dietary components 
rich in catechins are therefore of particular interest. A rich source of catechins is the 
leaf of the tea plant, Camellia sinensis. The leaf composition varies according to 
factors such as strain, climate, season, age of leaf and horticultural practices. Catechins 
may be present at up to 30 % of the dry leaf weight. Typical concentrations of the 
principal tea catechins in young leaf are shown in table 1 (Graham, 1992). Other 
catechin derivatives including epigallocatechin digallates and bisfiavanols have also 
been identified in green tea leaf. Flavonols and their glycosides may also be present at 
concentrations up to 3—4 %.
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Table 1. Principal catechins in green tea leaf (% dry leaf weight)
(+)-Catechin 
(-)-Epicatechin 
(-)-Epicatechin gallate
1-2 (+)-Gallocatechin 1-3
1-3 (-)-Epigallocatechin 3-6
3-6 (-)-Epigallocatechin gallate 7-13
During the manufacture of black tea the enzyme polyphenol oxidase catalyses the 
oxidation of catechins to quinones which undergo condensation reactions to form the 
theaflavins, thearubigins and other compounds which give black tea its characteristic 
sensory properties. Black tea retains approximately 5-10 % of the catechins originally 
present in the green leaf. In black tea beverage catechins typically make up between 
3-10 % of the extract solids while theaflavins and thearubigins account for 3-6 % and 
12-18 % respectively (Graham, 1992). In green tea manufacture inactivation of 
oxidative enzymes through steaming or pan firing gives a final product with a 
composition similar to that of the fresh leaf As is the case with black tea, the 
composition of green tea beverage will depend on the composition of the fresh leaÇ 
processing conditions employed in product manufacture and the brewing conditions. 
Typically the extractable solids in green tea beverage contain 30-42 % catechins, 5-10 
% flavonols and 2-4 % other fiavonoids (Graham, 1992).
There has been speculation that green tea may be of benefit to general health for 
centuries. In the thirteenth century the Zen priest Eisai wrote about the effectiveness of 
green tea in prolonging life and maintaining good health. Since then it has been 
assigned many physiological properties including anti-depressant, anti-inflammatory 
and anti-atherosclerotic activities. It has also been shown to be of benefit in the 
treatment of viral hepatitis (Blum et a l, 1977). Today, with the implication of ROS in 
a growing number of diseases, there is significant interest in the antioxidant activity of 
green tea. Combined with other activities including a possible role in modulation of 
carcinogen metabolism and reduction of plasma triglycerides the question of whether 
habitual consumption of green beverage is successful in disease prevention and 
prolonging life is an intriguing one.
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8.1. Epidemiology
The effect of green tea consumption on human health has been the subject of a limited 
number of epidemiology studies. Female practitioners of chanoyu (Japanese tea 
ceremony) in Tokyo have been found to have a standard mortality ratio of 0 55 when 
women living in Tokyo were used as a standard population (Sadakata et a l, 1992). In 
a case control study carried out in Shanghai, an area of widespread green tea use, a 
protective effect against oesophageal cancer was found (Gao et a l, 1994). Frequent 
consumption of green tea (more than 10 cups per day) has been associated with a 
significant reduction of relative risk of stomach cancer in Kyushu, Japan (Kono et a l, 
1988). Other investigators have also found a lower incidence of stomach cancer in 
frequent consumers of green tea beverage (Yu and Hesich, 1991). Green tea has also 
been associated with a better survival rate from bladder cancer in male patients (Wakai 
et a l, 1993). In addition to a possible role in protecting against cancer, green tea 
consumption has also been associated with a reduction of serum total cholesterol and 
triglycerides and an increase in the proportion of high density lipoprotein cholesterol 
(Tmai and Nakachi, 1995). The prevalence of heart disease also reduced with 
increasing green tea consumption in this study population.
Other studies have, however, shown green tea to be positively associated with disease. 
In Taiwan green tea consumption has been positively associated with stomach cancer 
(Lee et a l, 1990). Individuals drinking more than five and seven cups of green tea per 
day have also been found to have a higher incidence of pancreatic cancer (Mizuno et 
al, 1992) and ulcerative colitis (Higashi et a l, 1991) respectively. Green tea has also 
been significantly associated with lung cancer (Tewes et a l, 1990). The benefits of 
habitual consumption of green tea are therefore by no means proven.
8.2. Mutagenicity and carcinogenicity of green tea
As alluded to previously, catechins do not possess the structural features required for 
mutagenesis and accordingly show a complete absence of mutagenicity in the Ames 
test (Steele et a l, 1985). Whole green tea has, however, been shown to be mutagenic 
in the Ames test (Tewes et a l, 1990). This activity was detected only in the presence 
of glycosidase enzymes. A possible explanation for this is the conversion of non- 
mutagenic flavonol glycosides present in green tea beverage to mutagenic aglycones. 
This could account for the carcinogenicity of green tea seen in some epidemiological
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studies. The carcinogenicity of flavonols, even when given to rodents at high doses is, 
however, a matter of contention. In humans absorption of quercetin appears to be very 
low and this possibility may be unlikely.
In a similar manner to individual fiavonoids, green tea extracts have been shown to 
reduce the mutagenicity of known mutagens. Wang et a l (1989a) found that the 
polyphenolic fraction of green tea inhibited mutagenicity induced by benzo[<2]pyrene, 
aflatoxin Bj and 2-aminofluorene in Salmonella typhimurium TA100 and TA98 in the 
presence of rat liver microsomal activation system
The anticarcinogenic activity of green tea has been extensively studied in animal 
tumour bioassay systems. Green tea and green tea extracts have been shown to 
antagonise tumourigenesis induced by chemical carcinogens at sites including the skin, 
lung, forestomach, liver, duodenum, oesophagus and colon (Mukhtar et a l, 1994a). 
Protection against ultraviolet B-induced skin cancer has also been demonstrated (Wang 
et al, 1991). Using murine skin as a model, topical and oral administration of green tea 
have been shown to protect against tumour initiation, promotion and complete 
carcinogenesis induced by chemical carcinogens (Mukhtar et a l, 1994b). Green tea has 
also been shown to protect against tumour progression induced by free radical 
generating compounds and to cause partial regression of established skin papillomas in 
female mice. Anticarcinogenic activity has been demonstrated at concentrations as low 
as 0 05 % green tea polyphenol extract in the drinking water of SENCAR mice treated 
with DMBA and TPA (Wang et a l, 1989b). Green tea is therefore an effective 
anticarcinogen. Antioxidant and free radical scavenging activity, modulation of 
carcinogen metabolism and interaction with the ultimate carcinogens are all properties 
of green tea which may contribute to this effect. These will be discussed below.
8.3. In vitro radical scavenging activity of green tea
The radical scavenging activity of green tea and individual catechins has been studied 
in several different systems. Zhao et a l (1989) found that water extracts of green tea 
and green tea catechins were efficient free radical scavengers, possessing activity 
greater than that of vitamin E and vitamin C in a polymorphonuclear system Efficient 
scavenging of superoxide was also demonstrated. In studies of green tea extracts 
Tanizawa et a l (1984) found a caffeine fraction and a fraction containing a mixture of 
(+)-catechin and (-)-epicatechin (EC) to have the strongest antioxidant activity in an
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air oxidized linoleic acid system When studied individually EC was found to be more 
potent than (+)-catechin and a-tocopherol and nearly equal to butylated 
hydroxyanisole (BHA). Caffeine also showed significant antioxidant activity in this 
study. Green tea has been shown to increase the induction time of lard oxidation by a 
factor of approximately 10 (Ho et ah, 1992). When individual tea components were 
investigated antioxidant activity decreased in the order gallic acid > (-)- 
epigallocatechin gallate (EGCG) = (—)-epigallocatechin (EGC) > (—)-epicatechin 
gallate (ECG) > EC. Caffeine possessed no antioxidant activity in this study. 
Matsuzaki and Hara (1985) found a similar order of potency to that of Ho et al (1992) 
when individual catechins were tested by the active oxygen method on lard.
Tea catechins have also been shown to inhibit lipid peroxidation in rat liver 
mitochondria and microsomes (Okuda et a l, 1983). In agreement with studies on 
lipids, (+)-catechin and EC had lower activity than EGCG. The activity of all three 
catechins was, however, significantly greater than that of a-tocopherol in both 
systems.
Green tea catechins are therefore potent antioxidants in vitro, displaying activity 
greater than that of a-tocopherol and vitamin C in some studies. The antioxidant 
activity of black tea has attracted less interest. Ho et a l (1992) did, however, find one 
of the black teas they tested to be of a similar potency to green tea. This could be a 
reflection of its high gallic acid content. The theaflavins of black tea have also been 
shown to inhibit lipid peroxidation in erythrocyte ghost membranes and a microsomal 
system (Shiraki et a l, 1994).
8.4. In vivo antioxidant activity
Studies in which oral administration of green tea has been shown to protect against 
skin cancer induced by topical application of chemical carcinogens (Wang et a l, 1992) 
and ultraviolet B radiation (Wang et a l, 1991) indicate that the chemopreventive 
agents present in green tea are absorbed from the gastrointestinal tract in a biologically 
active form Several compounds with antioxidant activity, including a-tocopherol, 
ascorbic acid and p-carotene have been reported to inhibit UV light-induced 
carcinogenesis. Thus the antioxidant components of green tea may be biologically 
available.
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8.4.1. Animal studies. A limited number of studies have investigated the antioxidant 
activity of green tea and individual catechins in vivo. A single subcutaneous dose of 
(+)-catechin (400 mg/kg) one hour prior to administration of ethanol has been shown 
to inhibit the increase in liver chemiluminesence seen on giving ethanol alone (Videla et 
al, 1983). Similarly, a single dose of (+)-catechin (100 mg/kg) attenuated the increase 
in liver chemiluminescence produced by carbon tetrachloride (Fraga et a l, 1987). 
Subcutaneous administration of a single dose of (+)-catechin (400 mg/kg) to rats has 
been shown to abolish pulmonary lipid peroxidation resulting from glutathione 
depletion, without sparing glutathione (Videla et a l, 1985). Oral administration of 
green tea catechins has also been shown to reduce oxidative damage. Supplementation 
of a rodent diet containing 30 % peiilla oil with 1 % of a mixture of tea catechins 
significantly reduced plasma lipid peroxidation and increased plasma a-tocopherol 
levels (Nanjo et a l, 1993). In rats fed a diet providing more than 30 % of calories from 
ethanol addition of (+)-catechin to the ethanol solution (300 mg/kg/day) abolished the 
increase in myocardial conjugated dienes seen on ethanol alone (Édes et a l, 1986). 
These studies are of particular note since they illustrate the potential of orally 
administered catechins to inhibit in vivo lipid peroxidation.
The reduction in oxidative damage seen in these studies may obviously be due to the 
radical scavenging properties of catechins. This may occur either directly or through 
interaction with other antioxidant nutrients. When a single dose of (+)-catechin is given 
shortly before the oxidant challenge radical scavenging is likely to be the case. In more 
long term studies other properties of catechins may contribute to any reduction in 
oxidative damage. In this regard mice fed a polyphenolic fraction isolated from green 
tea for 30 days show an increase in glutathione peroxidase and catalase activity in the 
small bowel, lung and liver (Khan et a l, 1992).
8.4.2. Human studies. In patients with chronic hepatitis, administration of (+)- 
catechin for 60 days resulted in normalisation of elevated serum TEARS (Par et a l, 
1985). This was accompanied by a significant increase in serum vitamin E. Serum 
concentrations of lipid peroxides in heavy smokers have also been inversely associated 
with green tea consumption (Tmai and Nakachi, 1995).
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8.5. Modulation of carcinogen metabolism
8.5.1. Phase I  and phase II enzymes. In addition to scavenging free radicals green tea 
may also protect against chemical carcinogenesis by reducing exposure to the active 
carcinogen. Blocking the metabolic activation of the pro-carcinogen, increasing 
detoxification of the ultimate carcinogen and interaction with the ultimate carcinogen 
to prevent it binding to DNA are all possible.
Cytochrome P450-dependent reactions are important in the metabolism of pro­
carcinogens and pro-mutagens to active forms. Addition of green tea polyphenols and 
individual catechins to rat liver micro somes has been shown to inhibit cytochrome 
P45O-dependent activities including aryl hydrocarbon hydroxylase (Wang et a l, 1988). 
Steele et al. (1985) found that in vitro addition of (+)-catechin inhibited P450 
dependent benzphetamine A-demethylase and ethoxyresorufin O-deethylase activities 
and NADPH-cytochrome c reductase in rat liver microsomes in vitro. Intraperitoneal 
administration of high doses of (+)-catechin over a 3 day period did not, however, 
affect these activities. The in vivo significance of inhibition of P450-dependent 
carcinogen metabolism has therefore been questioned.
Green tea has, however, been shown to increase the activity of phase II enzymes in 
vivo. Bu-Abbas et al. (1995) found that whole green tea increased the activity of UDP- 
glucuronyl transferase in the liver when given to rats at concentrations customarily 
consumed by humans for 4 weeks. A green tea polyphenol fraction given to SKH-1 
hairless mice as 0-2 % w/v of the drinking water for 30 days significantly increased the 
activity of glutathione ^-transferase in the small bowel and liver and the activity of 
quinone reductase in small bowel, liver and lung (Khan et a l, 1992). Sohn et al. 
(1994) found that 2 % w/v solutions of green and black tea significantly increased the 
activity of UDP-glucuronosyl transferase in rat liver after 6 weeks. Green and black tea 
also increased the activity of P4501A2, P4501A1 and P4502B1 in this study. 
Heterocyclic amines such as 2-amino-3-methylimidazo [4,5-y] quinoline (IQ) formed 
during cooking of meats are metabolised to reactive compounds by P4501A2. Thus the 
mutagenesis of IQ was enhanced with 8-9 liver fraction from rats that had been given 
green or black tea (Weisburger et a l, 1993). Bu-Abbas et al. (1994) have also found 
green tea to increase the activity of P4501A2 and P4504A1.
It can now be seen that green tea activates enzymes responsible for both carcinogen 
activation and deactivation. Binding of the ultimate carcinogen to prevent its
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interaction with DNA is a further possibility. In this regard green tea polyphenols have 
been shown to interact with the ultimate carcinogen of benzo[a]pyrene (Mukhtar et 
al, 1994b). The overall effect of green tea consumption will depend on the balance 
between these activities.
8.5.2. Inhibition of tumour promotion. Induction of ornithine decarboxylase and 
cyclooxygenase and lipoxygenase may be important factors in tumour promotion. 
Topical application of green tea polyphenols to mouse skin has been shown to inhibit 
the induction of cyclooxygenase and lipoxygenase (Katiyar et a l, 1992) and ornithine 
decarboxylase (Agarwal et a l, 1992) caused by TPA. Inhibition of gap junction 
intercellular communications is also a recognised property of tumour promoters. 
Production of free radicals and phosphorylation of gap junction proteins through 
activation of protein kinase C are two mechanisms proposed for this activity. A green 
tea extract containing (+)-catechin prevented the inhibition of gap junction intercellular 
communication produced by phénobarbital, paraquat and lindane (Klaunig, 1992). 
These tumour promoters have all been associated with the production of free radicals. 
EGCG has been shown to inhibit activation of protein kinase C by teleocidin 
(Yoshizawa et a l, 1987). Sigler and Ruch (1993) also found an aqueous extract of 
green tea to enhance gap junction intercellular communications in promoter treated 
cells.
9. Summary and aims
It can now be seen that exposure to free radicals is an ongoing and unavoidable 
process and that biological damage appears to be an inevitable consequence of this. At 
the same time the health benefits of dietary components with antioxidant activity has 
been suggested from observational epidemiological studies. One such group of 
compounds are the fiavonoids. Of the dietary components containing fiavonoids green 
tea is of particular interest. Not only is it a widely consumed beverage but it is also a 
rich source of the group of fiavonoids termed catechins. Whole green tea and 
individual catechins have been shown to scavenge free radicals in vitro and to increase 
the activity of antioxidant enzymes in vivo. A limited number of studies have also 
demonstrated in vivo antioxidant activity of green tea catechins in animals and humans. 
These studies do not, however, give an indication of the possible health benefits of 
habitual consumption of green tea beverage. The overall aim of this study was 
therefore to investigate the in vivo antioxidant activity of a moderate, and in dietary
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terms, realistic dose of green tea in humans. To this end the following steps were 
planned:
(1) methods for the analysis of biomarkers ofm vivo oxidative damage in animals to be 
set up and validated;
(2) the in vivo antioxidant activity of green tea to be investigated in conventional and 
vitamin E-deficient anim als fed diets containing either maize oil or fish oil as the lipid 
source;
(3) the methodology for analysis of the selected biomarkers to be transferred to 
humans;
(4) the in vivo antioxidant activity of green tea to be investigated in male smokers and 
non-smokers given a fish oil supplement.
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Chapter 2
Development of a method for the 
measurement of malondialdehyde in 
plasma and urine
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1. Introduction
The measurement ofMDA by its reaction with TEA is one of the most commonly used 
markers of lipid peroxidation. It is at the same time, however, one of the most heavily 
criticised methods, particularly when applied to biological samples. This criticism 
appears justified if MDA in a biological sample is derivatized with TEA without the 
addition of antioxidants to the reaction mixture or the resulting adduct is quantified 
without prior purification. In this form MDA analysis may be little more than an 
indication of resistance to oxidation or the quantity of MDA-producing substrate 
within the sample. Even these conclusions may be an over interpretation of the results. 
Criticisms of the basic reaction between MDA and TEA as a biomarker of in vivo lipid 
peroxidation include:
(1) the harsh conditions employed to develop the MDA-TEA adduct invite oxidation 
of any non-peroxidized PUFA within the sample;
(2) the amount of MDA measured in a sample is affected by the reaction conditions 
and reagents used to develop the MDA-TEA complex. Comparison between studies 
is, therefore, often hampered by differences in the methodology employed. The 
condition of the sample, other than its content of MDA or lipid hydroperoxides, will 
also affect the results obtained;
(3) in common with other lipid peroxidation products, MDA formation depends on the 
local environment and the nature of the PUFA peroxidized; only PUFA containing 
more than two double bonds give appreciable amounts of TEA reactive material 
(Halliwell and Gutteridge, 1989);
(4) malondialdehyde is a side product of eicosanoid formation. It is formed in 
equimolar amounts with thromboxane Ag and 12(L)-hydroxy-5,8,10-heptadecatrienoic 
acid from prostaglandin by the enzyme thromboxane synthase. It may also be 
formed from prostaglandin G2 and prostaglandin H ,^ endoperoxide intermediates in the 
prostaglandin synthesis pathway, during the assay itself. The increase in urinary MDA 
excretion resulting from vitamin E deficiency has been suggested to arise, in part, from 
cyclooxygenase activity. Draper et a l (1984) found that administration of a 
cyclooxygenase inhibitor to rats maintained on a tocopherol-stripped com oil diet 
reduced urinary MDA excretion by approximately 20 %. Inhibition of cyclooxygenase 
did not, however, affect urinary MDA excretion from vitamin E replete animals. MDA
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has also been suggested to arise from the reaction of acetaldehyde and glucose (Knight 
e ta l, 1988);
(5) compounds other than MDA react with TEA to form pigments with absorption 
spectra similar to that of the MDA-TBA adduct. Kosugi et a l (1987) reported that 
alk-2-enals react with TEA to from yellow, orange and red pigments. The absorption 
spectrum and retention time of the red pigment were similar to those of the genuine 
MDA-TBA adduct. Although the identity of this pigment was not confirmed, it was 
suggest to be other than the MDA-TBA adduct. Alka-2,4-dienals also produce a red 
pigment on reaction with TBA (Kosugi and Kikugawa, 1989). The reaction of 
biliverdin and TBA produces a pink solution with significant absorbance at 532 nm 
which does not contain MDA (Knight et a l, 1988);
(6) it has been suggested that MDA can arise from oxidative attack on a variety of 
non-lipid biomolecules including amino acids, DNA, carbohydrates and bile pigments 
(Gutteridge, 1982; Halliwell and Gutteridge, 1989; Janero 1990). While MDA 
formation from most of these non-lipid biomolecules has not been rigorously 
demonstrated it has, however, been shown to arise from oxidative damage to DNA 
(Janero 1990);
(7) MDA is extensively metabolised by mitochondrial aldehyde dehydrogenase (Siu 
and Draper, 1982). Twelve hours after intubation with 14C MDA 60-70 % of the 
administered radioactivity was recovered as expired C02.
These limitations are well recognised and can in some cases be minimised by 
modification of the basic assay procedure. Antioxidants such as butylated 
hydroxytoluene can be added to the reaction mixture to minimise oxidation of any non- 
peroxidized PUFA within the sample while HPLC can be used to separate the MDA- 
TBA adduct from interfering chromogens.
Many of the criticisms associated with quantification ofMDA as a biomarker of in vivo 
lipid peroxidation are, however, a consequence of events which cannot be accounted 
for by modification of the assay procedure. For example, it must be assumed that 
MDA originating from sources such as eicosanoid formation and the diet remains 
constant when attributing a change in MDA levels to in vivo oxidative damage. Such 
assumptions must, however, also be made when interpreting other biomarkers of lipid 
peroxidation. Conjugated dienes, ethane and F2 isoprostanes in biological samples do
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not arise exclusively from in vivo lipid peroxidation, or even in vivo oxidative events in 
general. The compound octadeca-9(c/s)l l(/nms)-dienoic acid, which has been 
suggested to arise from the diet and bacterial metabolism (Thompson and Smith, 
1985), may be a significant component of conjugated dienes in human samples. F2 
isoprostanes in plasma and urine samples may also arise from enzymatic formation 
(Morrow and Roberts, 1991). The extent to which breath alkanes represent in vivo 
lipid peroxidation when the subject is breathing room air is also small. Even if 
atmospheric air is removed from the lungs prior to sample collection breath ethane and 
pentane may not arise exclusively from in vivo lipid peroxidation.
The possibility that MDA may arise from oxidative attack on biomolecules other than 
lipid means that its use as a specific marker of lipid peroxidation can indeed be 
questioned. This does not, however, diminish its validity as an index of overall 
oxidative damage. Indeed this may be considered an advantage since it will encompass 
the effects of compounds modulating the oxidation of biomolecules other than lipids 
and may therefore give a more comprehensive indication of oxidative damage to 
biological systems. If this is to be considered a criticism then ethane production can 
also be criticised since it has been shown that ethane is produced from oxidative attack 
on the amino acid isoleucine as well as n-3 PUFA (Kessler and Remmer, 1990).
The fact that MDA is extensively metabolised means that changes in metabolism may 
be misinterpreted as changes in in vivo lipid peroxidation. This criticism does, 
however, once again apply to other lipid peroxidation products such as ethane and 
pentane.
It can now be seen that other biomarkers of lipid peroxidation suffer from some of the 
same problems as MDA. In a negative frame of mind one might conclude that the 
analysis of lipid peroxidation is so beset with problems that its use as a biomarker of in 
vivo oxidative damage should be abandoned completely. Assays for oxidative damage 
to DNA and proteins may therefore be preferable. These are, however, less well 
established and may in time be as heavily criticised as biomarkers of lipid peroxidation 
for as yet unforeseen reasons. Analysis of antioxidant nutrient may also prove useful as 
an indication of oxidative damage. This is, however, once again not without its 
problems. At this point it is therefore perhaps worth repeating what has been said many 
times before; measurement of as many biomarkers as possible is desirable when 
investigating in vivo oxidative damage. With this in mind MDA analysis might still 
have a place when used in conjunction with other biomarkers.
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The aim of this study was therefore to set up and validate an assay for MDA which 
m inim ised the problems associated with its analysis.
2. Methods
2.1. Assay Procedure
MDA in plasma and urine samples from humans and animals was derivatized with 1,3- 
diethyl-2-thiobarbituric acid (DETBA) using essentially the same procedure. Plasma 
samples were prepared by centrifuging blood for 10 minutes at 776 x g immediately 
after collection into EDTA. Analysis was performed on plasma 1 hour after blood 
collection and on mine samples after centrifugation for 10 minutes at 776 x g. Samples 
(0-5 ml) were mixed with 01 ml of 0-73 M butylated hydroxytoluene (BHT) solution 
prepared in ethanol and 5 ml saturated DETBA solution in 01 M phosphate buffer. 
The pH of the DETBA solution was adjusted to 3-25 prior to reaction using 
orthophosphoric acid. Samples were placed in a boiling water bath for 1 hour to 
develop the MDA-DETBA adduct. Fresh DETBA solution was prepared for each 
run. BHT and DETBA were obtained from Sigma Chemical Co. (Poole) while 
orthophosphoric acid was obtained from Fisons Scientific Equipment (Loughborough).
2.2. Sample clean up and analysis
2.2.1. Animal studies. When applied to plasma samples, the reaction mixture was 
centrifuged for 10 minutes at 540 x g after allowing to cool for 30 minutes. Samples of 
the supernatant were taken for analysis. This step was not necessary for urine samples 
which were taken for analysis directly after cooling for 30 minutes. The MDA- 
DETBA adduct was separated from interfering chromogens using an HPLC procedure. 
Separation was carried out on a 25 cm Kromasil C^g column (Hichrom Ltd, Reading) 
connected to a Spectra Physics SP8700 XR pump and AS 100 auto sampler (Thermo 
Separation Products, Stone). The MDA-DETBA adduct was eluted using a gradient 
solvent system Initial solvent conditions were 90 % water, containing 01 % 
triethanolamine, and 10 % acetonitrile. Acetonitiile was increased to 40 % at 40 
minutes using a linear gradient. Detection was carried out using a Spectra Physics UV 
2000 detector at a wavelength of 540 nm The identity and purity of the MDA- 
DETBA adduct from plasma and urine samples was confirmed by comparison of
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retention time and spectral data with those of the MDA-DETBA adduct prepared 
from 1,1,3,3-tetraethoxypropane (TEP) standard. The quantity of MDA within a 
sample was determined with reference to a standard curve constructed from TEP 
standard. The MDA-DETBA adduct was prepared from TEP using the procedure 
described for plasma and urine samples. TEP stock standard was prepared fresh each 
week and stored at 4 °C. Triethanolamine and TEP were obtained from Sigma 
Chemical Co. (Poole) while HPLC grade acetonitrile was obtained from Fisons 
Scientific Equipment (Loughborough).
2.2.2. Human studies. After allowing to cool for 30 minutes the MDA-DETBA 
adduct prepared from plasma, urine and TEP standard was extracted into butan-l-ol. 
To each sample 3 ml butan-l-ol were added and the mixture vortexed for 10 seconds. 
The butan-l-ol layer was separated by centrifugation for 5 minutes at 540 x g and 
removed. Samples were extracted with a further 2 ml butan-l-ol using the same 
procedure and the butan-l-ol extracts pooled. Prior to HPLC analysis butan-l-ol 
extracts (0-5 ml) were evaporated to dryness under nitrogen at 37 °C and the residue 
resuspended in 50:50 acetonitrile water (0 5 ml). Separation and quantification of the 
MDA-DETBA adduct were performed using the apparatus described in section 2.2.1. 
In this case the MDA-DETBA adduct was eluted isocratically using 50 % water, 
containing 01 % triethanolamine, and 50 % acetonitrile as solvent. Analytical grade 
butan-l-ol was obtained from Fisons Scientific Equipment (Loughborough).
2.3. Validation of methodology
2.3.1. Animal studies. The between-run reproducibility of the assay procedure was 
investigated by carrying out repeat analysis of the same plasma and urine samples and 
TEP standard. Eight aliquots of a freshly collected human plasma sample were taken 
for analysis. A different set of freshly prepared reagents were used for each aliquot. 
Similarly, the amount of MDA in a fresh human urine sample was measured in eight 
different aliquots. The day to day reproducibility of the assay was investigated by 
analysing an aliquot of 2-50 nmol/ml TEP standard daily for 7 days.
The stability of the MDA-DETBA adduct derived from plasma, urine and TEP 
standard was investigated by comparing the amount of MDA in freshly prepared 
samples with that in the same samples after standing in HPLC vials at room 
temperature for up to 18 hours.
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2.3.2. Human studies. The recovery and reproducibility of the butan-l-ol extraction 
procedure were investigated by comparing the amount of MDA in plasma and urine 
samples and TEP standard before and after extraction of the MDA-DETBA adduct. 
To provide sufficient volume for multiple butan-l-ol extractions 3 ml of sample or 
standard were mixed with DETBA solution and BHT solution in the normal ratio 
(0-5:5:0-1). After boiling for 1 hour and allowing to cool for 30 minutes the reaction 
mixture was analysed. Five aliquots of 5-6 ml were then extracted with butan-l-ol.
The between-run reproducibility of the entire assay procedure was investigated by 
carrying out repeat analysis on plasma and urine samples. Six aliquots of a freshly 
collected human plasma sample and freshly collected urine sample were taken for 
analysis. A different set of freshly prepared reagents were used for each aliquot.
The stability of the MDA-DETBA adduct in butan-l-ol at 4 °C in the dark and at 
room temperature, after reconstitution in the HPLC solvent, was also investigated.
2.3.3. Effect of green tea on MDA analysis. Given the in vitro antioxidant activity of 
green tea catechins and the vulnerability of plasma lipids to peroxidation during the 
assay procedure it is possible that green tea or green tea metabolites in plasma might 
protect against lipid peroxidation during the assay itself. From the study conducted by 
Lee et al. (1995) it can be estimated that the concentration of green tea catechins in 
plasma of animals maintained on green tea beverage as the sole source of drinking fluid 
is less than 0*01 % of that in the beverage. To investigate the in vivo antioxidant 
activity of green tea animals were provided with green tea beverage containing 35 
mg/100 ml freeze dried green tea extract (chapter 4). In human studies the dose of 
green tea was similar (chapter 6). To replicate the concentration of catechins 
anticipated in plasma, samples would therefore have had to be spiked with 
approximately 3 pg green tea extract/100 ml plasma. Spiking at such a low levels was, 
however, impractical. Samples were therefore spiked with 0-1 mg/ml. Five aliquots of 
plasma were taken for analysis immediately before and immediately after spiking.
The effect of green tea on analysis of urine samples was also investigated. According 
to Lee et al. (1995) the concentrations of EGC and EC in mine samples collected from 
rats maintained on a 0-9 % solution of green tea extract as the sole source of drinking 
fluid for 3 weeks are 1-1 % and 4-3 % of that in the beverage respectively. Oral 
administration of a single dose of 1-2 g green tea extract containing 7 % EGCG, 7 % 
EGC, 3 % EC and 3 % ECG to humans resulted in urinary excretion of ECG and EC,
50
but not EGCG or ECG (Lee et a l, 1995). The metabolism and urinary excretion of 
(+)-catechin appears similar in rats and humans (Hackett et a l, 1982; Hackett et a l, 
1983). Thus EGCG and ECG may also have been absent from the urine of rats 
maintained on green tea beverage. The concentration of catechins in urine samples is 
therefore likely to be less than 5 % that in the beverage. Assuming this level to be the 
maximum expected human urine was spiked with 1-75 mg green tea extract/100 ml. 
Five aliquots of urine were taken for analysed immediately before and immediately 
after spiking with green tea extract. Spiked and non-spiked urine sample were then 
stored at room temperature for 24 hours before a further 5 aliquots of each were taken 
for analysis.
3. Results
3.1. Animal studies
Using the HPLC procedure described in section 2.2.1, the MDA-DETBA adduct 
prepared from plasma and urine samples eluted as a distinct peak with a retention time 
of approximately 34 1 minutes. The retention time and spectral properties of this peak 
were identical to those of the MDA-DETBA adduct prepared from TEP standard. The 
between-run reproducibility of the assay when applied to plasma and urine samples is 
shown in table 2. Daily analysis of the 250 nmol/ml TEP standard over a 7 day period 
gave a coefficient of variation of 9T %. The MDA-DETBA adduct prepared from 
plasma, urine and TEP standard was stable for up to 18 hours at room temperature.
Table 2. Between-run reproducibility of the assay 
used for animal samples
Sample Mean S.D. CV%
Urine (n=8) 401 028 7-1
Plasma (n=8) 0 60 007 120
Values expressed as nmol MDA/ml plasma or urine
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3.2. Human studies
The MDA-DETBA adduct prepared from plasma and urine samples eluted as a 
distinct peak with a retention time of 3 6 minutes (figures 2 and 3 respectively). The 
retention time and spectral properties of this peak were similar to those of MDA- 
DETBA prepared from TEP standard.
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Figure 2. HPLC chromatogram of a plasma sample after reaction with DETBA. 
MDA-DETBA eluted at a retention time of 3-608 minutes.
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Figure 3. HPLC chromatogram of a urine sample after reaction with DETBA. MDA- 
DETBA eluted at a retention time of 3*666 minutes
Following butan-l-ol extraction the MDA-DETBA adduct could not be detected in 
the aqueous residue from plasma and urine samples and TEP standard. The recovery of 
MDA-DETBA prepared from TEP standard, urine and plasma samples averaged 96*4 
± 6*4 % (n=5), 107*8 ± 7*1 % (n=5) and 86*0 ± 6*4 % (n=5) respectively.
The between-run reproducibility of plasma and urine analysis is shown in table 3.
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Table 3. Between-nm reproducibility of the assay 
used for human samples
Sample Mean S.D. c v %
Urine (n=6) 3-81 029 7-6
Plasma (n=6) 054 006 111
Values expressed as nmol MDA/ml plasma and urine
The MDA-DETBA adduct prepared from human plasma and urine and TEP standard 
remained stable for at least 2 weeks when stored in butan-l-ol in the dark at 4 °C. 
After evaporation of butan-l-ol and resuspension in HPLC solvent the MDA-DETBA 
adduct remained stable for 6 hours at room temperature.
3.3. Effect of green tea extract on the analysis of plasma and urine samples
The effect of spiking plasma and urine samples with green tea extract is shown in table 
4. Green tea extract had no significant effect on the amount ofMDA measured in fresh 
plasma samples. Similarly, although the amount of MDA measured in fresh urine
samples spiked with green tea extract was slightly lower than that in the same sample
/
measured prior to spiking this difference did not reach statistical significance. After 
storage at room temperature for 24 hours the amount of MDA in urine samples 
increased slightly. This effect was seen in both spiked and non-spiked samples.
Table 4. Effect of green tea extract on analysis of plasma 
and urine samples
Sample No additions Green tea extract
Fresh plasma O 67 ± 0 04 0 74 ± 0 06
Fresh urine 3-19 ±0-21 3 04 ± 0 22
Urinet 339 ±032 3-21 ±0-30
Values are the mean ± S.D. of five aliquots of the same sample 
expressed as nmol MDA/ml. t Samples stored at room temperature in 
the light for 24 hours
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4. Discussion
Early studies with peroxidized PUFA demonstrated that free MDA could not account 
for all the TBA-reactive material present in the sample. For example, it has been shown 
that 98 % of the MDA in a sample of peroxidized fish oil was not originally present but 
was formed from the decomposition of lipid peroxides during the assay procedure 
(Halliwell and Gutteridge, 1989). The decomposition of PUFA hydroperoxides to 
MDA has been suggested to proceed through the formation of peroxyl radicals 
(Gutteridge and Quinlan, 1983). This is in agreement with the mechanism proposed by 
Pryor et al. (1976) which proceeds through cyclisation of peroxyl radicals. Peroxyl 
radicals are capable of hydrogen abstraction from non-peroxidized PUFA in addition to 
cyclisation. The very nature of the assay, aside from the conditions employed to 
develop the MDA-TBA adduct, therefore encourages peroxidation of any non- 
peroxidized PUFA within the sample. In this regard it has been shown that 
peroxidation of linolenic acid does not occur to any appreciable extent during the acid 
heating stage of the assay itself (Gutteridge and Quinlan, 1983). Addition of linolenic 
hydroperoxide to non-peroxidized linolenic acid was, however, found to double the 
yield of TBA-reactive material. This effect could be attenuated by addition of lipid- 
soluble antioxidants to the reaction mixture, with BHT being slightly more effective 
than vitamin E.
The importance of iron for optimal formation of MDA from lipid hydroperoxides has 
been demonstrated. Gutteridge and Quinlan (1983) found that removal of transition 
metals from reagents used in the TBA test inhibited development of TBA reactivity 
from linoleic hydroperoxide by 81 %. Hoving et al. (1992) and Wade and van Rij 
(1988) also illustrate the importance of iron for optimal TBA reactivity.
Thus both iron, to decompose lipid hydroperoxides, and antioxidants, to prevent 
oxidation of non-peroxidized PUFA, are important components of the assay medium. 
By controlling these factors slightly different characteristics of the sample such as the 
amount of MDA compared with the amount of lipid hydroperoxide, and the total 
amount of peroxidizable substrate within the sample can be investigated.
To prevent lipid peroxidation during the assay BHT was added to the reaction mixture 
in accordance with the recommendations of Hoving et al. (1992). They found that a 
BHT concentration of 12-95 mmol/1 afforded optimal protection against peroxidation 
of plasma lipids. BHT has also been shown to reduce the TBARS value of animal and
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human urine samples (Draper et a l, 1993). Since it does not appear to interfere with 
development of the MDA-TBA complex (Lepage et a l, 1991) it was therefore added 
to both plasma and urine samples prior to reaction with DETBA.
Removal of iron from the reaction mixture was considered inappropriate since this 
would have inhibited decomposition of lipid hydroperoxides in plasma samples. It has 
been suggested that endogenous transition metals in TBA test reagents are sufficient to 
stimulate hydroperoxide decomposition (Janero, 1990). Thus iron was neither added or 
removed from the reaction mixture. Given the fact iron appears to be a determining 
factor in the TBARS value of plasma samples (Wade and van Rij, 1988) it was, 
however, important that the amount of iron in the reaction mixture remained constant. 
Since no specific steps were taken to ensure this it may be considered a limitation of 
the current assay procedure. In this regard it was highly important that red cell 
haemolysis was avoided since this has been shown to result in artifactually high levels 
of the MDA-TBA adduct in plasma samples (Wong et a l, 1987; Wade and van Rij, 
1988).
The other conditions and reactants used were selected according to recommendations 
documented in the literature. DETBA was used instead of TBA since it has been 
shown that the MDA-DETBA adduct can be stored in organic solvent in the dark at 4 
°C for several weeks (Hoving et a l, 1992). Lepage et a l  (1991) suggested a 
temperature of 100 °C and a reaction time of 60 minutes for complete formation of the 
MDA-TBA complex. They also found that butan-l-ol was the only solvent leading to 
complete extraction of the MDA-TBA complex from the reaction mixture. Unlike 
Lepage et a l  (1991), who found that pH < 0-75 was essential for recovery of the 
MDA-TBA complex, recovery was complete at the pH of the reaction mixture, 3-25, 
in the current study. Wong et a l (1987) found that plasma samples collected into 
EDTA could be stored at 4 °C for at least 24 hours without any significant increase in 
their lipoperoxide content. In contrast similar storage of plasma in heparin or citrate 
resulted in a 15- and 2-fold increase in lipoperoxide content respectively. TEP 
standard was used rather than 1,1,3,3-tetramethoxypropane (TMP) since TMP is 
considerably more resistant to hydrolysis than TEP (Gutteridge 1975). A pH of 3-25 
has been shown to be optimal for the TBA reactivity of linolenic acid hydroperoxide 
and arachidonic acid hydroperoxide (Ohkawa et a l, 1978,). This pH also appears near 
optimal for the reaction of TEP standard with TBA and is within the pH range quoted 
for the optimal formation of the MDA-TBA adduct from plasma samples (Lepage et
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al, 1991). Ohkawa et al (1979) also found this to be the optimal pH for the reaction 
of tissue homogenates with TBA.
The HPLC procedures used to analyse plasma and urine samples from animals and 
hum ans successfully isolated the MDA-DETBA adduct from other chromogens 
present in the samples with absorbance at 540 nm The absorption spectrum of the 
MDA-DETBA adduct from plasma and urine samples was similar to that of the adduct 
prepared from TEP standard. When extracts prepared from plasma and urine samples 
were spiked with MDA-DETBA prepared from TEP standard the MDA-DETBA 
peak increased in size by the amount expected. On the basis of these observations the 
assay was considered to be a specific measure of the MDA content of the sample. The 
importance of isolating the MDA-DETBA adduct prior to analysis can be seen when 
the total peak area of the chromatogram is compared with that of the MDA-DETBA 
peak. In the case of the human plasma sample shown in figure 2 the MDA-DETBA 
peak accounted for 35 % of the material absorbing at 540 nm In the urine sample 
shown in figure 3 it accounted for 46 %. These chromatograms are typical of human 
plasma and urine samples. Failure to isolate the MDA-DETBA adduct would therefore 
have resulted in an overestimation of the amount ofMDA in plasma and urine samples. 
In agreement with this Wade and van Rij (1988) found that the spectral profile of TBA 
reacted plasma demonstrated the presence of interfering compounds which gave rise to 
an artifactual increase in lipid peroxide concentrations. Kosugi et a l (1993) found that 
the reaction of human urine with TBA produced pigments with absorption maxima at 
455 and 532 nm Direct spectrohpotometric quantification of the red pigment gave a 
value 20-30 % greater than that measured by HPLC. It is possible that some of the 
material interfering with measurement of the MDA-DETBA adduct might have 
originated from the reaction of other lipid peroxidation products with DETBA If these 
are identified and isolated by HPLC they might also prove useful as biomarkers of lipid 
peroxidation.
Addition of green tea extract to plasma samples did not affect their MDA content 
when measured using the technique described. Similarly, there was no significant 
difference in urinary MDA between spiked and non-spiked urine samples when 
measurements were made immediately after piking and after storage at room 
temperature for 24 hours. Thus green tea appears to afford no additional antioxidant 
protection, during the assay, above that provided by BHT added to samples prior to 
development of the MDA-DETBA adduct.
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When discussing the validity ofMDA as a biomarker of in vivo lipid peroxidation it is 
important to be aware of what the assay represents and the influence of exogenous 
factors on the MDA content of biological samples. It has been shown that oxidized 
lipids are absorbed from the human diet. The level of conjugated dienes in 
chylomicrons collected from humans 4 hours after a dose of highly oxidized com oil 
was significantly greater than that after consumption of a similar oil containing low 
levels of oxidized lipids (Staprâns et a l, 1994). Staprâns et al. (1993) also found that 
the amount of oxidized lipid in rat very low density lipoprotein (VLDL) and low 
density lipoprotein (LDL) is related to the peroxidation status of the diet. The peroxide 
value of VLDL and LDL from rats fed a diet containing 5 % com oil with a peroxide 
value of 82*5 nmol peroxide/g oil was approximately five times greater than that of 
VLDL and LDL from animals fed a 5 % com oil diet with 4*7 nmol peroxide/g oil. The 
amount of peroxidized lipids in chylomicrons also increased as the peroxide value of 
dietary oil increased. Bonnefont et al. (1989) reported that 43 % of serum TBARS are 
bound to LDL and VLDL. Plasma TBARS are therefore a reflection of the 
peroxidation status of the diet as well as events initiated in vivo. Given the effect of 
dietary peroxidation on the amount of oxidized lipid in chylomicrons, plasma TBARS 
might also be affected by the fed/fasted state at the time of sampling.
Urinary MDA excretion is also a reflection of MDA intake from the diet. jV-s-(2- 
propenal) lysine has been shown to be the predominant form of MDA in foods of 
animal origin (Piche et a l, 1988). Along with its TV-cc-acetyl derivative it has also been 
shown to be the main form ofMDA excreted in rat and human urine (Draper et a l, 
1988). Minor metabolites have been identified as adducts with the phospholipid bases 
serine and ethanolamine and with guanine (Draper and Hadley, 1990; Agarwal et a l, 
1994). McGirr et al (1985) reported that 27 % of the MDA fed to rats as /V-s-(2- 
propenal) lysine was recovered in the urine. Draper and Hadley (1990) suggested that 
this form of urinary MDA is, therefore, primarily of dietary origin. Thus, similar to 
plasma MDA, urinary MDA is also a reflection of dietary intake as well as in vivo lipid 
peroxidation. It must therefore be assumed that dietary intake of oxidized lipids and 
MDA, or its derivatives, remains constant when MDA is used as a biomarker of in vivo 
lipid peroxidation.
It is also important to be aware of what is actually being measured. Analysis of plasma 
samples will encompass lipid hydroperoxides as well as bound MDA and any free 
MDA which might be present. Compared with urinary MDA analysis it may, therefore, 
encompass more oxidative events and represent a more sensitive biomarker of lipid
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peroxidation. Plasma analysis does, however, only give a snapshot of lipid peroxidation 
at the time of sampling and may, in part, be a reflection of recent dietary intake of 
peroxidized lipids. Although urinary MDA analysis is also a reflection of MDA 
ingested from the diet it may be less susceptible to the effects of recent dietary intake, 
provided a 24 hour sample is collected.
One of the problems associated with the current assay is the lack of quality control 
from run to run. Although TEP standards were run each time plasma and urine samples 
were analysed the reaction conditions appear to affect formation of the MDA-DETBA 
adduct from TEP standard and biological samples in different ways. Hoving et al. 
(1992) reported that formation of MDA from TEP was unaffected by the 
concentration of iron, BHT and phosphoric acid in the reaction mixture. The 
concentration of these factors was, however, found to affect the amount of MDA 
measured in plasma lipid extracts. Formation of the MDA-TBA adduct from TEP 
standard also appears to be dependant on the pH of the reaction mixture to a greater 
extent than formation of the adduct from plasma samples. Lepage et al. (1991) 
reported that the optimum pH for formation of MDA-TBA from TEP standard was 
3-3-3 *7 while formation of the complex from plasma samples was complete between 
pH 2*5 and 4 5. Slight changes in the reaction conditions will therefore affect the 
amount of MDA measured in TEP standard and plasma samples in different ways. The 
importance of keeping constant the pH and other factors affecting generation of the 
MDA-TBA adduct can now be seen. Despite the fact that plasma may be stored for 24 
hours without any increase in TBARS it may also be prudent to ensure consistency in 
the time between collection of blood samples and measurement of plasma TBARS.
In conclusion, the assay described for plasma and urinary MDA analysis is a measure 
of the amount of MDA present within the sample after boiling for 60 minutes at pH 
3-25. While this method has been selected to eliminate interfering chromogens and 
minimise peroxidation during the assay procedure the amount of MDA derived from 
cyclooxygenase activity and ingestion of oxidized lipids, or MDA derivatives, cannot 
be compensated for. MDA analysis might therefore be more applicable to animal 
studies in which a controlled diet is used since the intake of peroxidized lipids and 
MDA may vary considerably in free living humans.
The values reported for plasma MDA using the current method are, however, similar to those 
reported in the literature (Ôhrvall et al, 1994)
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Chapter 3
Ethane exhalation as a biomarker of in 
vivo lipid peroxidation
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1. Introduction
In 1964 Hovart et a l (1964) reported pentane formation from methyl linoleate 
subjected to in vitro oxidation. Subsequently ethane and pentane were shown to be the 
principal volatile alkanes released from the peroxidation of n-3 and n-6 fatty acids 
respectively (Dumelin and Tappel, 1977). Oxidation of methyl linolenate in the 
presence of a copper catalyst also resulted in ethene formation at a yield of 46 % 
relative to ethane. Ethene evolution was, however, less than 1 % ethane formation in 
the presence of other transition metal catalysts. Peroxidation of the n-6 PUFA methyl 
arachidonate and methyl linoleate resulted in evolution of propane and butane in 
addition to pentane. These alkanes were released at a maximum of 8 % and 28 % 
respectively relative to pentane. Due to their low solubility in aqueous phases and high 
volatility, alkanes produced from in vivo lipid peroxidation in animals and man are 
exhaled in the breath. The predominant PUFA in biological membranes are of the n-6 
and n-3 variety. On these grounds ethane and pentane therefore appear to be the pre­
eminent biomarkers of in vivo lipid peroxidation available in breath samples. Moreover 
Frank et al. (1980) found the concentrations of ethane and pentane in breath samples 
collected from rats to be greater than that of ethene, propane and 72-butane.
In accordance with studies on pure fatty acids Clemens et al (1983) observed 
evolution of ethane, pentane, ethene, propane and 72-butane from whole erythrocytes 
and erythrocyte ghost membranes incubated with hydrogen peroxide/Fe2+-EDTA. 
Ethene, propane, 72-butane and 750-butane were also formed from haemoglobin under 
the same conditions. Ethane and pentane were not, however, detected in the absence of 
erythrocyte membranes indicating that these alkanes are specific products of 
membranes ,. Kessler and Remmer (1990) reported formation
of ethene, propane and butane from free methionine, free leucine and peptide-bound 
leucine respectively in an iron/ascorbate/GSH system chosen in an attempt to reflect in 
vivo conditions. Small amounts of ethane were also generated from free isoleucine in 
this system. Pentane was not, however, produced from any of the amino acids tested. 
Pentane therefore appears to be the preferred biomarker if a pure measure of in vivo 
lipid peroxidation is required, although the possibility that it might be produced by an 
as yet unidentified source can not be excluded. These observations do not, however, 
diminish the validity of ethane exhalation as an index of in vivo ROS damage. Other 
hydrocarbons may also prove useftd as biomarkers of overall oxidative damage to 
biological systems. In this regard increased exhalation of Zsobutene has been reported 
in rats chronically treated with ethanol (Frank et a l, 1980) and in humans given the
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anaesthetic halothane (Hempel et a l, 1980). It has been suggested that isobutene 
originates firom oxidative attack on leucine (Remmer et a i, 1989).
It can now be seen that there are several potential biomarkers of in vivo ROS damage 
available in breath samples. The overwhelming majority of studies investigating in vivo 
oxidative damage which have monitored breath hydrocarbons have, however, focused 
on ethane and pentane. Indeed ethane and pentane exhalation has been well 
documented in response to a variety of situations associated with ROS damage. The 
same does not appear to be true for other low molecular weight hydrocarbons. Factors 
which affect ethane and pentane exhalation independent of lipid peroxidation, such as 
metabolism and oxygen tension, have also been extensively studied. Again the same 
does not appear to be true for other hydrocarbons and their value and reliability as 
biomarkers of in vivo oxidative damage remains to be determined.
The possibility that ethane exhalation could be used as a biomarker of in vivo lipid 
peroxidation resulting from an oxidative challenge was advanced by Riely et al (1974) 
when it was demonstrated that administration of carbon tetrachloride to mice increased 
ethane evolution and that this effect could be attenuated by prior administration of oc- 
tocopherol. Since then increased ethane and pentane exhalation has been reported in 
animals subjected to a variety of treatments associated with ROS damage. These 
include reperfusion injury (Kazui et a l, 1992), dosing with carbon tetrachloride and 
ethanol (Roster et a l, 1977), exposure to 100 % oxygen (Habib et a l, 1988) and 
feeding diets low in selenium and/or vitamin E (Tappel and Dillard, 1981; Kivits et a l, 
1982) or high in cod liver oil (Duthie et al, 1987; Odeleye et a l, 1991). Ethane and 
pentane production has also been shown to correlate with other indices of lipid 
peroxidation including liver conjugated dienes (Sagai and Tappel, 1979) and urinary 
TBARS (Eskstrom et a l, 1986). Ethane and pentane are, however, only minor end 
products of lipid peroxidation. Clemens and Remmer (1982) found that MDA 
formation from erythrocytes treated with hydrogen peroxide was 1000 times greater 
than pentane production. Pentane and ethane formation from pure linoleic acid and 
linolenic acid subject to peroxidation has been reported to be a m axim um  of 10 % and 
4*3 % of the conjugated diene formation respectively (Dumelin and Tappel, 1977). In 
vivo, pentane production from rats injected with carbon tetrachloride corresponded to 
about 0-2 % of the lipid peroxides, measured as conjugated dienes (Sagai and Tappel, 
1979). Nevertheless ethane analysis has been suggested as one of the most sensitive 
methods available for the measurement of lipid peroxidation, allowing detection of in 
vitro n-3 fatty acid peroxidation when it reaches 0-03 % of total n-3 fatty acids (Bums
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and Wagner, 1991). In vivo alkane analysis has several advantages over other 
commonly used biomarkers of lipid peroxidation. It is a non-invasive technique which 
gives an indication of lipid peroxidation at the time of sampling and is suitable for 
repeat measurement in both humans and animals. Other commonly used biomarkers of 
in vivo ROS damage such as the TBARS assay require processing techniques which 
make them susceptible to artifactual interference post sampling. Provided adequate 
collection and storage procedures are observed, alkane analysis appears less 
susceptible to this limitation. Certain theoretical aspects of alkane analysis do, 
however, require further investigation. Notably the possibility that a proportion of the 
alkanes present in breath samples originate from the actions of the gastrointestinal flora 
on fatty acids within the gastrointestinal tract rather than in vivo lipid peroxidation has 
not been fully addressed. This possibility was of particular significance to the current 
studies since it was intended to feed a diet high in PUFA when investigating the in vivo 
antioxidant activity of green tea in an attempt to increase the susceptibility of biological 
membranes to lipid peroxidation and consequently increase antioxidant requirements. 
The aims of this investigation were therefore:
(1) to recommission the recirculation apparatus previously used to measure alkane 
production in animals;
(2) confirm the reproducibility of alkane analysis using this system;
(3) determine the origin of breath alkanes, in vivo lipid peroxidation or the action of 
the gastrointestinal flora on fatty acids within the gastrointestinal tract, and ascertain 
the validity of ethane production as a biomarker of lipid peroxidation stimulated by a 
high PUFA diet.
2. Methods
2.1. Validation of breath collection apparatus
The apparatus used to collect and concentrate breath samples from rats had lain 
dormant for some time prior to the current study. It was therefore necessary to 
recommision it and confirm that it was both free from alkane contamination and leak 
tight. The possibility that it might be contaminated with ethane and/or pentane was 
investigated by carrying out blank runs. These entailed operating the pump and
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circulating air throughout the apparatus without an animal or any desiccant in the 
chamber. Before each run the apparatus was thoroughly flushed with cylinder air 
containing no detectable ethane or pentane. The effects of cleaning the apparatus and 
changing the pump on background alkane contamination were then investigated. To 
clean the apparatus it was dismantled and all components except the pump were 
soaked and scrubbed in a scouring agent and acetone. The effect of the desiccants 
silica gel (self-indicating silica gel, 4-7 mesh, Tisons Ltd, Loughborough, UK) and 
calcium sulfate (Sikkon Fluka Universal Desiccant, 1-3 mm, Fluka, Gillingham, UK) 
on background levels of ethane and pentane within the apparatus and the circulating 
concentration of these alkanes following injection of the corresponding standard (01 
% ethane in nitrogen, 0*07 % pentane in air, Phase Separations Ltd, Deeside) into the 
animal chamber was also investigated. The entire system was tested for leaks by 
forcing compressed air into the chamber and observing any drop in pressure. Loss of 
ethane from the apparatus through leaks or adsorption was investigated by injecting 
ethane standard into the animal chamber and monitoring the concentration of ethane 
within the apparatus over a 2 hour period during which the pump was operated and air 
circulated through the system
2.2. Animals and study design
2.2.1. Reproducibility of alkane analysis. The reproducibility of alkane analysis was 
investigated in animals maintained under baseline conditions (i.e. animals consuming a 
standard rat chow diet which were not subject to any factors associated with oxidative 
stress) prior to its use as a biomarker of oxidative damage in subsequent studies. 
Samples of total body gas were collected from three female Lister Hooded rats (9 
weeks old) maintained on LAD 1 animal diet (SDS Ltd, Witham) daily for 4 
consecutive days and analysed for ethane and pentane. Background levels of ethane 
and pentane within the apparatus were also monitored on these days. The 
reproducibility of ethane production was then investigated following a protocol similar 
to that intended for use in subsequent studies. Samples were collected from a group of 
six female Lister Hooded rats (9 weeks old) at weekly intervals for 3 weeks.
2.2.2. Role of the gastrointestinal flora in ethane production. Twelve conventional 
female Lister Hooded rats (9 weeks old) were randomly divided into two groups of 
six. After measurement of baseline ethane production one group (MO) received a 
semi-synthetic diet containing 50 g/kg maize oil as the lipid source while the other
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group (FO) received a similar diet containing 50 g/kg of the fish oil MaxEPA 
(Sevenseas Ltd, Hull). The composition of semi-synthetic diet and fatty acid 
composition of the maize oil and MaxEPA are given in tables 5 and 6 respectively. 
After 1 week on the MO diet and 1 and 2 weeks on the FO diet ethane production was 
measured. Groups of six germ-fiee female Lister Hooded rats matched for age and 
weight were subject to the same dietary treatments, maize oil or fish oil. However, 
since it was not possible to return animals to germ-free conditions after ethane analysis 
it was only possible to measure ethane production once from each germ-free animal. 
Baseline ethane production and measurements taken after 1 week (MO and FO diets) 
and 2 weeks (FO diet only) were therefore carried out in separate groups of germ-free 
animals. The maize oil and fish oil diets used were irradiated to maintain germ-free 
conditions; both conventional and germ-free animals received the same irradiated diets. 
Animals were allowed free access to food which was vacuum sealed into daily portions 
and stored at -20 °C until use. Fresh food was provided daily. Conventional animals 
were fed the same irradiated GR3 diet (SDS Ltd, Witham) as germ-free animals for 5 
weeks prior to the study to minimise any differences between the two groups apart 
from the gastrointestinal flora.
Table 5. Composition of semi-synthetic diets
Component g/kg
Maize starch 652
Casein 100
Sucrose 100
Cellulose 50
Lipid 50
Mineral mix 35
Vitamin mix? 8-6
dl-Methionine 3
Choline chloride 1-4
t a-tocopherol supplied by lipid component of the diet: 
MO diet 40 mg/kg, FO diet 50 mg/kg
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Table 6. Fatty acid composition (mol%) of 
maize oil and MaxEPA
Fatty acid Maize oil MaxEPA
16:0 103 16-5
16:1 n9 01 11-8
18:0 14 3-8
18:1 n9 24-7 12-9
18:2 n6 607 3-8
18:3 n3 12 3-1
20:3 n6 0-2 6-5
20:4 n6 - 0-7
20:5 n3 06 19-4
22:4 n6 0-1 1-3
22:5 n3 - 1-5
22:6 n3 02 10-2
2.3. Sample collection and alkane analysis
2.3.1. Sample collection. Samples of total body gas were collected using the 
recirculation system developed by Preece et al. (1988). Single rats were sealed into a 
collection chamber which was connected to a recirculation system and the expired air 
circulated through the system using a Capex 2D electrical air pump with a teflon 
laminated head (Charles Austin Air Pumps Ltd, Weybridge) at a rate of 200 ml/min. 
Chamber air passed first through a cylinder containing a Neotronics oxygen sensor 
(Wessex Power Technology Ltd, Poole) connected to a servo valve via a Neotronics 
OTOX 90 oxygen monitor. Removal of oxygen by respiration in concentrations falling 
below the lower limit set on the oxygen monitor (21 %) resulted in an influx of medical 
grade oxygen (BOC Ltd, Guildford) into the apparatus via the servo valve. Passage 
through a second cylinder containing 6-16 mesh self-indicating soda lime (BDH Ltd, 
Pool) removed carbon dioxide. The recirculating air then passed through a 5 ml gas 
sampling loop connected to a Valeo gas sampling valve (Valeo Instruments Co., 
Houston, USA) and through the pump back into the chamber. Samples were taken for 
analysis via pneumatic operation of the gas sampling valve, an operation controlled
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automatically from the gas chromatograph. Water vapour was adsorbed by 25 g 
calcium sulfate (Sikkon Fluka Universal Desiccant, 1-3 mm, Fluka, Gillingham) placed 
in the chamber under a stainless steel grill on which the animal sat. Animals were 
sealed into the chamber via a glass observation port. With the exception of this 
observation port and parts of the pump the system was constructed entirely from 
stainless steel. All connections were made with swagelock fittings (Phase Separations 
Ltd, Deeside, UK). Laboratory air, which may contain hydrocarbons, was removed 
from the apparatus when sealing an animal into the chamber by flushing with 
compressed air previously scrubbed for ethane and pentane. After each run the 
chamber was cleaned and the desiccant and soda lime replaced.
Sample
loop
Gas sampling 
valve To column
Animal
chamber Soda limePump
Oxygen sensor
Servo
valve 21 0%
Oxygen
monitor
Oxygen
cylinder
Figure 4. Breath collection apparatus
2.3.2. Analysis. Alkane analysis was performed using a Perkin Elmer 8500 gas 
chromatograph (GO) equipped with a flame ionisation detector operated at 250 °C. 
Gas flows through the detector were 35 ml/min hydrogen and 350 ml/min air. Pentane 
and ethane were analysed separately using a 3 m x 12 mm id. 15 % OV-1 column and 
a 5 m x 2 mm id. 80-100 mesh Poracil C column (Phase Separations Ltd, Deeside, 
UK) respectively. Elution from both columns was carried out isothermally at 35 °C 
using nitrogen carrier gas at a flow rate of 35 ml/min. Data analysis was performed
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using Nelson analytical software (Perkin Elmer Nelson Systems Inc. Cupertino, USA) 
with reference to standard curves constructed by injection of known amounts of ethane 
and pentane standard gas into the animal chamber. All gas lines to the recirculation 
apparatus and GC were fitted with stainless steel puritubes filled with activated 
charcoal (Phase Separations Ltd, Deeside, UK) to remove hydrocarbon contaminants. 
Activated charcoal has been shown to be the most effective ethane adsorbent at room 
temperature (Lawrence and Cohen, 1982).
2.4. Peroxidation of diets
The MDA content of the semi-synthetic diets was measured using the method 
described in chapter 3. Portions of diet (OT g) taken after storage were reacted with 
DETEA in the same way as plasma and urine samples. The malondialdehyde content 
was estimated with reference to a standard curve constructed from TEP standard as 
described.
2.5. Statistical analysis
Comparisons between treatment groups were performed using student t test and 
analysis of variance with Tukey-Kramer multiple comparison test as appropriate.
3. Results
3.1. Validation of apparatus
Leak testing the apparatus by introducing compressed air through the tap on top of the 
chamber revealed some leaks which were sealed by tightening the appropriate fittings. 
The background concentration of pentane within the apparatus recorded without a rat 
or desiccant in the chamber is shown in figure 5. Over a 90 minute period during which 
time the apparatus was sealed and the pump operated there was a steady accumulation 
of pentane (or possibly a compound that coelutes with pentane) within the system 
Cleaning the chamber and recirculation system resulted in a significant decrease in 
pentane accumulation (P<0-05 after 90 minutes recirculation compared with 
corresponding measurements taken before cleaning). Changing the pump resulted in a
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much greater reduction in pentane accumulation (P<0-001 after 90 minutes 
recirculation compared with corresponding measurements taken before cleaning and 
changing the pump). These measures did not, however, completely purge the source of 
pentane contamination from the apparatus.
The accumulation of pentane within the apparatus during blank runs could, however, 
be prevented by silica gel, which was used as a water absorbent in preliminary 
experiments (figure 6). Measurements made after 90 minutes recirculation with 25 g 
silica gel in the animal chamber were not significantly different from those made at time 
0. They were, however, significantly lower than the corresponding measurements made 
without silica gel (P<0 01). Silica gel also affected the response to injection of pentane 
standard (figure 6). Following injection of 100 pi 0-7 % pentane into the animal 
chamber the recirculating concentration of pentane within the apparatus when the 
chamber contained silica gel was, on average, only 13 % of that recorded when the 
same amount of pentane standard was injected and silica gel absent from the animal 
chamber. Calcium sulfate had no significant effect on either the background 
accumulation of pentane within the apparatus or the recirculating concentration of 
pentane, measured after 90 minutes, following injection of pentane standard (figure 7).
Unlike pentane, ethane could not be detected in the recirculation apparatus after at 
least 90 minutes recirculation when blank runs were carried out both with and without 
calcium sulfate in the animal chamber. Similarly, the recirculating concentration of 
ethane following injection of ethane standard into the animal chamber was not 
significantly affected by calcium sulfate or the duration of recirculation (up to 90 
minutes).
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3.2. Reproducibility of alkane analysis
Measurement of alkane production did not appear to stress the animals since normal 
sleeping and preening behaviour was observed while animals were in the animal 
chamber. There was no significant difference in pentane accumulation within the 
apparatus when measurements taken with an animal and calcium sulfate in the animal 
chamber were compared with blank runs (background) carried out without an animal 
(table 7). This effect was consistent in all three animals used. Baseline ethane 
production could, however, be detected after 30 minutes recirculation (table 8).
Table 7. Accumulation of pentane in the recirculation apparatus operated
with and without a female Lister Hooded rat in the chamber.
Time in chamber (minutes)
0 30 60 90
Animal 1 22 ± 8 49± 10 78 ± 9 93± 10
Animal 2 22 ±26 63 ±27 79 ± 6 90 ± 6
Animal 3 29 ± 16 68 ±23 87± 12 110 ± 9
Background 14± 18 46 ± 34 73 ±41 97 ±50
Values are expressed as peak area. Each value represents the mean ± S.D. of four 
measurements carried out on consecutive days. There was no statistically significant 
difference in pentane accumulation between individual animals or animals and 
background
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Table 8. Baseline ethane production from female Lister Hooded rats.
Time in chamber (minutes)
0 30 60 90
Animal 1 0 1-6 ± M 2*2 ± 0*6 2-7 ±0-8
Animal 2 0 1-4 ±0-2 2 2 ± 0-5 2-9 ±0-5
Animal 3 0 1*8 ±0-3 31 ± 0 4 3-6 ±0-3
Background 0 0 0 0
Values expressed as nmol/kg. Each value represents the mean ± S.D. of four 
measurements carried out on consecutive days.
The reproducibility of ethane analysis from week to week is shown in table 9. There 
was no statistically significant difference in ethane production between weeks 0, 1 and 
2.
Table 9. Reproducibility of ethane production measured in
female Lister Hooded rats (n=6).
Week
0 1 2
3 1 ± 0 5 2-9 ± 0-5 3-2 ±0-8
Values are mean ± S.D. expressed as nmol/kg/90 minute recirculation. 
There were no statistically significant differences between weeks 0,1 and 
2.
3.3 Role of gastrointestinal flora in ethane production
There was no statistically significant difference in ethane production between 
conventional and germ-free animals at baseline when both groups were maintained on 
the same irradiated GR3 diet (table 10). Replacing the GR3 diet with the semi­
synthetic MO diet resulted in a significant increase in ethane production from germ- 
free animals after 1 week (P<0-0001). Ethane production from conventional animals
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was, however, unaffected by the MO diet and was significantly lower than that from 
germ-free animals after 1 week on this diet (P<0-001). Substituting the GR3 diet for 
the FO diet resulted in a large increase in ethane production from both conventional 
and germ-free animals after 1 week which was maintained after a further week on this 
diet. Ethane production from germ-free animals was slightly greater than that from 
conventional animals after both 1 and 2 weeks on this diet. There was however no 
significant difference between the two groups.
Table 10. Effect of the gastrointestinal flora on ethane production from rats fed
diets of different fatty acid composition
Maize oil MO Fish oil FO
Baseline 1 week Baseline 1 week 2 weeks
Conventional 2-2 2-59 2-7 22*7&b 26-7°
animals ± 0-3 0*8 0-5 3 8 97
Germ-free 2-2t 6-9d 2-2Î 29-4*’a 30-9b
animals ± 0-3 08 03 5-4 120
Values are mean ± S.D. of six animals per group expressed as nmol/kg/90 minutes 
recirculation. Letters indicate significant difference from corresponding baseline a P<0-05, 
b P<0 01. c P<0-001, d PcO.OOOl. ÎP<0*001 compared with corresponding 1 week MO. ® 
P<0 001 compared with germ-free 1 week MO.  ^Germ-free MO and FO baseline same group of 
animals.
4. Discussion
In agreement with Lawrence and Cohen (1982) silica gel was found to adsorb alkanes 
at room temperature and could not be used to remove water vapour while collecting 
samples from rats. Background levels of pentane within the recirculation apparatus 
were, however, unaffected by calcium sulfate. Similarly, although the concentration of 
pentane within the recirculation apparatus following injection of pentane standard was 
slightly reduced by addition of calcium sulfate to the animal chamber this effect was 
not statistically significant after 90 minutes recirculation. Calcium sulfate also had no 
statistically significant effect on the concentration of ethane within the recirculation
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apparatus following injection of ethane standard and was therefore used as desiccant 
throughout the animal experiments.
The major PUFA in animal tissues are linoleic acid and arachidonic acid, both of which 
are of the n-6 variety (Kneepkens et a l, 1994). Lepage and Roy (1986) estimated the 
ratio of n-6 to n-3 PUFA in body tissues to be 4:1. The flame ionisation detector 
response per mole of pentane is approximately 2-5 times greater than that of ethane. At 
first glance pentane therefore appears to be a more sensitive biomarker of in vivo lipid 
peroxidation compared with ethane. Given the very low levels of alkanes encountered 
in breath samples collected from animals and humans, which require concentration 
prior to analysis, measurement of pentane production therefore appears preferable to 
ethane analysis, although both alkanes should, of course, be measured when possible. 
Like other methods used to monitor in vivo lipid peroxidation alkane analysis does, 
however, suffer from both theoretical and practical problems to which pentane appears 
more vulnerable than ethane. This is particularly so if a recirculation system is used to 
collect and concentrate samples. In the current study pentane analysis also proved 
problematical. The background concentration of pentane within the recirculation 
apparatus increased when blank runs were carried out without an animal or silica gel in 
the animal chamber. Although cleaning and, to a much greater extent, changing the 
pump reduced the level of contamination these steps could not prevent it completely. 
Cleaning might have removed any dirt or oil which could have been a source of 
pentane. The dramatic effect of changing the pump is, however, surprising when it is 
realised that the Capex 2D pump initially used was replaced by an outwardly identical 
pump of the same model. However, neither pump was purchased new for the current 
study and the work load and other factors associated with each are unknown. 
Repeated operation of the apparatus failed to produced any further decrease in pentane 
accumulation below that shown in figure 5.
Despite the background accumulation of pentane within the apparatus an attempt was 
made to measure pentane production from female Lister Hooded rats. As can be seen 
from table 7 pentane production from all the rats used was indistinguishable from 
background levels within the apparatus, measured on the same day as the animal 
studies, even after 90 minutes recirculation. Other investigators have previously 
recorded endogenous pentane production from rats using similar equipment and over a 
shorter time period (Frank et a l, 1980; Filser et a l, 1983). In the present experiment, 
ethane production could, however, be detected after 30 minutes recirculation. For this
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and other reasons discussed below pentane analysis was abandoned and ethane used to 
monitor in vivo lipid peroxidation.
The use of ethane and pentane exhalation as biomarkers of in vivo lipid peroxidation is 
based on the assumption that exhalation is a direct reflection of formation from 
decomposition of lipid hydroperoxides. Accordingly it is assumed that any change in 
the concentration of ethane or pentane in breath samples would be caused exclusively 
by a corresponding change in the degree of in vivo lipid peroxidation or hydroperoxide 
decomposition. Although this statement may hold true for many conditions associated 
with ROS damage it is not always the case and changes in exhalation must be 
interpreted with caution in some situations. For example, exposure to elevated 
concentrations of oxygen or smoking may alter exhalation through mechanisms 
independent of the ROS damage associated with these conditions. Alkanes are also 
subject to cytochrome P450-dependant metabolism. Indicative of this phenomenon is 
the observation that the concentration of alkanes in a closed recirculation system 
containing Wistar or Sprague-Dawley rats approaches a steady level as the duration of 
the experiment continues (Frank et a l, 1980; Filser et a l, 1983; Remmer et a l, 1984). 
Thus changes in the rate of alkane metabolism will affect the perceived level of lipid 
peroxidation independent of the actual level of peroxidation occurring in vivo. For 
example, although ethanol and carbon tetrachloride are associated with oxidative 
damage, and as such would be expected to increase alkane exhalation, they also 
diminish alkane metabolism. Acute administration of ethanol has been shown to inhibit 
pentane metabolism in Sprague-Dawley and Wistar rats by as much as 87 % (Remmer 
et a l, 1984), while carbon tetrachloride, which destroys cytochrome P450 in the liver 
and other tissues, has been shown to decrease pentane clearance by Sprague-Dawley 
rats by 85 % (Allerheiligen et a l, 1987). If a recirculation system is used to collect 
breath samples, alkanes will be subject to metabolism both prior to release and on 
reabsorption by the lungs. Measurements carried out using this system are therefore 
particularly vulnerable to effects of altered alkane clearance.
Allard and associates have reported the concentration of ethane in human breath 
samples collected after breathing hydrocarbon-free air for 4 minutes to be in the order 
of 11 pmol/kg/min while the corresponding pentane concentration is 6 pmol/kg/min 
(Allard et a l, 1994a,b). Seabra et al. (1991) reported the concentrations of ethane and 
pentane in human breath to be 3*51 and 212 pmol/kg/min respectively after breathing 
hydrocarbon-free air for 10 minutes. Although there is a large difference in the 
concentrations reported by these two groups (which may be explained by the different
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wash-out times employed) the concentration of ethane was, nonetheless, consistently 
greater than that of pentane. This ratio of exhaled alkanes is not consistent with the 
reported ratio of n-6 to n-3 PUFA in the body. Similarly, the ratio of ethane to pentane 
accumulating in a recirculation system containing Wistar or Sprague-Dawley rats is 
greater than that anticipated from in vivo lipid peroxidation (Frank et a l, 1980; 
Remmer et a l, 1984). The kinetics of ethane and pentane accumulation from rats in a 
closed system are also dissimilar. These observations can be explained by the finding 
that the rate of alkane metabolism increases with increasing molecular mass (Frank et 
al, 1980). Thus metabolic clearance of pentane by Sprague-Dawley rats is much more 
rapid than that of ethane (Frank et a l, 1980; Daugherty et a l, 1988). Remmer et a l 
(1984) calculated the clearance of ethane and pentane by Sprague-Dawley rats in a 
closed system to be 0-5 1/h and 2-21/h respectively. Pentane production is therefore far 
more vulnerable to changes in metabolism than ethane production. For example, 
administration of 0*3 ml/kg carbon tetrachloride to NMRI mice resulted in a 40- and 
25-fold increase in pentane and ethane production respectively (Remmer et a l, 1984). 
As alluded to previously, carbon tetrachloride destroys cytochrome P450 when it is 
reduced to a radical and therefore diminishes alkane metabolism in addition to 
stimulating lipid peroxidation. Paracetamol, which was shown to have no effect on 
pentane metabolism, resulted in a three-and 10-fold increase in pentane and ethane 
production respectively. Similarly, treatment of male Wistar rats with FeCl^, which was 
also shown to have no effect on ethane or pentane metabolism, resulted in an 
approximately seven-fold increase in ethane production compared with a two-fold 
increase in pentane production (Filser et a l, 1983). Preece et a l  (1988) reported 
ethane to be the most sensitive biomarker of in vivo lipid peroxidation in breath 
samples collected from mice treated with iron nitrilotriacetate.
Thus it can be concluded that, compared with pentane, ethane is not only a more 
sensitive biomarker of in vivo lipid peroxidation but it is also more reliable and more 
representative of the actual level of lipid peroxidation occurring in vivo. This is 
especially so if samples are collected and concentrated using a recirculation system 
Ethane also appears to be the alkane of choice if diets rich in fish oil are fed in an 
attempt to increase the susceptibility of biological membranes to lipid peroxidation, as 
was intended when investigating the in vivo antioxidant activity of green tea. Duthie et 
al (1987) observed a two-fold increase in ethane production when the 5 % lard diet of 
Lister Hooded rats was replaced with a similar diet containing 5 % cod liver oil for 2 
weeks. Pentane production measured in the same animals decreased by 50 % in 
response to this dietary change. Feeding rats fish oil has also been reported to increase
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ethane exhalation and diminish pentane exhalation following carbon tetrachloride 
administration (Remmer et ah, 1984).
The method of pentane analysis has also been criticised. KohlmuUer and Kochen 
(1993) reported that the packing materials commonly used to analyse short chain 
hydrocarbons, including Poracil C, Tenax GC, activated alumina and Poraplot Q, fail 
to separate pentane from isoprene, although separation could be achieved using a 
Poraplot U column. In breath samples collected from healthy humans KohlmuUer and 
Kochen (1993) reported the concentration of pentane to be only 5 % that of isoprene. 
Springfield and Levitt (1994) found isoprene coeluted with pentane on columns packed 
with Chromosorb 102 or Carbopack B. After removal of isoprene from human breath 
samples most of the peak initially identified as pentane using a column packed with 
Chromosorb 102 was eliminated. Thus most of the peak previously identified as 
pentane in studies using the columns listed above might have been isoprene. Any 
change in isoprene exhalation could therefore be misinterpreted as a change in lipid 
peroxidation. Given that pentane exhalation is only 5 % that of isoprene any genuine 
change in pentane exhalation in response to a change in in vivo lipid peroxidation could 
also be severely underestimated or even masked. Cailleux et al. (1992) reported the 
isoprene concentration in human blood to be much greater than that measured in the 
blood of animals including the rat (37 ± 25 nmol/1 human, <1 nmol/1 rat). Isoprene 
contamination therefore appears to be a much more significant factor in studies with 
humans compared with animal investigations.
Female Lister Hooded rats were selected as the experimental animals for no other 
reason than the size of the chamber in which the animals were contained during sample 
collection. Their small size compared with Wistar rats, which were also available at the 
University of Surrey, allowed the use of older animals. Another unexpected advantage 
of Lister Hooded rats might have been slower metabolic clearance of alkanes 
compared with other commonly used strains of rat. Remmer et al. (1984) found that 
the rate of pentane metabolism is strain dependent, being much more rapid in Wistar 
compared with Sprague-Dawley rats. When samples of total body gas were collected 
from these strains using a recirculation system the concentrations of ethane, and 
particularly pentane, within the apparatus approached a steady state level within 2 
hours, an observation indicative of metabolism (Frank et al, 1980; Filser et al, 1983; 
Remmer et a l 1984). Duthie et al (1987) reported that the concentration of these 
alkanes in a similar closed system containing Lister Hooded rats increased linearly for
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at least 6 hours. Thus Lister Hooded rats might be particularly suited to experiments in 
which it is intended to monitor alkane production.
One of the factors which calls into question the validity of alkane exhalation as a 
biomarker of in vivo lipid peroxidation and is of particular significant to the current 
study is the possibility that alkanes present in breath might derive from the action of 
the gastrointestinal flora on fatty acids within the gastrointestinal tract in addition to in 
vivo lipid peroxidation. The term in vivo will be used here and throughout the 
remainder of this chapter to indicate peroxidation within the body, distinct from events 
within the gastrointestinal tract. The degree, if any, to which this is the case is likely to 
depend on the experimental conditions employed. It is to be anticipated that the 
gastrointestinal flora would be a more significant source of ethane and pentane when 
diets rich in n-3 and n-6 PUFA are fed compared with other situations associated with 
ROS damage which do not involve either dietary manipulation or changes in the 
gastrointestinal flora. Accordingly the increase in ethane exhalation reported by Duthie 
et al. (1987) when the lard diet of rats was replaced by a similar diet containing fish oil 
might not have been solely due to an increase in in vivo lipid peroxidation. The 
evidence presented in support of this hypothesis appears to consist primarily of the 
findings of Gehnont et al. (1981). They observed that removal of linoleic acid from the 
diet, starving, addition of ascorbic acid to the drinking water or diet and addition of 
antibiotics to the drinking water decreased pentane release from vitamin E-deficient 
rats. Oral administration of peroxidized linoleic add, but not unoxidized linoleic acid, 
to normal rats was also shown to stimulate pentane release. From these observations 
they concluded that the major source of pentane in the total body gas of vitamin E- 
deficient rats is not in vivo lipid peroxidation but the action of intestinal bacteria on 
linoleic hydroperoxide. As will be discussed below their observations can in part be 
explained in terms other than pentane production by the gastrointestinal flora and 
might have been peculiar to the vitamin E-deficient animals and vitamin E-deficient diet 
on which they were maintained.
First of all it is important to establish that ethane and pentane are indeed produced 
from in vivo lipid peroxidation independent of the gastrointestinal flora. Roberts et al. 
(1983) found that ethane production from suckling new-born rats increased between 1 
and 2 days of age and decreased thereafter to a stable level at 3 days which was 
maintained for at least a week. There was no consistent change in pentane production 
during the first 3 days of life. Similar observations have been made in humans. Ethane 
and pentane exhalation from premature infants increased each day for the first 4 days
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of life and decreased thereafter (Pitkânen et a l, 1990). In these same individuals the 
highest ethane and pentane values were recorded prior to the introduction of enteral 
feeding. The gastrointestinal tract is not colonised at birth and the gastrointestinal flora 
takes several days to establish itself (Kneepkens et a l, 1994). These observations are 
therefore consistent with ethane and pentane production independent of the 
gastrointestinal flora. The increase in ethane and pentane exhalation accompanying 
treatment with FeCl^ or paracetamol (Filser et a l, 1983; Remmer et a l, 1984), both of 
which have no effect on alkane metabolism, is also indicative of alkane exhalation 
subsequent to in vivo lipid peroxidation.
Increased alkane exhalation independent of the gastrointestinal flora has also been 
demonstrated in response to a lipid challenge. Van Gossum et a l (1988b) reported that 
intravenous infusion of a lipid emulsion rich in linoleic acid increased pentane 
exhalation from both normal healthy humans and patients undergoing home parenteral 
nutrition. Similarly, parenteral infusion of a safflower oil emulsion increased pentane 
exhalation in human infants and new-born rabbits without affecting ethane exhalation 
(Wispe et a l, 1985). The increase in alkane exhalation observed in this study appears 
to reflect the fatty acid composition of the lipid emulsion (77 % linoleic acid and no 
linolenic acid). Intravenous infusion of a soybean oil emulsion has also been reported 
to increase alkane production in new-born rabbits (Wispe et a l, 1986). In this case 
both ethane and pentane exhalation increased. Again this was consistent with the 
composition of the lipid infusion (54 % linoleic acid, 8 % linolenic acid). Thus the 
increase in peroxidizable substrate available after parenteral lipid infusion appears to 
result in increased in vivo lipid peroxidation and the lipid infusion itself rather than 
membrane PUFA, appears to be the principal source of the increased lipid 
peroxidation, as might be expected. Acute enteral administration of lipid has also been 
shown to increase alkane production. Mooradian et a l (1994) reported a significant 
increase in ethane production from rats gavaged with 8 ml/kg nutralipid. The 
magnitude of this effect was found to depend on the age of the animals, with the 
response of 24-month-old animals only 50 % of that seen in 4-month-old animals. 
Given that the rat gastrointestinal flora would be established by 4 months of age this 
age-related difference is difficult to explain in terms of ethane production from bacteria 
within the gastrointestinal tract. Rather it might reflect a difference in in vivo lipid 
peroxidation after absorption into the body. Thus it appears that in vivo lipid 
peroxidation, and therefore alkane production, might also be stimulated by orally 
administered lipid. The possibility that the gastrointestinal flora is at least contributing
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to the increase in ethane production seen by Mooradian et al. (1994) cannot, however, 
be ruled out since ethane production increased in both 4-and 24-month-old animals.
It can now be concluded that the amount of ethane and pentane in breath samples 
which has originated from in vivo lipid peroxidation depends on the recent intake of 
fatty acids (either enterally or parenterally) which are not an integral part of cell 
membranes in addition to membrane PUFA composition. Thus, although the reduction 
in pentane release observed by Gehnont et al. (1981) in response to starving, feeding a 
fat-free diet, or a diet containing oleic acid as the lipid source may be explained in 
terms of removal of the substrate for the gastrointestinal flora, it is also possible that 
these effects were due to a decrease in peroxidizable substrate available in vivo. This 
latter possibility is particularly pertinent to the study of Gehnont et a l (1981) since the 
experimental animals they used were consuming a vitamin E-deficient diet and were 
presumably themselves deficient in vitamin E since they were maintained on this diet 
from weaning until 6 months old. As will be discussed below, the effects of recent diet 
on m vivo lipid peroxidation might have been exacerbated under these circumstances. 
The correlation between pentane in total body gas and the amount of food eaten during 
the day prior to analysis observed by Gehnont et al (1981) can also be explained in 
similar terms.
Gehnont et a l (1981) concluded that linoleate hydroperoxide, rather than unoxidized 
linoleic acid, is the substrate for pentane production by the gastrointestinal flora. 
Unfortunately they did not provide any data regarding the peroxide content of the 
vitamin E-deficient diet they used or factors which will affect it such as the conditions 
under which the diet was prepared and stored or the frequency with which animals 
were provided with fresh food. Even if it was prepared and stored under conditions 
chosen to minimise peroxidation and replaced frequently it is to be expected that the 
diet would have contained a greater concentration of lipid peroxidation products 
compared with a similar diet containing vitamin E. It is under conditions such as these 
that pentane production by the gastrointestinal flora is likely to be seen if the 
hypothesis of Gehnont et al (1981) is correct. Hie conditions used were, however, 
also likely to exacerbate any effect the diet might have on in vivo lipid peroxidation. 
Because the diet was deficient in vitamin E dietary PUFA would have been more 
susceptible to in vivo peroxidation compared with PUFA from a similar diet containing 
vitamin E. Similarly, increased in vivo peroxidation of dietary PUFA might be 
anticipated in the vitamin E-deficient animals used compared with animals replete in 
vitamin E. Thus the conditions used by Gehnont et a l (1981) might have enhanced
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pentane production from both the gastrointestinal flora and in vivo lipid peroxidation. 
These therefore remain alternative explanations for their observations.
In support of their conclusion Gehnont et al (1981) reported that addition of ascorbic 
acid to the diet of vitamin E-deficient animals resulted in a dramatic reduction in 
pentane release such that it was similar to that measured from normal animals 
maintained on a standard rat chow. They postulated that this effect was mediated 
through a reduction in the hydroperoxide content of the diet. As will be discussed in 
chapter 4 the oxidation status of the diet appears to be a key determinant of in vivo 
alkane production. Thus, if they are correct and ascorbic acid did indeed protect the 
diet from peroxidation its effect can be explained by a reduction in in vivo pentane 
formation as well as by a reduction in formation by the gastrointestinal flora. Removal 
of vitamin E from the diet of normal animals for a short period also increased pentane 
release. Again this effect is consistent with both possibilities. The observation that 
pentane release could also be reduced by addition of ascorbic acid to the drinking 
water is not obviously consistent with the hypothesis of Gehnont et a l (1981) since it 
would not have protected dietary PUFA from peroxidation. It is possible that this 
treatment attenuated in vivo lipid peroxidation, particularly in the vitamin E-deficient 
animals used, and therefore reduced in vivo pentane production. The possibility that 
ascorbic acid might have protected linoleic acid from peroxidation within the 
gastrointestinal tract or directly interfered with pentane production by the 
gastrointestinal flora cannot be ignored. Similar to the effect of adding ascorbic acid to 
the diet, a single dose of a-tocopherol also reduced pentane production to a level 
similar to that measured from control animals. Although the exact detail was not given, 
this dose does not appear to have been given with the diet and would not, therefore, 
have reduced the peroxide content of the diet. Once again this observation is not 
obviously consistent with the theory presented by the authors (Gehnont et al, 1981). 
Given the likelihood that the animals dosed with a-tocopherol were severely deficient 
in vitamin E and the fact that they were releasing approximately 70 times more pentane 
than control animals, a plausible explanation for this effect is a reduction in in vivo lipid 
peroxidation. In accordance with this explanation breath pentane has been shown to 
correlate with plasma vitamin E levels in humans (Lemoyne et a l, 1987). The capacity 
of orally administered a-tocopherol to reduce alkane production in healthy humans has 
also been demonstrated (Van Gossum et a l, 1988a; Hoshino et al, 1990). Bacteria in 
the human bowel are mainly in the colon while vitamin E is absorbed in the small bowel 
(Van Gossum and Decuyper, 1989). It is therefore unlikely that the reduction in
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pentane exhalation caused by cc-tocopherol in these studies was due to an affect on the 
gastrointestinal flora.
A further piece of evidence presented by Gelmont et a l (1981) in support of their 
conclusion is the finding that oral administration of 0 5 ml peroxidized linoleic acid 
induced the rat to produce pentane whereas unoxidized linoleic acid did not. Once 
again this observation is consistent with both possible explanations, production by the 
gastrointestinal flora and in vivo lipid peroxidation. This finding is, however, important 
in one aspect. If alkanes are indeed produced from lipid hydroperoxides the apparent 
non-effect of unoxidized linoleic acid indicates that peroxidation of dietary lipid does 
not occur to any significant extent within the gastrointestinal tract. The reduction in 
pentane release observed by Gelmont et al. (1981) when ascorbic acid was added to 
the drinking water or animals were given a single dose of a-tocopherol is therefore 
unlikely to be mediated through a reduction in peroxidation within the gastrointestinal 
tract.
Alternative explanations can therefore be found for the observations of Gelmont et al 
(1981) discussed so far. One piece of evidence presented by these authors is, however, 
difficult to refute. Addition of antibiotics to the drinking water of vitamin E-deficient 
rats reduced pentane release to a level similar to that measured from control animals, 
similar to the effect of a single dose of a-tocopherol. Other investigators have, 
however, reported that antibiotics have no effect on alkane production. Using normal 
rats which were not deficient in vitamin E and presumably maintained on a diet which 
was also adequate in vitamin E, Remmer et a l (1989) found the same antibiotics used 
by Gelmont et a l (1981) did not diminish exhalation of any of the alkanes or alkenes 
they monitored. The observations of Gelmont et a l (1981) might therefore have been 
peculiar to the vitamin E-deficient animals or the vitamin E-deficient diet on which 
they were maintained. Vitamin E deficiency itself does not necessarily increase alkane 
production (Duthie et a l, 1987). The elevated pentane release from the vitamin E- 
deficient animals used by Gelmont et al (1981) might therefore have been caused by 
the diet on which they were maintained. Accordingly the effects of the various 
treatments they investigated may have been related to this diet, rather than the vitamin 
E-deficient nature of the animals, as was suggested. It is likely that the diet used by 
Remmer et a l (1989) was relatively free of peroxidation products compared with that 
used by Gelmont et al (1981). This slight difference in experimental design means that 
the results obtained by Remmer et al (1989) do not necessarily bring into question 
those obtained by Gelmont et a l (1981). The observations of Remmer et a l (1989)
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0do, however, indicate that the gastrointestinal flora^^i/not a significant source of 
alkanes or alkenes in animals maintained under the conditions they employed. On these 
grounds ethane and pentane exhalation can therefore be considered as valid biomarkers 
of in vivo lipid peroxidation in such animals provided there are no changes in diet or 
the gastrointestinal flora. The validity of alkane exhalation as a biomarker of in vivo 
lipid peroxidation is, however, still far from certain if the diet is deficient in antioxidant 
nutrients, rich in PUFA or subject to any other conditions which are likely to result in a 
high peroxide content.
In the present series of experiments it was intended to investigate the in vivo 
antioxidant activity of green tea in animals maintained on normal (replete in vitamin E) 
diets and vitamin E-deficient diets containing either maize oil or fish oil as the lipid 
source. These conditions are, unfortunately, likely to result in alkane production by the 
gastrointestinal flora if Gelmont et al. (1981) are correct. It was therefore necessary to 
establish unequivocally whether or not the gastrointestinal flora produces alkanes from 
fatty acids or fatty acid hydroperoxides within the gastrointestinal tract before 
continuing with further studies. To this end semi-synthetic maize oil and fish oil diets 
of the same composition as those intended for use in future studies were fed to groups 
of conventional and germ-free animals and ethane production compared between the 
two groups. Despite the fact that the diets used in this study were of the same 
composition as those intended for use in subsequent studies there were important 
differences in preparation procedures which meant that the diets used in this case were 
peroxidized to a greater extent than those used in subsequent studies. To maintain 
germ-free conditions the diets used in this study were irradiated, a procedure which 
was not carried out on diets used in subsequent studies. Irradiation would be expected 
to result in peroxidation of dietary lipid and destruction of vitamin E. The diets used in 
subsequent studies were prepared in weekly batches and stored at -20 °C immediately 
after preparation and until use. The irradiated diets were stored at room temperature 
for 3 days and prepared in one batch. This would be expected to further increase 
peroxidation of dietary lipid which does indeed appear to have been the case since the 
irradiated and non-irradiated fish oil diets contained 118*0 and 14*6 nmol MDA/g 
respectively.
Thus in fight of the preceding discussion it now appears reasonable to assume that if 
there is no significant difference in ethane production between conventional and germ- 
free animals fed the irradiated maize oil and fish oil diets alkane production can be
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considered a valid index of in vivo lipid peroxidation in subsequent studies in which the 
diet has not been irradiated and has a lower MDA content.
There was no significant difference in ethane production between germ-fiee and 
conventional animals at baseline, confirming that the gastrointestinal flora is not a 
significant source of ethane production in animals fed a standard rat chow containing 
vitamin E, even if it has been irradiated. After 1 week on the maize oil diet there was a 
significant increase in ethane production from germ-free animals only. This effect is not 
obviously consistent with the gastrointestinal flora as the principal source of alkane 
production. It must, however, be remembered that the maize oil diet was rich in n-6 
PUFA. Pentane production might therefore have been a better marker of alkane 
production by the gastrointestinal flora in these animals.
The GR3 diet fed to the germ-free animals from weaning until the start of the study 
contained 2 % fish meal and was therefore unlikely to have a lower n-3 PUFA content 
than the maize oil diet with which it was replaced. The three-fold increase in ethane 
production from germ-free animals accompanying replacement of the GR3 diet with 
the maize oil diet is therefore perhaps surprising. A possible explanation for this is that 
lipid peroxidation products within the maize oil diet, formed on irradiation and storage 
at room temperature, stimulated peroxidation of membrane PUFA. This possibility can 
also explain some of the observations of Gelmont et al. (1981) which they attributed to 
the gastrointestinal flora as alluded to previously. The restriction of this effect to germ- 
free animals is surprising when it is realised that both conventional and germ-free 
animals were fed the same irradiated GR3 diet prior to the study. Differences in 
membrane fatty acid composition which could result in a different spectrum of alkanes 
subsequent to in vivo peroxidation of membrane PUFA therefore appear unlikely. This 
finding may, however, indicate that the germ-free animals were more susceptible to in 
vivo lipid peroxidation, stimulated by the diet, compared with conventional animals. 
Again this explanation strengthens the possibility that some of the findings of Gelmont 
et al. (1981) were due to peroxidation of membrane PUFA subsequent to ingestion of 
a peroxidized diet since their study was conducted in vitamin E-deficient animals.
After 1 week on the fish oil diet there was a significant increase in ethane production 
from both germ-free and conventional animals which was maintained after a further 
week on this diet. There was no significant difference in ethane production between 
germ free and conventional animals at either of the time points measured. Again this is
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not obviously consistent with the gastrointestinal flora as the principal source of 
alkanes in samples of total body gas collected from rats.
Although it can now be concluded that the gastrointestinal flora is not a significant 
source of ethane production in rats fed the irradiated maize oil, fish oil and GR3 diets 
used in this study, the possibility that alkanes might originate from the faeces must, 
however, be addressed before alkane production can be truly accepted as a biomarker 
of in vivo lipid peroxidation. Gelmont et al. (1981) found that pentane evolution from 
the tail end of rats was 14 times greater than that from the head end when faeces were 
produced. In the absence of faeces pentane produced from the tail end was only 15 % 
of that seen when faeces were present and production from the head end was now five 
times greater than that from the tail end. In agreement with Gelmont et al. (1981), 
Hiele et al. (1991) reported production of pentane on incubation of human faeces with 
com oil and concluded that pentane was formed by faecal flora if supplied with lipid 
substrate. Kivits et al. (1981) also demonstrated production of ethane, propane and 
pentane from the faeces of rats fed a sunflower oil diet. Alkanes present in breath, 
whether they originate from in vivo lipid peroxidation or the gastrointestinal flora, 
might therefore be a minor component of the alkanes collected from whole rats 
enclosed in a recirculation system, such as that used in the current investigation. Thus, 
although the gastrointestinal flora does not appear to be a significant source of ethane 
the validity of ethane as a biomarker of in vivo lipid peroxidation in animals is still 
debatable. Other investigators have, however, reported that ethane could not be 
detected from fresh urine or faeces (Preece et a l, 1988). In the current study ethane 
production when faeces were produced was not significantly different from that when 
there were no faeces in the animal chamber.
In conclusion the relationship between dietary fatty acid composition and alkane 
production has been reaffirmed. The gastrointestinal flora is not a significant source of 
ethane production in rats fed the diets rich in n-3 and n-6 PUFA used in this study. 
Similarly, the faeces do not appear to have been a significant source of alkanes in 
animals fed such diets. The dramatic increase in ethane production seen on replacing 
the GR3 diet with the fish oil diet is therefore a consequence of events in vivo. Ethane 
production can therefore be considered a valid biomarker of in vivo lipid peroxidation 
in humans and animals.
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Chapter 4
Investigations into the antioxidant 
activity of green tea in animals
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1. Introduction
With reference to chapter 1 section 6 it can be seen that the opportunity for a 
compound to display in vivo antioxidant activity is facilitated by imposition of a mild 
oxidative stress, which results in a measurable increase in biomarkers of ROS damage, 
on the study group. The ultimate aim of these studies was to investigate the antioxidant 
activity of green tea in humans. A treatment was therefore required which was both 
ethically acceptable and proven to increase biomarkers of ROS damage in animals and 
humans. Ideally the capacity of antioxidant nutrients to attenuate this effect would also 
have been demonstrated. Possible treatments include smoking, vigorous physical 
exercise, ethanol consumption and increasing the PUFA component of the diet. Of 
these, increasing the PUFA component of the diet appears an acceptable and reliable 
method of increasing antioxidant requirements which can be used in both animals and 
humans (Muggli, 1994). Fish oils are particularly suited for this purpose since they 
contain relatively high concentrations of the highly unsaturated fatty acids EPA and 
DHA.
It has been shown that the fatty acid composition of rat tissue phospholipids reflects 
the fatty acid composition of the diet on which the animal is maintained (Watanabe et 
ai, 1989. Saito and Nakatsugawa, 1994). L'Abbé et a l (1991) found that increasing 
the amount of n-3 PUFA in the diet resulted in an increase in the amount of DHA in rat 
heart and liver total lipids. This was accompanied by a reduction in arachidonic acid or 
linoleic acid, depending on the sex of the animal and the particular organ studied, and 
an increase in the unsaturation index. Swanson and Kinsella (1986) reported that 
cardiac phospholipids from rats fed a diet containing 5 % menhaden oil had higher 
levels of EPA and DHA and lower levels of arachidonic acid when compared with 
corresponding phospholipids from rats fed a similar diet containing hydrogenated 
coconut oil as the lipid source. Cardiac phospholipids from animals fed the menhaden 
oil diet also had a greater unsaturation index. Feeding diets rich in cod liver oil and 
salmon oil has also been reported to increase the proportion of DHA and EPA in 
cardiac phospholipids, in place of linoleic acid and arachidonic acid, and to increase the 
unsaturation index in the case of the salmon oil diet (Gudbjamason and Oskarsdottir, 
1977; Nalbone et al, 1988).
Thus it has been well documented that the highly unsaturated fatty acids in fish oil are 
incorporated into phospholipids in place of less saturated fatty acids and that this 
results in an increase in the unsaturation index. Increasing the fish oil component of the
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diet would therefore be expected to increase the susceptibility of biological membranes 
to lipid peroxidation and increase antioxidant requirements. Muggli (1994) estimated 
that the minimum amount of vitamin E needed to compensate for the elevated vitamin 
E demand caused by EPA and DHA is 1-5 and 1-8 mg a-tocopherol/g respectively. If 
these requirements are not met depletion of antioxidant nutrients and lipid peroxidation 
may occur. Indeed these are well documented consequences of fish oil 
supplementation.
Erythrocyte membranes prepared from rats given 4 g/kg/day sardine oil for 7 or 14 
days were more susceptible to lipid peroxidation induced by Fe2+-ascorbate than those 
obtained from control animals receiving an equivalent amount of mineral oil (Garrido 
et a l, 1989). Slices of liver and heart taken from rats consuming a 10 % menhaden oil 
diet have also been shown to release greater levels of TEARS in vitro after incubation 
at 37 °C when compared with slices taken from animals fed a similar diet containing 10 
% com oil-lard (Leibovitz et al. 1990).
Fish oil supplementation has also been shown to deplete antioxidant nutrients. Nalbone 
et al. (1988) reported that the concentration of vitamin E in serum from rats fed a diet 
containing 12-5 % salmon oil was less than half that measured in serum collected from 
animals fed a similar diet containing com oil in place of salmon oil, despite the fret that 
the salmon oil diet contained 28 % more a-tocopherol than the com oil diet. Meydani 
et al. (1987) reported lower levels of vitamin E in plasma and liver samples from mice 
maintained on a 5 % fish oil diet compared with mice fed diets matched for vitamin E 
content with either coconut oil or com oil as the lipid source. DAquino et al (1991) 
also reported significantly lower levels of vitamin E in plasma and liver samples from 
animals fed a fish oil diet compared with animals fed a coconut oil diet containing the 
same amount of vitamin E. It has been suggested that the low vitamin E status in 
animals fed high PUFA diets such as these is a consequence of reduced absorption of 
the vitamin from the gastrointestinal tract as well as increased consumption in vivo 
(Muggli, 1994).
It is well documented that increasing the fish oil component of the diet increases 
biomarkers of lipid peroxidation. The capacity of antioxidant nutrients to attenuate this 
effect has also been demonstrated. Odeleye et a l (1990) reported a 125-fold increase 
in ethane exhalation when the mixed oil diet of Sprague-Dawley rats was replaced with 
a similar diet containing 3-96 % cod liver oil. In a subsequent study replacing the 
mixed oil diet with the fish oil diet resulted in a similar increase in ethane exhalation
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and an approximately two-fold increase in hepatic conjugated dienes (Odeleye et al., 
1991). Supplementing the diet with additional a-tocopherol (95 mg/kg) attenuated the 
increase in both these biomarkers.
Cho and Choi (1994) reported that the level of TEARS in plasma samples collected 
from rats maintained on a 9 % menhaden oil diet was significantly greater than that in 
samples collected from animals fed a similar diet matched for vitamin E with soybean 
oil as the lipid source. This difference in lipid peroxidation was seen despite the fact 
that there was no significant difference in plasma vitamin E levels between the two 
groups when expressed as ng/ml. Indeed the plasma vitamin E concentration was 
actually greater in animals fed the menhaden oil diet when expressed as p-g/mg lipid. 
Supplementing the menhaden oil diet with an additional 110 mg/kg a-tocopherol 
significantly reduced plasma TEARS. Saito and Nakatsugawa (1994) reported that 
serum TEARS in rats fed a sardine oil diet were significantly greater than those in 
animals maintained on diets matched for vitamin E with either lard or soybean oil as 
the lipid source. In this case liver a-tocopherol levels were significantly lower in 
animals fed the fish oil diet compared with the other two dietary groups. Liver ascorbic 
acid levels were also lower in animals fed the fish oil diet. D'Aquino et al. (1991) found 
that serum TEARS were approximately three times greater in animals fed a fish oil diet 
compared with animals fed a similar diet with the same vitamin E content and coconut 
oil in place offish oil.
Increasing the amount of fish oil in the diet has also been shown to increase urinary 
TEARS (L'Abbé et al. 1991). De Schrijver et al. (1992) reported that replacing the 
beef tallow component of a rat diet with the fish oil MaxEPA resulted in an increase in 
urinaiy TEARS when the MaxEPA component of the diet rose above 1 8 %  (w/w of 
the total diet). The use of urinary TEARS as a biomarker of in vivo lipid peroxidation 
in animals fed diets containing highly unsaturated fatty acids such as those in fish oil is, 
however, complicated by the finding that MDA ingested in the diet is in part excreted 
in the urine (Draper et a l, 1984). Increasing the amount of PUFA in the diet is 
therefore likely to increase the amount of MDA ingested from the diet as well as 
stimulating in vivo lipid peroxidation. Thus, although steps can be taken to minimise 
peroxidation of dietary PUFA, any increase in urinary TEARS resulting from an 
increase in the PUFA component of the diet must be inteipreted with caution. 
Dhanakoti et al. (1987) found that urinary MDA excretion from animals fed a fish oil 
diet was significantly greater than that from animals fed diets containing either com oil 
or coconut oil. The difference between dietary groups was, however, completely
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abolished by feeding a PUFA free diet for 48 hours. On the basis of these observations 
it was suggested that MDA in the diet was the principal source of MDA in the urine. 
Draper et al. (1984) also found that urinary MDA excretion from animals fed a high 
PUFA diet containing fish oil was significantly greater than that from animals fed a low 
PUFA diet devoid of fish oil. Once again feeding a PUFA-free diet for 48 hours 
resulted in a dramatic reduction in urinary MDA excretion from animals fed the high 
PUFA diet, with a smaller reduction in MDA excretion from animals fed the low 
PUFA diet. In this case urinary MDA excretion from animals fed the high PUFA diet 
was, however, still approximately twice that from animals fed the low PUFA diet after 
the PUFA-free period. Increasing the vitamin E component of the high PUFA diet 
reduced urinary MDA excretion measured after consuming the PUFA-free diet for 48 
hours. Thus urinary MDA excretion from animals fed a high PUFA diet containing fish 
oil might, at least in part, reflect events initiated in vivo which can be attenuated by 
increasing antioxidant intake. The possibility that the effect of the PUFA-free diet was 
not solely due to removal of dietary MDA from the urine must also be considered. As 
will be discussed later, in vivo peroxidation of dietary PUFA during metabolism and 
disposition after absorption from the gastrointestinal tract might contribute to the 
increase in lipid peroxidation associated with a high PUFA diet. Feeding a PUFA-free 
diet prior to sample collection would therefore remove MDA arising from this 
component of in vivo lipid peroxidation as well as that arising from the diet. 
Nevertheless any increase in urinary TEARS seen on replacing the standard rat chow 
with a high PUFA diet must still be interpreted with caution.
It can now be seen that biomarkers of lipid peroxidation, including ethane exhalation 
and plasma and urine TEARS, are higher in animals fed diets containing fish oil 
compared with animals fed similar diets containing lipids with a lower unsaturation 
index and that increasing vitamin E intake can reduce lipid peroxidation in these 
animals. As will be discussed in chapter 6 fish oil supplementation has also been shown 
to increase lipid peroxidation in humans. Increasing the amount of fish oil in the diet 
was therefore considered a suitable method of increasing antioxidant requirements 
when investigating the in vivo antioxidant activity of green tea, particularly now that 
doubts about the origin of exhaled hydrocarbons following treatment with fish oils 
have been resolved.
Another more obvious method of increasing antioxidant requirements is to deplete the 
study group of one or more antioxidant nutrients. In this regard tocopherol-stripped 
dietary oils are available giving the opportunity to feed vitamin E-deficient diets which
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are otherwise nutritionally adequate. Such diets have been shown to elevate 
biomarkers of ROS damage in the liver (Duthie et a l, 1987) and, more importantly, 
plasma, urine and breath of rats (discussed later). This approach can, however, be 
criticised on the basis that antioxidant nutrients are located either in an aqueous or lipid 
environment in vivo. Thus, although a water-soluble antioxidant might possess potent 
biological activity it might not necessarily attenuate oxidative damage associated with 
vitamin E deficiency. The validity of testing the antioxidant activity of the water- 
soluble components of green tea beverage in vitamin E deficient animals can therefore 
be questioned. However, the mechanism(s) through which green tea might reduce in 
vivo oxidative damage appear largely unknown and might in some way involve sparing 
and/or recycling vitamin E or even acting as a vitamin E substitute. Investigating the 
antioxidant activity of green tea in conventional and vitamin E deficient rats might 
therefore provide information about the mechanism(s) through which it displays in vivo 
antioxidant activity, if any.
The aims of this study were therefore:
(1) to investigate the antioxidant activity of green tea in conventional rats;
(2) to investigate the antioxidant activity of green tea in rats with a low vitamin E 
status.
2. Methods
2.1. Animals and study design
2.1.1. Antioxidant activity of green tea in conventional animals. Twenty-four 
conventional female Lister Hooded rats (9 weeks old) maintained on LAD1 animal diet 
(SDS Ltd, Witham) from weaning were randomly divided into four groups of six. Two 
groups received a semi-synthetic diet containing maize oil as the lipid source while the 
other two received a similar semi-synthetic diet containing the fish oil MaxEPA The 
semi-synthetic maize oil and fish oil diets were of exactly the same composition as 
those used when investigating ethane production by the gastrointestinal flora (chapter
3, tables 5 and 6). TTiere was, however, no need to maintain germ-free conditions in 
this study. Accordingly there was no need to irradiate the diets used in this case and in 
this respect the two studies differ. For each diet, one group of animals was maintained
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on normal drinking water while the other was provided with green tea beverage as the 
sole source of drinking fluid. The green tea used was a freeze dried extract (Nikken 
Foods Co., Ltd, Tokyo, Japan) given at a concentration of 35 mg/100 ml. To monitor 
the effects of the maize oil and fish oil diets and green tea beverage, breath and 24 hour 
urine samples were collected prior to the study and after 1 and 2 weeks on the maize 
oil diet and 1, 2 and 3 weeks on the fish oil diet. These were analysed for ethane and 
MDA respectively. At the end of the study blood samples were collected and plasma 
MDA measured. Plasma MDA was also measured in a fifth group of animals 
maintained on LAD1 diet. These were the same group of animals as those used to 
investigate the reproducibility of ethane production from week to week (chapter 2, 
table 6). Semi-synthetic maize oil and fish oil diets and green tea beverage were 
available ad libitum throughout the study. To minimise peroxidation of dietary lipid the 
semi-synthetic diets were prepared fresh each week and vacuum sealed into daily 
packages which were stored at -20 °C until used. Fresh food was provided daily at 
approximately 8.30 a.m. Green tea beverage was also prepared and provided fresh 
each day at this time. Animals were housed at 21 °C with 12 hour light/dark cycle.
2.1.2. Antioxidant activity of green tea in animals with a low vitamin E status.
Twenty-four female Lister Hooded rats were fed a semi-synthetic vitamin E-deficient 
diet from weaning at 3 week for 6 weeks. The composition of the vitamin E-deficient 
diet was the same as that of the other semi-synthetic diets used in preceding studies 
(table 5). In this case the diet contained 50 g/kg tocopherol-stripped maize oil as the 
lipid source. At nine weeks old, animals were randomly divided into four groups of six. 
One group was maintained on the tocopherol-stripped maize oil diet and normal 
drinking water for a further 2 weeks before blood samples were taken for MDA 
analysis. A second group was maintained on this diet and provided with green tea 
beverage in place of drinking water. The remaining two groups received a semi­
synthetic diet with 50 g/kg vitamin E-deficient MaxEPA as the lipid source. One of 
these groups was maintained on normal drinking water while the other received green 
tea beverage. Breath and 24 hour urine samples were collected prior to the 
introduction of the fish oil diet and/or green tea and after 1 and 2 weeks of treatment 
for ethane and MDA analysis respectively. After 2 weeks, blood samples were 
collected for plasma MDA analysis. To act as a vitamin E-positive control group a 
further group of six female Lister Hooded rats were weaned onto the semi-synthetic 
maize oil diet containing 40 mg/kg a-tocopherol. After 8 weeks on this diet ethane 
exhalation and plasma and urinary MDA were measured. Diets and green tea beverage
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were prepared, stored and provided as described for the study with conventional 
animals.
2.2. Analysis
2.2.1. Ethane production. Ethane production was monitored using the method 
described in chapter 3.
2.2.2. MDA assay. Plasma, urinary and dietary MDA were analysed as described in 
chapter 2.
2.2.3. Statistical analysis. Comparisons between treatment groups were performed 
using student t  test and analysis of variance with Tukey-Kramer multiple comparison 
test as appropriate.
3. Results
3.1. Effect of dietary lipid and green tea on biomarkers of lipid 
peroxidation in conventional animals.
3.1.1. Maize oil. Replacing the LAD1 animal diet on which* the animals were 
maintained prior to the study with the semi-synthetic maize oil diet containing 40 
mg/kg a-tocopherol resulted in a statistically significant reduction in ethane production 
after 1 week (P<0*01) which was maintained after a further week on this diet (figure 
8). The magnitude of this effect was similar in animals maintained on normal drinking 
water and animals provided with green tea beverage and there was no significant 
difference in ethane production between these two groups after both 1 and 2 weeks on 
this diet.
Replacing the LAD1 diet with the semi-synthetic maize oil diet also resulted in a slight 
reduction in urinary MDA excretion after one week which did not reach statistical 
significance (figure 9). Urinary MDA excretion was further reduced after 2 weeks on 
this diet and was then significantly lower than baseline levels in animals maintained on 
normal drinking water and in animals provided with green tea beverage. There was no 
significant difference in urinary MDA excretion between animals provided with normal
For food and fluid intakes and body weights during the study see appendix 2. j
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drinking water and animals provided with green tea beverage after both 1 and 2 weeks 
on the this diet.
The effects of the maize oil diet and green tea beverage on plasma MDA are shown in 
figure 10. The MDA content of plasma samples collected from animals provided with 
the maize oil diet and normal drinking water for 2 weeks was significantly lower than 
that of samples collected from animals maintained on the LAD1 diet and normal 
drinking water (P<0-001). Plasma MDA was further reduced in animals provided with 
the maize oil diet and green tea beverage for 2 weeks ( P<0*001 compared with 
animals provided with the maize oil diet and normal drinking water).
3.1.2. Fish oil. Replacing the LAD1 diet with the fish oil diet resulted in an increase in 
ethane production from animals provided with normal drinking water and animals 
provided with green tea beverage after 1 week (figure 8). There was a further increase 
in ethane production from both groups after 2 weeks on this diet such that values were 
now significantly greater than baseline. After 3 weeks on this diet, ethane production 
from both groups was not significantly different from that measured at two weeks. 
There was no statistically significant difference in ethane production between animals 
provided with green tea beverage and animals provided with normal drinking water 
after 1. 2 and 3 weeks on the fish oil diet. Compared with animals fed the maize oil 
diet, ethane production was approximately two-to four-fold greater in animals fed the 
fish oil diet, a difference which reached statistical significance after both 1 and 2 weeks 
(P<0001).
Similar to its effect on ethane production, the fish oil diet caused an increase in urinary 
MDA excretion after 1 week which was maintained after a further 1 and 2 weeks on 
this diet (figure 9). This effect was consistently greater in animals maintained on 
normal drinking water compared with animals provided with green tea beverage. 
However, due to the large degree of inter-individual variability the difference in mean 
values between animals maintained on normal drinking water and provided with green 
tea beverage did not reach statistical significance. Urinary MDA excretion from 
animals provided with the fish oil diet was approximately five times greater than that 
from animals provided with the maize oil diet after both 1 and 2 weeks (P<0*001).
The MDA content of plasma samples collected from animals provided with the fish oil 
diet and normal drinking water for 3 weeks was not significantly different from that of 
samples collected from animals maintained on the LAD1 diet (figure 10). Plasma MDA
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was, however, significantly lower in animals provided with the fish oil diet and green 
tea beverage compared with animals provided with this diet and normal drinking water 
(P<0'05). MDA in plasma samples from animals fed the fish oil diet and normal 
drinking water was significantly greater than that in plasma samples from 
corresponding animals provided with the maize oil diet (P<0001)
3.2. Effect of dietary lipid and green tea on biomarkers of lipid 
peroxidation in rats fed the tocopherol-stripped maize oil diet from 
weaning.
3.2.1. Maize oil. Replacing the drinking water of rats maintained on the tocopherol- 
stripped maize oil diet from weaning with green tea beverage had no effect on ethane 
production or urinary MDA excretion after both 1 and 2 weeks (figures 11 and 12). 
Similarly, the difference in plasma MDA between animals maintained on the 
tocopherol-stripped maize oil diet and normal drinking water and animals maintained 
on this diet with green tea beverage for 2 weeks did not reach statistical significance 
(figure 13).
3.2.2. Fish oil. Replacing the tocopherol-stripped maize oil diet with the vitamin E- 
deficient fish oil diet resulted in a statistically significant increase in ethane production 
and urinary MDA excretion after 1 week which was maintained after a further week on 
this diet (figures 11 and 12). The magnitude of this effect was similar in animals 
provided with normal drinking water and animals provided with green tea beverage 
and there was no statistically significant difference in either biomarker between these 
two groups after both 1 and 2 weeks. Plasma MDA was, however, significantly greater 
in animals provided with the fish oil diet and green tea beverage compared with 
animals provided with this diet and normal drinking water (P<0-02). Plasma MDA was 
also significantly greater in animals provided with the vitamin E-deficient fish oil diet 
for 2 weeks compared with animals maintained on the tocopherol-stripped maize oil 
diet (figure 13, P<0-01).
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11 Maize oil/water (n=6) 
M Maize oil/tea (n=6)
□  Fish oil/water (n=6)
■  Fish oil/tea (n=6)
0 (Baseline) 1 2
Weeks on experimental diet
Figure 8. Ethane production from conventional animals; effect of experimental diets 
and green tea. Letters indicate significant difference from corresponding baseline (a 
P<0-05, b P<0-01, c PO-OOl). Asterisk indicates significant difference from animals 
fed maize oil diet and water (P<0-001). Values are mean ± S.D. (n=6).
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□ Maize oil/water (n=6) 
M Maize oil/tea (n=6)
0  Fish oil/water (n=6)
■ Fish oil/tea (n=6)
0 (Baseline) 1 2  3
Weeks on experimental diet
Figure 9. Urinary MDA excretion from conventional animals; effect of experimental 
diets and green tea. Letters indicate significant difference from corresponding baseline 
(a P<0‘05, b P<0-01). Asterisk indicates significant difference from animals fed maize 
oil diet and water ( f  <0-001). Values are mean ± S.D. (n=6).
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□  W ater
LAD 1 Maize oil Fish oil
Diet
Figure 10. MDA in plasma samples from conventional animals; effect of experimental 
diets and green tea. Letters indicate significant difference from animals fed 
corresponding diet with normal drinking water (a P<0-05, b P<0*001). Asterisk 
indicates significant difference from animals fed maize oil diet and water (P<0*001). ¥  
significant difference from animals maintained on LAD1 diet (P<0*001). Values are 
mean ± S. D. (n=6).
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□ Vitamin E positive maize 
oil control (n=6)
M Maize oil/tea (n=6)
□ Fish oil/water (n=6)
■ Fish oil/tea (n=6)
0(Baseline) 1 2
Weeks on e^erimental diet
Figure 11. Ethane production from animals fed tocopherol-stripped maize oil diet 
from weaning; effect of vitamin E deficiency, tocopherol-stripped fish oil diet and 
green tea. Letters indicate significant difference from corresponding baseline (a 
P<0*01, b P<0*001). Values are mean ± S. D. (n=6).
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H Vitamin E positive maize 
oil control (n=6)
M Maize oil/tea (n=6)
□ Fish oil/water (n=6)
■ Fish oil/tea (n=6)
0(Baseline) 1 2
Weeks on e^erimental diet
Figure 12. Urinary MDA excretion from animals fed tocopherol-stripped maize oil 
diet from weaning; effect of vitamin E deficiency, tocopherol-stripped fish oil diet and 
green tea. Letters indicate significant difference from corresponding baseline (a 
P<0-05, b P<0‘01). Asterisks indicate significant difference from vitamin E  positive 
maize oil control group (*P<0-05, ** P<0-01). Values are mean ± S. D. (n=6).
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□  W ater
Vitamin E Maize oil Fish oil
Control
Diet
Figure 13. MDA in plasma samples from animals fed tocopherol-stripped maize oil 
diet from weaning; effect of vitamin E deficiency, tocopherol-stripped fish oil diet and 
green tea. Letters indicate significant difference from animals fed corresponding diet 
and normal drinking water (a P<0*02). Asterisk indicates significant difference from 
animals fed tocopherol-stripped maize oil diet and water (P<0-01). Values are mean ± 
S.D. (n=6).
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3.3. Effect of vitamin E deficiency on lipid peroxidation
3.3.1. Maize oil. There was no significant difference in ethane production between 
animals fed the semi-synthetic tocopherol-stripped maize oil diet from weaning 
(vitamin E deficient animals) and animals weaned onto the semi-synthetic maize oil diet 
containing 40 mg/kg a-tocopherol (vitamin E positive maize oil control group) (figure 
11). Similarly the difference in plasma MDA between the vitamin E deficient animals 
and the vitamin E positive maize oil control group did not reach statistical significance 
(figure 13). Urinary MDA excretion was, however, significantly greater fiom all three 
groups of vitamin E-deficient animals compared with the vitamin E positive maize oil 
control group (figure 12).
3.3.2. Fish oil. The response of conventional and vitamin E-deficient animals to their 
respective fish oil diets is shown in figures 14 and 15. Ethane production fiom vitamin 
E-deficient animals fed the vitamin E-deficient fish oil diet and normal drinking water 
was significantly greater than that from corresponding conventional animals fed a 
similar fish oil diet containing vitamin E (figure 14, P<0-001 and P<0-05 after 1 and 2 
weeks respectively). Urinary MDA excretion fiom vitamin E-deficient animals 
provided with the vitamin E-deficient fish oil diet was greater than that fiom 
corresponding conventional animals, a difference which reached statistical significance 
after 2 weeks (figure 15, P<0-05). There was, however, no significant difference in 
plasma MDA between conventional and vitamin E-deficient animals fed their 
respective fish oil diets (6 9 ± 0*6 and 6-6 ±1*2 nmol MDA/ml respectively).
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Figure 14. Ethane production from conventional and 
vitamin E deficient animals fed similar fish oil diets with 
and without vitamin E respectively. Letters indicate 
significant difference from conventional animals (a 
P<0-05? b P<0*001). Values are mean ± S. D. (n=6).
□  Conventional
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Figure 15. Urinary MDA excretion from conventional 
and vitamin E deficient animals fed similar fish oil diets 
with and without vitamin E respectively. Letters indicate 
significant difference from conventional animals (a 
P<0*05). Values are mean ± S. D. (n=6).
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4. Discussion
As alluded to previously, vigorous physical exercise and ethanol consumption have 
both been shown to result in oxidative damage. However, as discussed below, neither 
of these sources of oxidative stress appeared ideally suited for the current 
investigation.
Vigorous physical exercise can increase whole body oxygen consumption up to 20-fold 
(Witt et a l, 1992) and is, therefore, also likely to increase production of oxygen- 
centred free radicals. In agreement with this, exercise has been shown to stimulate lipid 
peroxidation in humans and animals (Packer et a l, 1994). Notably exercise has been 
well documented to increase pentane exhalation (Snider et a l, 1986; Pincemail et a l, 
1990; Kneepkens et a l, 1994). The capacity of antioxidant nutrients, primarily vitamin 
E, to attenuate the exercise-induced increase in oxidative damage has also been 
demonstrated in humans and animals (Packer et a l, 1994). Nevertheless the use of 
exercise as a source of oxidative stress was considered inappropriate for several 
reasons:
(1) the effect of exercise on lipid peroxidation in humans is inconsistent and appears to 
depend on the training state of the subject, intensity of the exercise and location of the 
sample site (Witt et a l, 1992). There is, therefore, no guarantee that a period of 
exercise will increase biomarkers of ROS damage throughout the study group;
(2) the soundness of alkane production as a biomarker of in vivo lipid peroxidation 
following vigorous physical exercise can also be questioned. Snider et a l (1986) 
suggested that the increase in alkane exhalation following exercise is not due to an 
increase in in vivo lipid peroxidation but represents mobilisation of alkanes from body 
stores due to increased blood flow and respiratory rate. They concluded that lipid 
peroxidation cannot be detected during moderate physical exercise using pentane as a 
biomarker unless the subject breaths hydrocarbon free air for 3 days prior to sample 
collection;
(3) Kohlmüller and Kochen (1993) found that many of the column packing materials 
commonly used for alkane analysis fail to separate pentane from isoprene. Using a 
column which separated these compounds they reported an approximately four-fold 
increase in isoprene exhalation from healthy humans stressed by exercise on a bicycle 
ergometer up to 300 W. There was, however, no increase in pentane exhalation from 
these same individuals. It is therefore possible that isoprene might have been
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responsible for the apparent increase in pentane production associated with vigorous 
physical exercise reported in some studies.
Interpretation of alkane exhalation following treatment with ethanol is complicated by 
the finding that ethanol is metabolised by the same isoform of cytochrome P450 as 
ethane and pentane (Remmer et a l, 1989). Thus, although an acute dose of ethanol 
has been shown to increase alkane exhalation it has also been shown to inhibit pentane 
metabolism by up to 87 % (Remmer et a l, 1984). Any increase in alkane production 
following an acute dose of ethanol does not, therefore, necessarily represent an 
increase in in vivo lipid peroxidation. Indeed Remmer et al (1989) reported that the 
increase in ethane and pentane production following a single dose of ethanol (5 g/kg) 
was entirely due to reduced metabolic clearance. Chronic ethanol consumption has, 
however, been reported to have no affect on alkane metabolism, at least in rats 
(Remmer et a l 1984)
It can now be seen that neither exercise nor alcohol consumption are suitable sources 
of oxidative stress for the current investigation. It was therefore decided to feed a high 
PUFA diet, either alone or in combination with vitamin E deficiency, in an attempt to 
increase antioxidant requirements when investigating the in vivo antioxidant activity of 
green tea.
The composition of alkanes in rat breath has been shown to reflect the fatty add 
composition of the diet (Kivits et a l, 1981). Replacing the 5 % lard diet of rats with a 
similar diet containing 5 % cod liver oil has been shown to double ethane production, 
while pentane production is reduced by approximately 50 % in response to this dietary 
change (Duthie et a l, 1987). Pentane production from rats fed a diet containing com 
oil has been shown to be twice that from animals fed diets containing either lard or 
coconut oil (Dillard et a l, 1978). These observations reflect the fact that the principal 
fatty acids in cod liver oil are of the n-3 variety while those in maize oil are of the n-6 
variety. The finding that ethane production from animals provided with the fish oil diet 
was significantly greater than that from animals fed the maize oil diet in the present 
experiment is therefore not surprising. Similarly the respective increase and decrease in 
ethane production accompanying replacement of the LAD1 diet with the fish oil and 
maize oil diets is not surprising when it is realised that the LAD1 diet contained 
approximately 2 % fish meal. It is therefore highly likely that the semi-synthetic fish oil 
and maize oil diets represented high and low n-3 PUFA ingestion respectively. It is to 
be expected that the response of pentane production to these dietary changes would
107
have been the opposite to that seen for ethane; greater pentane production from 
animals fed the maize oil diet compared with animals fed the fish oil diet and an 
increase in pentane production on substituting the maize oil diet for the LAD1 diet. 
The increase in ethane production accompanying the fish oil diet in the current study 
does not, therefore, necessarily indicate that this diet induced a greater degree of 
oxidative damage compared with the maize oil diet. Indeed if pentane production had 
been used as a biomarker the opposite conclusion might have been reached.
The effect of the experimental diets on urinary MDA excretion was similar to their 
effect on ethane production; greater MDA in urine samples collected from animals 
provided with the fish oil diet compared with animals provided with the maize oil diet 
and a respective increase and decrease in urinary MDA excretion following 
replacement of the LAD1 diet with the fish oil and maize oil diets. From these 
observations it might be concluded that in vivo lipid peroxidation associated with these 
diets decreased in the order fish oil > LAD1 > maize oil. Caution must, however, once 
again be exercised before reaching this conclusion since only PUFA containing three or 
more double bonds give appreciable amounts of TBA-reactive material (Halliwell and 
Gutteridge, 1989). The principal unsaturated fatty acid in the maize oil diet was the 
dienoic PUFA linoleic acid while EPA and DHA, containing 5 and 6 double bonds 
respectively, were the principal fatty acids in the fish oil diet. Thus once again the 
biomarker chosen might have been inappropriate for the purpose of comparing lipid 
peroxidation in animals fed the maize oil diet with that in animals fed the fish oil diet. It 
is also highly likely that the fish oil diet contained more MDA than the maize oil diet. 
MDA consumed in the diet is, in part, excreted in the urine. The greater level of MDA 
in urine samples collected from animals fed the fish oil diet might, therefore, have 
originated from the diet as well as in vivo lipid peroxidation. The difference in urinary 
MDA between the two groups does not, therefore, necessarily mean that they were 
exposed to different levels of oxidative stress. In this regard fish oil supplementation 
has been shown to increase the susceptibility of LDL to oxidation when measured 
using the TEARS assay (Tripodi et a l, 1991) but to have no affect when total volatiles 
generated are used as the end point (Frankel et a l, 1994).
Despite these considerations the fish oil diet can still be thought of as the greater 
oxidative challenge since its unsaturation index (defined as the number of double bonds 
in each fatty acid x mole percent of each fatty acid) was considerably greater than that 
of the maize oil diet (235 and 155 respectively). The concentration of vitamin E in 
plasma samples collected from animals fed a fish oil diet has also been shown to be
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lower than that in anim als fed a com oil diet matched for vitamin E content (Nalbone 
et a i, 1988).
The MDA content of plasma samples collected from conventional animals maintained 
on the maize oil diet for 2 weeks was significantly lower than that of samples collected 
from animals maintained on the basal LAD1 diet and animals fed the fish oil diet for 3 
weeks in agreement with the effect of this diet on ethane production and urinary MDA 
excretion. The significant increases in ethane production and urinary MDA excretion 
accompanying replacement of the LAD1 diet with the fish oil diet were not, however, 
reflected in an increase in plasma MDA. The increase in urinary MDA excretion 
associated with the fish oil diet might have been largely due to ingestion of MDA fiom 
the diet rather than in vivo lipid peroxidation. The increase in ethane production 
associated with the fish oil diet might also have originated in part from peroxidation 
events initiated in the diet (discussed below), ff plasma MDA is taken in preference to 
these other biomarkers of lipid peroxidation this raises the disturbing possibility that 
the effects of fish oil supplementation on in vivo lipid peroxidation might be largely 
artifactual. The increase in in vivo lipid peroxidation associated with fish oil diets might 
therefore have been grossly over estimated in the past. The use of plasma MDA as a 
biomarker of in vivo lipid peroxidation in animals provided with a diet rich in fish oil is 
not, however, without its complications. Although Cho and Choi (1994) reported that 
plasma MDA was greater in animals fed a diet containing 9 % menhaden oil compared 
with anim als fed a similar diet containing soybean oil this difference was only slight 
when expressed as nmol MDA/ml plasma. When expressed as nmol MDA/mg plasma 
lipid, plasma MDA in animals fed the menhaden oil diet was over double the level 
measured in anim als fed the soybean oil diet, a difference which was statistically 
significant (P<0*05). This reflects the fact that plasma total lipids in animals fed the 
menhaden oil diet were approximately 50 % those measured in animals fed the soybean 
oil diet and plasma TEARS have been shown to correlate positively with plasma lipids 
(Frank et a l, 1994; Ôhrvall et a l, 1994). Thus, although plasma MDA in the current 
study was not significantly greater in animals fed the fish oil diet compared with 
animals fed the LAD1 diet when expressed as nmol/ml it is quite possible that a 
significant difference would have emerged if the effects of fish oil on plasma lipids had 
been accounted for. Unfortunately the relationship between plasma MDA and plasma 
lipids was not realised at the time of the experiment and plasma lipids were not 
measured. The apparent non-effect of the fish oil diet on plasma MDA does not, 
therefore, necessarily contradict the increase in ethane production and urinary MDA 
excretion associated with this diet.
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It can now be seen that the sensitivity of the biomarkers chosen to monitor lipid 
peroxidation might have been low in animals fed the maize oil diet. These same 
biomarkers were, howevei better suited to the measurement of lipid peroxidation in 
anim als fed the fish oil diet. Taken together with the finding that the biomarkers 
selected were generally elevated by the fish oil diet while they were reduced by the 
maize oil diet and the fact that the fish oil diet represented a greater oxidative challenge 
than the maize oil diet it might be anticipated that the opportunity for green tea to 
display biological antioxidant activity was greater in animals fed the fish oil diet. In this 
regard urinary MDA excretion was lower in conventional animals fed the fish oil diet 
and green tea beverage compared with animals fed this diet and normal drinking water. 
Although this effect did not reach statistical significance at any of the time points 
measured it was consistent after 1, 2 and 3 weeks. At this point it is important to 
remember that a portion of the MDA consumed in the diet is excreted in the urine. 
Studies in which antioxidant supplementation has been shown to diminish urinary 
MDA excretion, and possibly ethane production, can therefore be criticised if the 
antioxidant is added to the diet, which is sometimes the case. For this reason the green 
tea extract was supplied as a beverage rather than mixed in with the diet. This does 
not, therefore, prevent comparisons between animals provided with normal drinking 
water and anim als provided with green tea beverage from being drawn since both 
groups were maintained on the same fish oil diet and there was no significant 
difference in food consumption, and therefore MDA consumption, between them. 
Nevertheless if MDA ingested from the diet was a significant component of the MDA 
measured in urine samples collected from these animals it could have masked any 
effect green tea might have had on in vivo lipid peroxidation. The opportunity for 
green tea to display in vivo antioxidant activity using this biomarker might therefore 
have been facilitated by maintaining the animals on a PUFA-free diet for a short period 
prior to sample collection and throughout the 24 hour collection period since this 
would have reduced the amount of urinary MDA originating from the diet. The effect 
of green tea on urinary MDA excretion might have reached statistical significance if 
this step had been taken. As will be discussed below this step would, however, also 
remove any in vivo lipid peroxidation associated with the metabolism of fish oil 
immediately after ingestion and is therefore not as straightforward as it first appears. 
There was no significant difference in urinary MDA excretion between animals fed the 
maize oil diet with water and animals provided with this diet and green tea beverage. In 
light of the previous discussion this is perhaps not surprising.
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MDA in plasma samples collected from conventional animals fed either experimental 
diet, maize oil or fish oil, was significantly lower in animals provided with green tea 
beverage compared with animals maintained on normal drinking water. Given the 
possibility that peroxidation of plasma lipids might have occurred during the reaction 
of MDA with DETBA it is equally possible that green tea catechins, or their 
metabolites, present in plasma samples displayed antioxidant activity during the assay 
itself The effect of green tea on plasma MDA might therefore have been due to 
antioxidant activity in vitro rather than in vivo. There was, however, no significant 
difference in the MDA content of plasma samples measured with and without addition 
of the green tea extract used in these studies (chapter 2 section 3.3) indicating that it 
afforded no additional antioxidant protection above that provided by the BHT added 
prior to the assay.
Unlike plasma and urinary MDA there was no consistent difference in ethane 
production fiom conventional animals provided with the fish oil diet and normal 
drinking water and animals provided with this diet and green tea beverage. The 
question as to why ethane production appears less responsive to the affects of green 
tea compared with these other biomarkers of lipid peroxidation is an intriguing one. 
The finding that one biomarker of lipid peroxidation responds to a particular treatment 
while there is no change in another is, however, by no means new. There are several 
possible explanations for this:
(1) it is likely that a proportion of the ethane exhaled during the 90 minute collection 
period represented wash-out of exogenous ethane, taken up fiom atmospheric air, 
from the body (see chapter 5). This might have masked any effect of green on in vivo 
ethane production;
(2) as discussed in chapter 2 it has been shown that alkane production is a function of 
recent fatty acid intake as well as the PUFA composition of cellular membranes. In 
agreement with this ethane production from a female Lister Hooded rat gavaged with 
0-5 ml of the fish oil supplement EPAforte, which has a similar n-3 PUFA content to 
the MaxEPA used in this study (22 % EPA, 15 % DHA), was 12 nmol/kg/90 minutes 
over the 90 minutes immediately following gavage. Four hours after this dose of fish 
oil ethane production measured fiom the same animal was not significantly different 
fiom that measured prior to dosing (3 4 and 3-6 nmol/kg/90 minutes before and 4 
hours after gavage respectively). There was no period of food withdrawal prior to 
collection of breath samples when investigating the in vivo antioxidant activity of green
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tea and samples were collected at different times of the day ranging from 8.30 a.m to 
4 p.m. Thus differences in the fed/fasted state of the animals could have been a source 
of variability associated with ethane production which might have masked any 
difference in the mean value between the group provided with normal drinking water 
and the group provided with green tea beverage. In hind sight it might have been 
prudent to feed the animals a PUFA-free diet for a set period prior to sample collection 
to wash-out any ethane production associated with the recent diet. Again this step 
would, however, also have washed out any in vivo lipid peroxidation associated with 
metabolism of the fish oil;
(3) ethane production from conventional animals fed the semi-synthetic fish oil diet 
when investigating the role of the gastrointestinal flora in ethane production (chapter 
3) was approximately five times greater than that from conventional animals fed a 
semi-synthetic fish oil diet of exactly the same composition in this study. The animals 
used in these studies were of the same strain, sex and age and produced similar 
amounts of ethane prior to the introduction of the fish oil diet. The only difference 
between them was the diet on which they were maintained prior to introduction of the 
fish oil diets. In the current study animals were maintained on LAD1 animal diet while 
those used in the previous study were maintained on irradiated GR3 diet. Given that 
ethane production was similar in the two groups at baseline it appears highly unlikely 
that this difference could have accounted for the dramatically different response of the 
two groups to the fish oil diet. Although the fish oil diets used in these studies were 
prepared using the same components and were therefore of the same composition they 
did, however, differ in one important aspect; the diet used in chapter 3 was irradiated 
while there was no need to carry out this procedure in the current study. As a result of 
this the fish oil diet used when investigating the role of the gastrointestinal flora in 
ethane production contained approximately eight times more MDA than the fish oil 
diet used in this study (118-0 and 14-6 nmol MDA/g diet respectively). It therefore 
appears that the peroxidation status of the diet is an important determinant of ethane 
production, as has been previously suggested for pentane production (Gelmont et aL, 
1981). Accordingly a proportion of the ethane production associated with the fish oil 
diet might have been a reflection of events which were initiated within the diet rather 
than in vivo. The ability of green tea to protect against this component of ethane 
production might be limited compared with its capacity to protect against events 
initiated in vivo. Thus, once again any effect of green tea on in vivo ethane production 
could have been masked. If the peroxidation status of the diet is an important
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determinant of ethane production it might also have exacerbated variability associated 
with the recent intake of fatty acids.
Thus ethane produced from peroxidation events initiated in vivo might have been only 
a component of the ethane collected in the total body gas of animals provided with the 
fish oil diet. Accordingly the antioxidant activity of green tea might have been active 
against a small component of the ethane collected and might have been largely masked.
Similar to urinary MDA, green tea had no effect on ethane production from 
conventional animals fed the maize oil diet. In light of this the effect of green tea on 
plasma MDA in conventional animals fed the maize oil diet is perhaps surprising. The 
only statistically significant effect of green tea in animals fed the fish oil diet was, 
however, also seen on plasma MDA. Plasma MDA might therefore be more responsive 
to green tea compared with ethane production and urinary MDA. Possible reasons for 
this include:
(1) plasma MDA might represent a more sensitive assay. While ethane production and 
urinary MDA excretion are measures of specific end products of the peroxidation 
pathway plasma MDA includes lipid hydroperoxides and therefore more oxidative 
events;
(2) plasma MDA might be more representative of events initiated in vivo compared 
with ethane production and urinary MDA which might be largely artifactual.
As alluded to previously the opportunity for green tea to display in vivo antioxidant 
activity using urinary MDA excretion and ethane production as biomarkers might have 
been facilitated by feeding the animals a PUFA-free diet prior to sample collection. 
There are, however, possible complications associated with such a wash-out period 
which must be considered. It has been shown that an acute dose of n-3 PUFA results in 
an approximately 3-fold increase in ethane production. Other investigators have also 
reported an increase in alkane production following a single dose of PUFA. The 
increase in lipid peroxidation accompanying a diet rich in fish oil might therefore have 
two components, a chronic increase due to enrichment of cellular membranes with 
EPA and DHA and a more acute increase associated with the metabolism of PUFA 
each time it is consumed. This raises the possibility that the reduction in urinary 
TEARS seen by Dhanakoit and Draper (1987) on replacing a fish oil diet with a low 
PUFA diet might have been due to a reduction in in vivo lipid peroxidation as well as
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elimination of dietary MDA from the urine. This is perhaps an area which requires 
further investigation. As far as ethane production is concerned it would be interesting 
to feed animals a diet rich in n-3 PUFA and measure ethane production after the 
system has become saturated with PUFA, but before enrichment of cellular membranes 
has occurred to any significant extent, and compare this with ethane production after 
incorporation of EPA and DHA into cellular membrane. For example, compare ethane 
production after feeding a fish oil diet for 24 hours with that after 4 weeks on the same 
fish oil diet.
Thus feeding a PUFA-ftee diet might remove some of the in vivo lipid peroxidation 
associated with diets rich in fish oil. This step might also reduce the variability 
associated with measurement of lipid peroxidation in animals fed such diets and 
therefore increase the opportunity for compounds possessing in vivo antioxidant 
activity to show an effect. This would of course also eliminate the dietary component 
from urinary MDA. The mechanism through which green tea might protect against in 
vivo lipid peroxidation must be considered at this point. If the effect of green tea was 
predominantly in the chronic phase through, for example, protection of PUFA in cell 
membranes from oxidation, introduction of a PUFA-free period prior to sample 
collection would be a distinct advantage. I f  however, the effect of green tea was 
principally in the acute phase, reducing lipid peroxidation during the metabolism and 
disposition of the highly unsaturated fatty acids in fish oil, introduction of such a wash­
out period might also wash-out the effect of green tea. The mechanisms through which 
green tea might protect against in vivo lipid peroxidation associated with a fish oil diet 
cannot be ascertained from the results of the current study. The merits of feeding a 
PUFA-free diet as a means of reducing variability and improving the study design 
therefore remain to be seen.
Vitamin E deficiency has been shown to increase urinary TEARS (Lee et aL, 1992). It 
has also been shown that diets deficient in antioxidants are more susceptible to in vitro 
peroxidation compared with diets containing antioxidants (Gonzalez et aL, 1992). 
Since dietary MDA is in part excreted in the urine it is therefore possible that the 
increase in urinary MDA associated with vitamin E deficiency might be a result of 
MDA ingestion from the vitamin E-deficient diet as well as greater in vivo lipid 
peroxidation. Nevertheless, the increase in urinary MDA excretion associated with the 
tocopherol-stripped maize oil diet in the current study appears to be a reflection of 
events initiated in vivo. Draper et aL (1984) found that the level of TEARS in urine 
samples collected from animals maintained on a tocopherol-stripped com oil diet was
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significantly greater than that in samples collected from animals fed the same diet 
supplemented with vitamin E. The tocopherol-stripped com oil diet used by Draper et 
al (1984) did not, however, cause an immediate increase in urinary TEARS, as would 
be anticipated if dietary MDA was responsible for the increase in urinary TEARS 
associated with it.
Green tea had no significant effect on urinary MDA excretion in animals fed the 
tocopherol-stripped maize oil diet. Given the fact that the animals were deficient in an 
antioxidant nutrient and producing a significantly greater amount of urinary MDA as a 
consequence of this, it might have been expected that this was an ideal situation in 
which to demonstrate physiologically important antioxidant activity associated with 
green tea beverage.
Despite the fact that the increase in urinary MDA excretion associated with the 
tocopherol-stripped maize oil diet appears to have been due to in vivo lipid 
peroxidation the increase in this parameter associated with the vitamin E-deficient fish 
oil diet must, however, be interpreted with caution. Although the dramatic reduction in 
urinary TEARS seen by Dhanakoti and Draper (1987) on replacing a fish oil diet with 
a PUFA-free diet might have been in part due to removal of the substrate for acute in 
vivo lipid peroxidation, the contribution of dietary MDA to urinary MDA has, 
nevertheless, been demonstrated (Draper et a l, 1984). The susceptibility of diets 
containing fish oil to peroxidation while in the food bowl is dramatically affected by 
their antioxidant content. Gonzalez et al (1992) reported that the TEARS value of a 
fish oil diet containing no BHT, immediately after mixing, was approximately 2-5-fold 
greater than that of a similar fish oil diet containing 0-02 % BHT. After 24 hours in the 
food bowl the TEARS value of the non-supplemented diet was 3 -9 times greater than 
that of the supplemented diet. Fritsche and Johnston (1988) reported that the peroxide 
value of menhaden oil mixed into an experimental diet and placed in food bowls at 20- 
25 °C increased 3-fold over a 24 hour period. There was no appreciable increase in the 
peroxide value of a similar menhaden oil diet supplemented with 0-02 % t- 
butylhydroquinone under the same conditions. In the current study the MDA content 
of the vitamin E-deficient fish oil diet was approximately twice that of the fish oil diet 
containing a-tocopherol (33-b nmol MDA/g vs 14-6 nmol MDA/g respectively). Thus 
the greater level of urinary MDA in samples collected from vitamin E-deficient animals 
fed the vitamin E deficient fish oil diet compared with corresponding conventional 
anirmk might, in part, have originated from the relatively high level of MDA in the 
diet. As a consequence of this it is possible that any effect green tea had on in vivo
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lipid peroxidation in these anim als was masked to a greater extent than in conventional 
animals fed the fish oil diet containing vitamin E. Thus although green tea appears to 
have no affect on urinary M D A  excretion from vitamin E-deficient animals fed the 
v itamin E-deficient fish oil diet while it does appear to affect M D A  excretion from the 
corresponding conventional animals, it would be unwise to conclude that green tea has 
greater antioxidant activity in conventional animals on the strength of this observation 
alone. Nevertheless taken together with the lack of effect of green tea on urinary M D A  
excretion from v itamin E-deficient animals fed the maize oil diet the capacity of green 
tea to compensate for vitamin E deficiency is questioned by the findings of the present 
study.
Vitamin E deficiency has also been reported to increase alkane exhalation (Lawrence et 
aL, 1984). The composition of breath hydrocarbons is determined, at least in part, by 
the fatty acid composition of the diet. This is not surprising given the relationship 
between dietary fatty acids and phospholipid fatty acid composition. As a result of this 
the true effect of vitamin E deficiency on alkane production may be distorted in studies 
in which the vitamin E-deficient diet and the control diet have a different fatty acid 
composition, which is sometimes the case. Nevertheless pentane production from rats 
fed a tocopherol-stripped com oil diet has been shown to be significantly greater than 
that from rats fed the same com oil diet supplemented with vitamin E (Dillard et a i, 
1977; Dillard et a l, 1978; Downey et a l, 1978). As discussed earlier alkane 
production might in part be determined by the peroxidation status of the diet. The 
increase in alkane exhalation associated with vitamin E deficiency might therefore be 
due to the peroxidation status of the diet as well as in vivo lipid peroxidation, similar to 
urinary MDA. In the studies carried out by Dillard et al. (1977) and Downey et al. 
(1978) there was a gradual increase in pentane exhalation as the duration of feeding the 
vitamin E-deficient diet continued. This observation is suggestive of pentane exhalation 
subsequent to in vivo lipid peroxidation rather than peroxidation of the vitamin E- 
deficient diet. Alkane production can therefore be considered a reflection of in vivo 
lipid peroxidation in these studies. The animals used in these studies were, however, 
fasted for up to 24 hours prior to sample collection. Fasting for 24-48 hours has been 
shown to dramatically increase lipid peroxidation, measured as urinary MDA 
excretion, in animals previously fed diets containing either com oil or fish oil as the 
lipid source (Dhanakoti and Draper, 1987). The difference in alkane production 
between conventional and vitamin E-deficient animals following a period of fast does 
not, therefore, necessarily indicate that vitamin E-deficient animals produce greater 
amounts of alkanes due to in vivo lipid peroxidation when in the fed state. It may
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simply reflect greater susceptibility of vitamin E-deficient animals to lipid peroxidation 
stimulated by fasting. In agreement with this Gelmont et a l (1981) found that pentane 
production from animals fed a vitamin E-free diet was 70 times greater than that from 
animals maintained on a rat chow diet but this difference could be completely abolished 
by feeding a fat-free diet for 2 days. In the current study the amount of MDA in the 
vitamin E-deficient fish oil diet was greater than that in the fish oil diet fed to 
conventional animals (33 6 and 14 6 nmol MDA/g respectively) and breath samples 
were collected from animals in the fed state. The difference in alkane production 
between the two groups might therefore have been largely due to the diet itself rather 
than the nature of the animals. In agreement with this Duthie et al (1987) reported 
that there was no difference in ethane production from animals severely deficient in 
vitamin E and vitamin E normal animals when they were fed diets containing the same 
cod liver oil supplement. It is therefore likely that any effect green tea had on in vivo 
ethane production was masked to a greater extent in vitamin E-deficient animals fed 
fish oil compared with the corresponding conventional animals. Green tea also had no 
effect on ethane production from the vitamin E-deficient animals fed the maize oil diet. 
Once again pentane production might have been a better biomarker of lipid 
peroxidation in these animals.
It can now be seen that the difference in ethane production and urinary MDA excretion 
between conventional and vitamin E-deficient animals fed their respective fish oil diets 
with and without vitamin E might have been largely due to the peroxidation status of 
the diet rather than the nature of the animals themselves. Ike level of oxidized lipids in 
VLDL and LDL prepared from rats has also been shown to correlate with the level of 
oxidized lipids in the diet (Stapràns et a l, 1993). The fact that there was no significant 
difference in plasma MDA between conventional and vitamin E-deficient animals fed 
their respective fish oil diets is, therefore, perhaps surprising.
Green tea had no significant effect on plasma MDA in animals fed the tocopherol- 
stripped maize oil diet. The antioxidant activity of green tea in these animals might 
simply have been overwhelmed by the oxidative damage resulting from vitamin E 
deficiency. There was, however, no significant difference in plasma MDA between 
animals fed the tocopherol-stripped maize oil diet and the vitamin E positive maize oil 
control group. This does not, therefore, appear to be an explanation. Given its effect 
on plasma MDA in conventional animals fed the maize oil diet this finding indicates 
that the capacity of green tea to attenuate lipid peroxidation may have been diminished 
in the vitamin E-deficient animals. Plasma MDA in animals provided with the vitamin
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E-deficient fish oil diet and green tea beverage was significantly greater than that in 
animals provided with this diet and normal drinking water (P<0-02). In the 
corresponding conventional animals this situation was reversed. Once again this is 
consistent with a protective affect against lipid peroxidation in conventional animals 
but not vitamin E-deficient animals. The effect of green tea on urinary MDA excretion 
is also suggestive of antioxidant activity in conventional, but not vitamin E-deficient 
animals. From these results it might therefore be speculated that the capacity of green 
tea to attenuate in vivo lipid peroxidation in animals fed the maize oil and fish oil diets 
was dependant on the presence of vitamin E. This is perhaps a reasonable conclusion 
since the anim als used in these studies were not actually exposed to increased levels of 
aqueous free radicals. It is therefore possible that vitamin E was the antioxidant put 
under pressure and only antioxidants recycling or substituting for vitamin E would 
have been protective. The capacity for antioxidants recycling vitamin E to protect 
against lipid peroxidation might have been limited in animals fed the tocopherol- 
stripped diets. Antioxidants which would be effective in attenuating lipid peroxidation 
in these anim als would be those which have the ability to directly substitute for vitamin 
E rather than those which can recycle vitamin E radicals. The lack of effect of green 
tea in these animals may therefore be indicative of its inability to do this. Again this is 
perhaps not surprising. It must be remembered that these are only possible 
explanations for the effects seen. The other possibility which remains is that the effect 
of green tea in vitamin-E deficient animals was simply masked by peroxidation events 
initiated within the diet which dominated the response of lipid peroxidation biomarkers 
and for which green tea might have been unable to compensate for.
Overall one of the limitations of these studies might have been the short duration of the 
dietary regimes. If  the animals had been provided with the fish oil diet for a longer 
period depletion of antioxidant nutrients, if it occurred at all, might have been more 
extensive. This might have resulted in a greater increase in biomarkers of lipid 
peroxidation. Both these events might have increased the opportunity for green tea to 
demonstrate in vivo antioxidant activity. There was, however, no apparent trend 
towards greater levels of the chosen biomarkers as the duration of the study continued.
In conclusion the results of this study illustrate the relationship between dietary fatty 
acid composition and biomarkers of in vivo lipid peroxidation. Although increasing the 
amount of highly unsaturated lipids in the diet through fish oil supplementation appears 
to increase ethane exhalation and urinary MDA excretion these effects may have been 
due in part to peroxidation events initiated within the diet rather than in vivo.
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Accordingly the in vivo antioxidant activity of green tea may have been effective 
against only a proportion of the fish oil induced increase in these biomarkers. The 
difference in ethane exhalation and urinary MDA excretion between conventional and 
vitamin E deficient animals fed their respective fish oil diets may also have been due in 
part to the peroxidation status of the diet. Despite these possible limitations the data 
are suggestive of in vivo antioxidant activity of green tea in animals replete in vitamin 
E. There is, however, no evidence to suggest that green tea has antioxidant activity in 
the vitamin E-deficient animals. This may indicate that the in vivo antioxidant activity 
of green tea in this study was dependent on an interaction with vitamin E. From the 
results of the current investigation the following suggestions can be made regarding 
future studies:
(1) increase the number of animals used. From the current data it has been calculated 
that there would be a 90 % chance of the difference in urinary MDA excretion between 
vitamin E-normal animals provided with the fish oil diet and normal drinking water for 
1 week and corresponding animals provided with green tea beverage reaching 
statistical significance (P<0-05) if the experiment was repeated with 15 animals in each 
group;
(2) given the possibility that the increase in lipid peroxidation accompanying the fish oil 
diet may have originated in part from peroxidation events initiated prior to ingestion, 
biomarkers of protein and DNA oxidation may provide a more accurate assessment of 
in vivo oxidative damage;
(3) providing the animals with a PUFA free diet for a set period prior to sample 
collection may have reduced the portion of ethane exhalation and urinary MDA 
excretion arising from dietary sources.
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Chapter 5
Development of a method for the 
measurement of ethane in human
breath
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1. Introduction
The analysis of breath alkanes is a truly non-invasive biomarker of lipid peroxidation 
which, provided adequate precautions are taken, does not have to be completed 
immediately after sample collection. In these respects alkane analysis can be considered 
advantageous over other biomarkers of in vivo lipid peroxidation. The latter point may 
be a significant benefit in human studies, which often involve measurement of more 
than one biomarker, since it is generally advisable to measure lipid peroxidation in 
biological samples as soon as possible after sample collection. Furthermore breath 
alkane analysis is not susceptible to lipid peroxidation during the assay itself; as may 
occur with assays measuring lipid peroxidation in plasma. The direct nature of the 
assay, giving an indication of lipid peroxidation at the time of sampling, may also be an 
advantage in some situations. Alkane analysis is, however, not without its problems. 
Although these have, in the main, been discussed in chapter 2 one problem which was 
not addressed is the possibility that . a portion of the alkanes in human breath
might originate from exogenous sources, even after removal of ambient air from the 
lungs. This may prove to be a serious complication associated with the assay. 
Nevertheless alkane analysis appears to be at least no worse than other biomarkers of 
lipid peroxidation and, given the advantages associated with it, is therefore worthy of 
further investigation as a biomarker of lipid peroxidation in humans.
Increased alkane exhalation has been reported in humans suffering from a number of 
conditions associated with free radical damage. Sedghi et al (1994) reported that 
patients suffering from ulcerative colitis exhaled significantly more ethane than healthy 
controls. Ethane exhalation was found to correlate with chemiluminescence in rectal 
tissue samples in these patients. Total body irradiation (Arterbery ef a l, 1994), and 
reperfiision of the transplanted liver (Risby et a l, 1994) have also been shown to 
increase ethane exhalation while increased pentane exhalation has been reported in 
patients suffering from acute myocardial infarction (Weitz et a l, 1991) or vitamin E 
deficiency (Lemoyne et a l, 1987). Increased alkane exhalation has also been reported 
in numerous other conditions including Alzheimer's disease, schizophrenia, cystic 
fibrosis and multiple sclerosis (Kneepkens et a l, 1994). At this point it must be 
remembered that detection of ethane and pentane, and indeed lipid peroxidation in 
general, does not necessarily implicate free radical damage as the causative agent in a 
disease. Increased alkane exhalation must therefore be interpreted with caution in some 
situations where free radical damage is not anticipated.
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There are two problems associated with the measurement of alkanes in human breath 
samples. Firstly the low levels of ethane and pentane in breath necessitate 
concentration prior to analysis. Alkane analysis is not, therefore, as straightforward as 
analysis of other biomarkers of lipid peroxidation. Several techniques can be employed 
to overcome this problem:
(1) cryofocusing. Alkanes from large volumes of breath are adsorbed onto a trapping 
material at low temperature. They are then desorbed into a smaller volume of gas by 
rapid heating. This technique has been extensively employed by Van Gossum and co­
workers (Van Gossum et a l, 1992). In their procedure pentane from 50 ml of breath is 
concentrated on activated alumina at -90 °C and desorbed by heating to 200 °C. 
Seabra et al. (1991) concentrated ethane and pentane on activated charcoal and Tenax 
at 0 °C and desorbed by rapidly heating to 250 °C. Massias et a l (1993) employed this 
method without the need for sub-ambient temperatures. In their technique ethane and 
pentane were trapped on Carbotrap and Carboseive SHI at 35 °C and desorbed at 350 
°C;
(2) re-breathing. Wade and Van Rij (1985) developed a rebreath system similar to 
those used in animal experiments, except in this case breath rather than total body gas 
was collected. This technique does, however, require a long collection period and may 
not be suitable for routine use. Compared with cryofocusing it is also more susceptible 
to the effects of altered alkane metabolism;
(3) on-line trapping. Zarling and Clapper (1987) developed a procedure in which 50 ml 
of sample were flushed into a 10 ml sampling loop. Peak broadening was prevented by 
an on line cold trap procedure on the GC column itself This approach is considerably 
simpler than the other techniques employed.
Ethane and pentane are ubiquitous pollutants in the urban environment which presents 
the second problem to their use as biomarkers of in vivo lipid peroxidation. Sexton and 
Westberg (1984) reported that the concentrations of ethane and pentane in urban air 
range from 80 to 223 pmol/1 and 110 to 340 pmol/1 respectively. These concentrations 
are considerably greater than the levels measured in breath samples collected after 
wash-out of ambient air from the lungs. The concentration in ambient air must 
therefore be accounted for if an indication of in vivo lipid peroxidation is to be 
obtained. There are two approaches to solving this problem:
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(1) the concentration in atmospheric air at the site of sampling can be measured and 
subtracted from the concentration in the sample;
(2) atmospheric air can be washed out from the body and/or lungs prior to sample 
collection.
Given the high, variable levels of alkanes in urban air the second procedure appears 
preferable. Introduction of a wash-out period does, however, increase the time 
required from the subject and can add to the cost and complexity of the assay. Thus, 
although hydrocarbon-free air must be breathed for 90 minutes before pentane 
exhalation reaches a stable level (Morita et a l, 1986) wash-out times generally 
employed are considerably shorter than this. Typical wash-out times include 3 minutes 
(Phillips and Greenberg 1992), 4 minutes (Lemoyne et a l, 1987; Refat et a l, 1991), 5 
minutes (Pitkànen et a l, 1990) and 10-15 minutes (Wispe et a l, 1985; Pincemail et 
al, 1990). If this technique is employed strict sampling and handling procedures must 
be observed to prevent contamination with atmospheric air.
The variation in wash-out times employed by different research groups means that 
there are no standard values for ethane and pentane exhalation from healthy humans. 
Ethane exhalation has been reported to range from 4830 pmol/1 when measured 
without a washout period to 24 pmol/1 after a 5 minute wash-out (Kneepkens et a l, 
1994). Corresponding values for pentane exhalation range from 4300 pmol/1 while 
breathing atmospheric air (Zarling et a l, 1992) to 12 pmol/1 after breathing a mixture 
of 80 % helium and 20 % oxygen containing less than 0 5 pmol/1 pentane for 90 
minutes (Morita et a l, 1986). Aside from the different wash-out times employed 
differences in collection procedure might also cause variations in values measured 
independent oîin vivo lipid peroxidation.
2. Methods
2.1. Sample collection and analysis
2.1.1. Collection procedure. Breath samples were collected into Cali-5-bond 5- 
layered gas sampling bags (Alltech Associates Ltd, Camforth) after breathing synthetic 
air for 4 minutes to remove atmospheric air from the lungs. The synthetic air used was
SfFPhillips et a l (1994) found that the alveolar pentane gradient (defined as the concentration 
in alveolar breath minus the concentration in inspired air) was zero in approximately 50 % 
of normal volunteers.
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BOC medical grade synthetic air containing <0 1 ppm total hydrocarbons (BOC Ltd, 
Guildford) and was supplied from Douglas bags (Harvard Apparatus Ltd, Edenbridge).
2.1.2. Analysis. Ethane analysis was performed using a Perkin Elmer 8500 gas 
chromatograph equipped with a Valeo gas sampling valve (Valeo Instruments Co., 
Houston, USA) and a flame ionisation detector operated at 250 °C. Gas flows to the 
detector were 35 ml/min hydrogen and 350 ml/min air. Ethane was eluted using a 6'% 
1/8" Carbosphere 80/100 column (Alltech Associates Ltd, Camforth) with nitrogen 
carrier gas at a flow rate of 35 ml/min. Gas lines to the GC were fitted with stainless 
steel puritubes filled with activated charcoal (Phase Separations Ltd, Deeside) to 
remove hydrocarbon contaminants. Samples were taken for analysis by connecting the 
gas sample bag to the inlet of a Capex 2D electrical air pump (Charles Austin Air 
Pumps Ltd, Weybridge). The pump outlet was connected to the gas sampling valve. 
The sample loop (165 ml) was filled with breath sample for 2 minutes and the loop 
contents flushed onto the column for 6 minutes. The column was maintained at 40 °C 
for 6 5 minutes while the loop contents were applied. To elute ethane a temperature 
gradient was employed. The column was heated to 220 °C at 30 °C/min and held at this 
temperature for 5 minutes. Ethane eluted with a retention time of 16*13 minutes. The 
column was then heated to 330 °C and held at this temperature for 3 minutes. Data 
analysis was performed using Nelson analytical software (Perkin Elmer Nelson 
Systems Inc., Cupertino, USA) with reference to a standard curve constructed from 
ethane standard gas (Phase Separations Ltd, Deeside). All connections were made 
using stainless steel tubing and Swagelock fittings.
2.2. Investigation into the effect of smoking on ethane production
Ethane exhalation was measured from a healthy non-smoking male volunteer aged 25 
immediately before and up to 4 hours after smoking a single cigarette. Smoking 
consisted of 10 inhalations from a commercially available filter cigarette. Four days 
after the initial study the experiment was repeated with the same brand of cigarettes 
and the same volunteer.
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3. Results
3.1. Validation of procedure
3.1.1. Sample collection. A typical chromatogram of laboratory air showing ethane as 
a distinct peak with a retention time of 16-13 minutes is shown in figure 16. Medical 
grade air and Zero grade air (BOC Ltd, Guildford) were found to contain ethane (130 
and 84 pmol/1 respectively) and could not be used to flush atmospheric air from the 
lungs. Ethane could not, however, be detected in BOC synthetic air containing <0-1 
ppm total hydrocarbons (figure 17).
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Figure 16. Chromatogram of laboratory air. Ethane eluted as a distinct peak with a 
retention time of 16-13 minutes.
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Figure 17. Chromatogram of BOC medical grade synthetic air containing <01 ppm 
total hydrocarbons. Ethane (retention time 16-13 minutes) below the limit of detection.
The effect of flushing atmospheric air from the lungs on ethane exhalation is shown in 
figure 18. Compared with levels measured while breathing laboratory air, there was a 
dramatic reduction in ethane exhalation when the subject breathed synthetic air for 1 
minute prior to sample collection. Ethane exhalation was further reduced by extending 
the wash-out time to 3 minutes. After this time ethane exhalation was, on average, 8 % 
of that measured while breathing laboratory air. Although there was a further reduction 
in ethane exhalation when the wash-out time was extended to 10 minutes this effect 
was minor. It was therefore decided to employ a wash-out period of 4 minutes to 
remove atmospheric air from the lungs. A typical chromatogram of a breath sample 
collected after a 4 minute wash-out period is show in figure 19.
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Figure 18. Effect of wash-out time on ethane exhalation. Values are mean ± S.D. of 
three values.
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Figure 19. Chromatogram of a breath sample collected from a healthy non-smoker 
after breathing BOC synthetic air for 4 minutes. Ethane eluted with a retention time of 
16-20 minutes.
To remove laboratory air from the Douglas bags used to deliver synthetic air they were 
flushed with oxygen-free nitrogen (BOC Ltd, Guildford) before use. Ethane could not 
be detected in the nitrogen used (figure 20). Douglas bags were evacuated (to vacuum) 
using a high vacuum pump (Edwards, Crawley) and filled with nitrogen. They were 
then evacuated (to vacuum) and flushed with nitrogen once more. Similarly, ethane 
from breath samples was completely removed from sample collection bags by 
evacuating (to vacuum) and flushing with nitrogen, a procedure which was carried out 
four times in this case.
128
N
h
«
H
Figure 20. Chromatogram of BOC oxygen-free nitrogen.
The Douglas bags used to deliver synthetic air to the subject were made from polyvinyl 
chloride. Of the materials tested by Lawrence and Cohen (1982) polyvinyl was found 
to be most impermeable to ethane. The concentration of ethane in air samples collected 
from the laboratory in which the Douglas bags were filled reached 300 pmol/1. Ethane 
in Douglas bags containing synthetic air was, however, found to remain below the limit 
of detection for up to 90 minutes after filling. Synthetic air in the gas collection bags 
remained free from ethane contamination for up to 48 hours. Breath sample remained 
stable in these bags for the same period.
3.1.2. Sample analysis. Performing blank runs in which the temperature programme 
was run without sample injection again showed that BOC oxygen free nitrogen 
contained no detectable ethane. To fill the sample loop it was found necessary to
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operate the Capex 2D electrical air pump for 2 minutes. The loop contents were fully 
flushed onto the column by diverting the carrier gas through the sample loop for 6 
minutes. To ensure good peak shape from run to run it was found necessary to heat the 
column to 330 °C after each run and maintain it at this temperature for 3 minutes.
Repeat analysis of a breath sample collected from a non-smoking individual gave a run 
to run coefficient of variation of 8 % (n=10). Ethane exhalation from the same non­
smoking individual, measured in samples collected at 8.30 a.m after an overnight fast, 
averaged 12 ± 2 pmol/1 over a 7 day period.
3.2. Effect of smoking on ethane exhalation
Ethane exhalation measured 4 minutes after smoking a single cigarette was 
approximately 70 times greater than that measured immediately before smoking (figure 
21). There was a rapid decline in ethane exhalation beyond this point such that it was 
not significantly different from pre-smoking levels after 4 hours.
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Figure 21. Effect of smoking on ethane exhalation. Values are mean and range of two 
experiments carried out 4 days apart with a non-smoker. Smoking consisted of 10 
inhalations from a commercially available cigarette. Time 0 represents measurements 
taken immediately before smoking.
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4. Discussion
Concentrating ethane in a large volume of breath by "cold" trapping on the analytical 
column itself is a relatively straightforward technique compared with other methods 
such as rebreathing or cryofocusing on a precolumn. Ethane from 165 ml of breath 
could be trapped on the Carbosphere 80/100 column by maintaining it at 40 °C during 
sample application. If the time the column was held at 40 °C was increased by 1 minute 
the retention time for ethane increased by 0 97 minutes. Using this technique it was not 
necessary to remove water vapour or carbon dioxide from samples prior to analysis, 
further simplifying the procedure.
Initially, attempts were made to measure endogenous ethane production without a 
wash-out period by subtracting the concentration of ethane in laboratory air from that 
measured in breath samples collected after breathing laboratory air for at least 1 hour. 
The concentration in laboratory air was, however, found to vary considerably from day 
to day. Concentrations as high as 300 pmol/1 were recorded, although this could be 
reduced to 70 pmol/1 if the laboratory window were left open overnight. Using this 
technique endogenous ethane production was also found to vary considerably and at 
times could not be detected at all. Similarly, there was considerable variation in ethane 
exhalation measured after flushing atmospheric air from the lungs with medical grade 
air or zero grade air, both of which contain ethane. Ethane exhalation could, however, 
be detected reliably after breathing BOC synthetic air which contained no detectable 
ethane. As can be seen in figure 18 a 4 minute wash-out period was adequate to flush 
atmospheric air from the lungs.
Ethane and pentane in atmospheric air are absorbed through the lungs (Morita et a l, 
1986). Breath ethane measured after removal of atmospheric air from the lungs might 
therefore comprise exogenous ethane washed out from the body as well as that 
endogenously produced from in vivo lipid peroxidation. Morita et a l (1986) reported 
that the concentration of pentane in breath samples collected from healthy humans 
decreased as the duration of breathing Heliox (20 % oxygen 80 % helium) containing 
0-5 pmol/1 pentane increased. Samples collected prior to this wash-out period and after 
30 and 60 minutes wash-out contained 79 ± 12, 14 ± 2 and 12 ± 7 pmol/1 pentane 
respectively. No further reduction in pentane exhalation was seen on extending the 
wash-out period beyond 60 minutes. On the basis of these results it was suggested that 
pentane-free air must be breathed for 60 minutes before pentane exhalation represents 
basal metabolic production from in vivo lipid peroxidation. Springfield and Levitt
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(1994) suggest that even this period may not be adequate to remove atmospheric 
pentane fiom the body while Snider et a l (1986) estimate that hydrocarbon-fiee air 
must be breathed for 3 days before exogenous pentane is fully flushed out. Such a 
wash-out period would obviously prohibit the use of alkane exhalation as a biomarker 
of in vivo lipid peroxidation. Even a wash-out period of 60 minutes may not be 
economically or practically viable if alkane analysis is to be performed in large numbers 
of volunteers or used for routine clinical analysis (synthetic air sufficient for a 4 minute 
wash-out period cost approxiamtely £4). Breath samples are therefore generally 
collected after a short wash-out period adequate to remove atmospheric alkanes fiom 
the lungs, but not the body. If the wash-out period used in the current study had been 
extended beyond 10 minutes there might have been a further gradual decline in ethane 
exhalation. This was not possible due to the high cost of the synthetic air used and the 
number of subjects employed. The method used was therefore a compromise between 
the ideal situation and that which was feasible.
Ethane exhalation has several advantages over pentane exhalation as a biomarker of in 
vivo lipid peroxidation (chapter 2). Ethane also appears less soluble than pentane in 
body components, which may be a further advantage. The blood to air partition 
coefficients for pentane and ethane at 37 °C are 0-42 and 014 respectively (Daugherty 
et a l, 1988). Pentane is also considerably more soluble than ethane in fat, muscle and 
viscera (Wade and van Rij, 1985). Uptake of pentane from atmospheric air is therefore 
likely to be more rapid and more extensive than that of ethane. In agreement with this 
Kivits et al (1981) found that 90 % of the pentane in a closed system containing a rat 
was removed by the animal over a 2 hour period. In a similar experiment with ethane 
approximately 10 % was removed over this time. The concentration of ethane in breath 
samples collected after removal of atmospheric air from the lungs may therefore be 
more representative of in vivo lipid peroxidation, as opposed to wash-out of 
exogenous ethane from the body, compared with pentane. Nevertheless Wade and van 
Rij (1986) found that ethane exhalation measured after breathing hydrocarbon- 
scrubbed air for 90 minutes was two-thirds that measured without this wash-out 
period.
In studies conducted with free living humans working and living in different 
environments intra- and inter-individual exposure to atmospheric ethane and pentane 
may vary considerably (Kneepkens et a l, 1994). This could result in changes in alkane 
exhalation independent of in vivo lipid peroxidation. For example, exposure in the 
work place may be considerably greater than that in the home for some individuals.
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Samples collected on a Friday afternoon may therefore contain considerably more 
exogenous ethane and pentane compared with samples collected before work on a 
Monday morning. Given the lower uptake of ethane from ambient air compared with 
pentane and its lower solubility in body components measurement of ethane might be 
less vulnerable to this source of error. Nevertheless when collecting multiple samples 
from the same individual over a period of weeks it may be important that sample 
collection is performed on the same day of the week and at the same time of day.
Springfield and Levitt (1994) illustrated the effect of body composition on elimination 
of exogenous pentane from the body. The solubility of pentane in lipid and blood was 
found to be approximately 53 and 0-6 times that in air respectively. On this basis they 
predicted that body fat provides an enormous pentane sink that turns over slowly due 
to the low solubility of pentane in blood conpared with lipid and the low blood flow 
per gram of fat. These predictions were confirmed in studies with rats exposed to 
pentane. After prolonged exposure to relatively high concentrations of pentane, 
conventional Sprague-Dawley rats and genetically obese Zucker rats displayed 
disparate elimination kinetics. The decline in pentane exhalation was initially rapid and 
was followed by a period of slow exponential decay. In conventional Sprague-Dawley 
rats the half-life of this exponential period was approximately 3 hours while in the 
obese Zucker rats the corresponding value was 8-5 hours. Wash-out of exogenous 
pentane was therefore much more rapid from Sprague-Dawley rats while pentane 
exhalation was considerably greater from the obese Zucker rats at any given time 
during the exponential wash-out phase. Given the inter-individual variability in human 
body composition this is a further source of error associated with alkane analysis to 
which pentane may be more vulnerable than ethane.
It can now be seen that alkane exhalation from humans, measured after flushing 
atmospheric air from the lungs, may, in part, be due to wash-out of exogenous alkanes 
from the body and that this may be subject to both intra- and inter-individual 
variability. This may prove to be a serious problem associated with the use of alkane 
analysis as a biomarker of in vivo lipid peroxidation. It may, for example, lead to 
erroneous conclusions regarding the effect of a treatment, as might be the case in 
response to exercise. Alkane exhalation may therefore prove to be a more appropriate 
biomarker of lipid peroxidation in laboratory animals since the animals used in a study 
can be maintained in a constant environment and exposed to the same atmospheric 
concentrations of ethane and pentane. The amount of ethane and pentane originating 
from exogenous sources should therefore be constant across treatment groups,
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provided that respiratory rate, blood flow to tissues and other factors affecting wash­
out of alkanes from the body are unaffected by the treatment. The inter-individual 
variability in body composition can also be minimised in animal studies, further 
reducing variability in alkane exhalation due to exogenous sources.
Despite these possible sources of error, increased alkane exhalation has, nevertheless, 
been reported in humans suffering from a number of conditions associated with free 
radical damage which do not appear to affect wash-out of exogenous alkanes from the 
body. Provided each individual acts as their own control and wash-out remains 
constant throughout the course of the study, alkane exhalation may, therefore, still be a 
valid biomarker of lipid peroxidation. Even if this is the case changes in in vivo alkane 
production may, however, be underestimated or masked by wash-out of exogenous 
alkanes.
Cigarette smoke has been shown to contain 20,000 pmol ethane/1 (Wade and van Rij, 
1986). The increase in ethane exhalation associated with smoking (Sakamoto, 1985; 
Wade and van Rij, 1986) might therefore comprise exogenous ethane from cigarette 
smoke as well as ethane originating from in vivo lipid peroxidation stimulated by 
smoking. In the current study, smoking a single cigarette resulted in a dramatic 
increase in ethane exhalation from a non-smoker which returned to baseline 
approximately 4 hours after smoking. Wade and van Rij (1986) found that ethane 
exhalation from a non-smoker returned to baseline 3 hours after smoking a single 
cigarette. In chronic smokers the wash-out time required to flush alkanes from smoke 
out of the body may, however, be considerably greater than this (Wade and van Rij, 
1986). Sakamoto (1985) found that ethane from cigarette smoke disappears from the 
lungs of smokers after 24 hours abstention from smoking. After this time ethane 
exhalation from smokers was still greater than that from non-smokers, an observation 
attributed to in vivo lipid peroxidation. Allard et a l (1994a) state that breath samples 
collected from smokers after 12 hours abstention from smoking are not affected by the 
contents of the smoke. The results of their study appear to confirm this since there was 
no significant difference in ethane exhalation from smokers and non-smokers after 
smokers had abstained from smoking for this period. Pentane exhalation from smokers 
was, however, significantly greater than that from non-smokers after this wash-out 
period. Supplementation with (3-carotene for 4 weeks diminished pentane exhalation 
from smokers such that it was not significantly different from non-smokers pentane 
exhalation. This suggests that, like ethane exhalation, pentane exhalation after 12 hours
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abstention from smoking is a product of in vivo lipid peroxidation rather than that 
absorbed from the 8,000 pmol/1 present in cigarette smoke (Wade and van Rij, 1986).
A further point which must be considered when measuring alkane exhalation is the 
composition of the sample. Breath samples consist of alveolar air and dead space air, 
retained in the mouth, nose, pharynx, trachea and bronchi, which plays little or no part 
in gaseous exchange. The breath concentration of a compound diffusing from blood 
into air in the lungs will therefore depend on the amount of alveolar air and dead space 
air in the sample collected. Alveolar air normally accounts for two-thirds of the tidal 
volume. The concentration of a compound measured in total breath samples is 
therefore approximately two-thirds its concentration in alveolar air (Wilson, 1986). In 
agreement with this Zarling and Clapper (1987) found that the concentrations of 
ethane and pentane in total breath were approximately two-thirds of those in alveolar 
breath (after accounting for ambient air). It is therefore essential that reproducible 
breath samples are obtained if alkane exhalation is to be used as a quantitative index of 
in vivo lipid peroxidation. Sample collection should therefore be as standardised as 
possible. The subjects should also be breathing normally prior to sample collection.
In conclusion the technique described offers a relatively straightforward method of 
measuring ethane in human breath samples. It does, however, require a run time of 
approximately 40 minutes. The degree to which ethane measured using this technique 
represents in vivo lipid peroxidation, rather than wash-out of exogenous ethane from 
the body, is unknown.
136
Chapter 6
Investigation into the antioxidant 
activity of green tea in humans
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1. Introduction
It has been well documented that humans given a dietary supplement of fish oil show 
an increase in plasma EPA and DHÀ and plasma TBARS. Meydam et al. (1991) 
reported that plasma EPA and DHA in women increased by nine- and two-fold 
respectively following supplementation with 6 g/day of the fish oil Promega for 3 
months. This was accompanied by a significant increase in plasma MDA up to 2 
months of supplementation. Beyond 2 months there was a reduction in plasma MDA 
such that values were no longer significantly different from baseline after 3 months of 
supplementation.
Brown and Whale (1990) investigated the effect of MaxEPA supplementation (15 
g/day) in non-smoking young men. Two weeks of supplementation resulted in a 
significant increase in plasma TBARS without affecting plasma vitamin E status. 
Similar to the observations of Meydani et a l (1991), the increase in plasma TBARS 
was transient and values were not significantly different from baseline after 4 weeks of 
supplementation. Plasma conjugated dienes and LDL TBARS were not significantly 
affected by fish oil supplementation. Concomitant administration of cc-tocopherol (270 
mg day) with the MaxEPA capsules resulted in a significant increase in plasma vitamin 
E but could not prevent the fish oil-induced increase in plasma TBARS.
Harats et al. (1991) also found that MaxEPA supplementation (10 g/day for 4 weeks) 
increased plasma TBARS without affecting serum vitamin E status. LDL TBARS and 
plasma and red blood cell EPA and DHA also increased in response to fish oil 
supplementation. In this case concomitant administration of cc-tocopherol acetate (400 
mg/day) with the MaxEPA capsules was successftd in attenuating the fish oil-induced 
increases in plasma and LDL TBARS.
Allard et al (1994b) investigated the effects of menhaden oil supplementation (8 g/day 
for 6 weeks). Supplementation resulted in a significant increase in plasma phospholipid 
EPA and DHA and plasma MDA without affecting plasma vitamin E status. Additional 
vitamin E (600 mg cc-tocopherol/day) could not prevent the fish oil-induced increase in 
plasma TBARS, despite the fact that it resulted in a 100 % increase in plasma vitamin 
E.
Haglund et a l (1991) found that supplementation with a fish oil containing 0*2 mg/g 
cc-tocopherol (30 ml/day for 3 weeks) resulted in a significant increase in plasma
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TBARS and a significant decrease in serum vitamin E. Both of these effects could be 
prevented by increasing the a-tocopherol content of the oil to 1 -0 mg/g.
Finally, Nair et a l (1993) found that men placed on a diet devoid of EPA and DHA for 
10 weeks (placebo period) had a plasma TBARS value of 165 gmol/l. After a further 
10 weeks on this diet during which they received fish oil capsules providing 5 g EPA 
and 2 g DHA/day (fish oil period) plasma TBARS were significantly increased to 3-72 
pmol/1. For the next 8 weeks they were provided with the controlled diet, fish oil 
capsules and 200 mg/day a-tocopherol (a-tocopherol period). After this period plasma 
TBARS were 0 98 pmol/1, a value significantly lower than that measured after the 
other periods. Plasma, platelet and red blood cell a-tocopherol were significantly lower 
after the fish oil period when compared with the placebo and a-tocopherol periods.
These studies conclusively demonstrate the capacity of fish oil supplementation to 
increase plasma TBARS. It is, however, interesting to note that vitamin E was 
protective against this effect in some studies but not in others. One might speculate 
that the inability of vitamin E to protect against the fish oil-induced increase in plasma 
TBARS is a consequence of MDA in the oil itself. This possibility does, however, 
appear unlikely in the study conducted by Brown and Whale (1990) since it would not 
explain the reduction in plasma TBARS between 2 and 4 weeks of fish oil 
supplementation. Moreover Harats et al (1991) also used MaxEPA and observed a 
protective effect for vitamin E against the fish oil-induced increase in plasma TBARS. 
With the exception of the study conducted by Harats et a l (1991), the protective 
effect of vitamin E was seen in studies in which fish oil supplementation resulted in a 
significant reduction in plasma vitamin E. There was no significant change in plasma 
vitamin E, subsequent to fish oil supplementation, in those studies in which additional 
vitamin E was ineffective. Low vitamin E status may therefore be required before 
additional vitamin E shows a protective effect.
Differences in sample handling and storage procedures and the methodology used to 
develop the MDA-DETBA complex may also contribute to the inconsistent effect of 
vitamin E in these studies. The effect of differences in these procedures is illustrated by 
comparing baseline levels of plasma MDA in non-smokers in the studies of Brown and 
Whale (1990) and Harats et al (1991), 4 nmol MDA/ml and 0-1 nmol MDA/ml 
respectively. It is highly unlikely that the difference between these studies is due 
entirely to differences in the study populations (Knight et a l, 1987).
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Fish oil supplementation has also been shown to increase urinary MDA excretion. The 
origin of this effect is, however, unclear. Piché et al. (1988) reported that MDA 
excretion from six adults increased significantly following supplementation with 30 
ml/day of a pharmaceutical grade of cod liver oil for 14 days. Supplementation with 10 
g/day MaxEPA for 50 days had no effect on urinary MDA excretion. The cod liver oil 
supplement was preservative-free and was found to contain MDA while MaxEPA 
contained both dodecylgallate and cc-tocopherol acetate. On the basis of these 
observations it was suggested that the increase in urinary MDA excretion subsequent 
to supplementation with the cod liver oil was due to MDA ingested in the oil itself 
rather than events initiated in vivo. Although this may indeed have been the case it is 
also possible that the increase seen was due in part to in vivo lipid peroxidation. The 
apparent non-effect of MaxEPA may have been due to the duration of 
supplementation; supplementation may have resulted in a transient rise in urinary MDA 
excretion, similar to that seen in plasma TBARS, which was not detected in this study.
Nelson et al. (1993) reported that urinaiy MDA excretion from men consuming a diet 
containing salmon for 40 days was significantly greater than that from the same 
volunteers after consumption of a diet devoid of salmon for the same period. 
Unfortunately the MDA content of cooked salmon was not measured in this study and 
the origin of this effect cannot be ascertained.
Cigarette smoking results in exposure to free radicals and depletion of antioxidant 
nutrients. Accordingly smokers may have elevated antioxidant requirements and may 
be more susceptible to oxidative damage when compared with non-smokers. As such 
smokers represent an ideal group for the current investigation.
Cigarette smoke can be divided into tar and gas phases by the use of a Cambridge filter 
which retains 99 9 % of the particulate matter with a size greater than 01 pm. Gas 
phase cigarette smoke contains more than 1015 carbon- and oxygen-centred radicals 
per puff (Pryor and Stone, 1993). Despite their short lifetimes, typically less than 1 
second, high concentrations of these radicals are maintained in smoke for more than 10 
minutes (Pryor and Stone, 1993). The tar in each puff of smoke contains 1014 radicals 
(Halliwell and Gutteridge, 1989). Many of the components of tar are water-soluble and 
aqueous extracts are capable of reducing molecular oxygen to superoxide. Cigarette 
smoke also contains traces of metals, including iron and copper (Halliwell and 
Gutteridge, 1989).
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The capacity of cigarette smoke to oxidize human plasma in vitro has been 
demonstrated. Cross et al (1993) found that exposure of plasma to gas phase cigarette 
smoke resulted in depletion of ascorbic acid and formation of lipid hydroperoxides and 
protein carbonyls. Supplementation with additional ascorbic acid was found to delay 
lipid peroxidation without affecting protein carbonyl formation. In similar experiments 
exposure of plasma to whole smoke also resulted in depletion of ascorbic acid and 
protein carbonyl formation. It did not, however, cause detectable lipid peroxidation. 
Gas phase cigarette smoke has also been shown to induce the oxidation of methyl 
linoleate (Niki et a l, 1993). No oxidation took place if whole smoke was used. The 
difference between gas phase smoke and whole smoke in this study was attributed to 
phenolic compounds in the tar.
The pro-inflammatory effects of smoking have been well documented. Smokers have 
been reported to have a higher peripheral blood leukocyte count than non-smokers and 
ex-smokers (Chan-Yeng and Dy Buncio, 1984; Hind et a l, 1990). Chan-Yeng and Dy 
Buncio (1984) also found a significant positive correlation between mean leukocyte 
count and cigarette consumption, expressed both as number of cigarettes per day and 
as pack-years. Van Antwerpen et a l (1993) reported that cigarette smoking was 
associated with a significant increase in total leukocyte count and the numbers of 
circulating neutrophils. Cigarette smoking was also associated with a significant 
increase in ROS generation from phorbol- 12-myristate- 13-acetate (PMA)-stimulated 
neutrophils in this study. The difference in ROS generation between smokers and non- 
smokers persisted after correction for total leukocyte count. Ludwig and Hoidal 
(1982) found that peripheral leukocytes from smokers with a white cell count greater 
than 9000 released significantly more superoxide than leukocytes from non-smokers 
with a corresponding count. This difference persisted when blood was collected from 
smokers after 12-14 hours abstention from smoking. Plasma myeloperoxidase activity 
has also been shown to increase during inhalation of cigarette smoke (Bosken et a l, 
1991).
Cigarette smoking has also been shown to increase the number and activity of 
macrophages and neutrophils in the lungs. Hubbard et al (1987) found that the lower 
respiratory tract epithelial lining fluid of smokers contained twice as many 
macrophages as that from non-smokers. Spontaneous release of superoxide and 
hydrogen peroxide from alveolar macrophages of smokers was approximately two- 
and eight-fold greater than that from non-smokers respectively. Hoidal et a l (1981) 
also found that smoking significantly increased the spontaneous and PMA-stimulated
141
release of superoxide from alveolar macrophages. Broncho alveolar lavage fluids from 
smokers have also been shown to contain significantly more neutrophils that those 
from non-smokers (Hunninghake and Crystal 1983).
Since cigarette smokers are exposed to free radicals from cigarette smoke and tar and 
from the pro-inflammatory effects of smoking, it is perhaps not surprising that the 
plasma concentrations of ascorbic acid (Schectman et a l, 1991, Duthie et a l, 1993; 
Bolton-Smith, 1993) and dehydroascorbic (Duthie et a l, 1991) in smokers have been 
reported to be lower and higher respectively when compared with those in non- 
smokers. Smokers have also been reported to have lower plasma levels of (3-carotene 
(Stryker et a l, 1988; Bolton-Smith, 1993). Conflicting reports exist regarding the 
effect of smoking on plasma vitamin E status (Bolton-Smith, 1993; Duthie et a l, 
1993, Van Antwerpen et a l, 1993).
The association between smoking and lower plasma levels of ascorbic acid and (3- 
carotene does not appear to be a simple one between ROS exposure and nutrient 
consumption. Bolton-Smith (1993) reported the antioxidant nutrient intake of subjects 
enrolled in the Scottish Heart Health Study (SHHS), a study of 10,359 middle-aged 
men and women from 22 Scottish districts. For both men and women, daily intake of 
ascorbic acid, vitamin E and carotene was significantly lower in smokers compared 
with non-smokers. An inverse dose-response-type effect was also observed for dietary 
intake of these nutrients and number of cigarettes smoked per day. The results of 
another much smaller study, the Scottish MONICA Antioxidant Vitamin Study 
(SMAVS), were also reported in this paper. Similar to the SHHS study, dietary intake 
of ascorbic acid and carotene was significantly lower in smokers.
The reduced plasma levels of ascorbic acid and (3-carotene in smokers do, however, 
also appear to be a reflection of increased utilisation in vivo. Kallner et al (1981) 
reported that smokers require an ascorbic acid intake of 140 mg/day to reach steady 
state concentrations and total body pools comparable to those in non-smokers 
consuming 100 mg/day. Absorption and renal handling of ascorbic acid were not 
significantly affected by smoking status and it was concluded that smoking increased 
metabolic turnover. Schectman et al (1991) reported that smokers require an ascorbic 
acid intake of >150 mg/day to maintain plasma concentrations not significantly 
different from those in non-smokers consuming 60 mg/day. Stryker et a l (1988) found 
that, after adjustment for dietary intake and other variables, plasma (3-carotene in men
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and women who smoked one pack of cigarettes/day was 72 % and 79 % of that in 
non-smokers respectively.
It can now be seen that smoking might be expected to increased in vivo oxidative 
damage and elevated biomarkers of this process. In this regard it has been well 
documented that smoking increases ethane and pentane exhalation (Sakamoto 1985; 
Wade and van Rij, 1986; Hoshino et a l, 1990). That this is a consequence of in vivo 
lipid peroxidation, rather than the alkanes present in cigarette smoke, has been 
suggested. Allard et al. (1994a) found that pentane exhalation from smokers could be 
significantly reduced by (3-carotene supplementation while Hoshino et al (1990) 
observed a similar effect for vitamin E.
The effect of smoking on other biomarkers of lipid peroxidation is less clear. Duthie et 
a/. (1991) found that conjugated dienes in plasma were significantly greater in smokers 
compared with non-smokers. Plasma TBARS were also elevated in smokers, although 
this effect did not reach statistical significance. In a subsequent study Duthie et al 
(1993) again found that smoking significantly increased conjugated dienes in plasma 
without significantly affecting plasma TBARS. Harats et al (1989) measured plasma 
and LDL TBARS in non-smokers and in smokers after 24-40 hours abstention from 
smoking. Although both parameters were slightly greater in smokers they were not 
significantly affected by smoking status. Acute smoking has, however, been shown to 
increase plasma lipid peroxidation (Harats et a l, 1990). TBARS in smokers’ plasma, 
native LDL, and LDL conditioned with smooth muscle cells (SMC) were significantly 
greater after acute smoking (5-7 cigarettes over a 90 minute period) when compared 
with measurements made after 40-48 hours abstention from smoking. The effect of 
smoking on plasma lipid peroxidation may therefore depend on recent smoking history. 
Nevertheless smokers’ blood components appear to be more susceptible to oxidative 
damage than those of non-smokers for some time after the direct effects of smoking 
are no longer detectable. Harats et al (1989) reported that there was no significant 
difference in native LDL TBARS between smokers and non-smokers when samples 
were collected from smokers 24-40 hours after abstention from smoking. LDL 
isolated from smokers after this period of abstention was, however, more susceptible 
to SMC-induced peroxidation than that from non-smokers. Smokers’ erythrocytes 
have also been shown to be more susceptible to hydrogen peroxide-induced lipid 
peroxidation (Duthie et a l, 1991).
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Smoking has also been shown to increase DNA damage. Urinary excretion of 8- 
hydroxy-deoxy-guanosine (SOHdG) has been shown to be 50 % greater in smokers 
(Loft et a l, 1992). Kiyosawa et a l (1990) reported that smoking two cigarettes in a 
10 minute period resulted in a 50 % increase in leukocyte SOHdG.
From the above discussion it can be concluded that fish oil supplementation and 
smoking are two situations which may increase antioxidant requirements, especially in 
combination. As such they may be situations in which green tea has the opportunity to 
demonstrate in vivo antioxidant activity.
The aim of this study was therefore to investigate the potential in vivo antioxidant 
activity of green tea in smokers and non-smokers given fish oil
2. Methods
2.1. Subjects and study design
2.1.1. Subjects. The study was conducted in ostensibly healthy men aged 40-60 years 
recruited from University of Surrey employees and people living in the Guildford area. 
From an initial group of 35 volunteers 9 non-smokers and 7 smokers were selected. 
Volunteers were screened by interview and a lifestyle questionnaire covering diet, 
health, physical activity and other factors considered pertinent to the study. Volunteers 
were rejected according to the following criteria: alcohol consumption > 21 
units/week, consumption of oily fish > 3 times/week, exercise > three 30 minute 
periods/week, fruit and vegetable consumption > 4 portions/day. Individuals with a 
history of heart disease, diabetes, allergy or any other chronic illness were excluded 
from the study, as were volunteers taking any form of vitamin or mineral supplement, 
herbal preparation or green tea beverage. The characteristics of the study groups are 
given in table 11.
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Table 11. Subject characteristics
Non-smokers
(n=9)
Smokers
(n=7)
Age (years) 51T ± 6-8 45*6 ± 6*7
Weight (kg) 83-7 ± 11-7 824 ± 182
BMI (kg/m2) 27-3 ± 2-5 26-1 ± 4-5
Alcohol
units/week 6-5 ± 6-0 3-4 ± 3-7
Cigarettes
number/day — 23-6 ± 9-9
years smoked — 18-9 ± 8-0
Values are expressed as mean ± S.D.
2.1.2. Study design. The study was a placebo-controlled single blind cross over 
design. Subjects received 10 x 1 g capsules/day of the fish oil MaxEPA (Sevenseas 
Ltd. Hull) for two periods of 4 weeks, referred to as period 1 and period 2, with a 3 
week wash-out between supplementation periods. During one supplementation period 
they also received 15 g green tea extract/day as 250 mg capsules. An HPLC 
chromatogram of the green extract is shown in figure 22. During the other they 
received outwardly identical capsules of placebo (maltodextrin). The green tea/placebo 
capsules contained 3 mg saccharin/capsule to act as a marker of compliance. Half of 
each group, smokers and non-smokers, received green tea during period 1 while the 
other half received placebo. During period 2 the treatment, green tea or placebo, was 
reversed. Capsules were taken after each main meal, four fish oil after breakfast, three 
after lunch and three after the evening meal. Two green tea/placebo capsules were 
taken with each dose of fish oil capsules. Subjects were instructed to maintain their 
normal dietary habits throughout the study with the exception of red wine and black 
tea which were prohibited from 1 week prior to sample collection and throughout the 
11 week study period. To monitor the effects of the treatment samples of blood, breath 
and urine were collected prior to each treatments period and after 2 and 4 weeks of 
supplementation. Blood and breath samples were collected at 8.30 am after an 
overnight fast while 24 hour urine samples were collected into 1 M hydrochloric acid 
from the morning of the day prior to blood and breath collection. The breath collection 
procedure is described in chapter 5. Blood samples (50 ml) were collected into EDTA 
tubes (Sarstedt Ltd, Leicester). Vigorous physical exercise and alcohol consumption
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were prohibited on the day prior to sample collection. Smokers were instructed to 
refrain from smoking for at least 8*5 hours prior to collection of blood and breath 
samples.
0.14 i
Caffeine
0.12  -
EGCG
0.08 -
EC
0.06 -
0.04 - ECO
0.02 -
20
Time (minutes)
Figure 22. HPLC chromatogram of the green tea extract use in the animal and human
studies For HPLC procedure see Robertson (1992)
2.2. Analysis
2.2.1. MDA analysis. Plasma and urinary MDA were determined using the procedure 
described in chapter 2.
2.2.2. Ethane exhalation. Breath samples were collected and analysed using the 
procedure described in chapter 5.
2.2.3. Protein Carbonyls. To 1 ml of fresh plasma 10 gl of each of the following 
protease inhibitors were added: leupeptin (0 1 mg/ml in water), aprotinin (01 mg/ml in 
10 mM Hep es, pH 8), pep statin (014 mg/ml in ethanol) and phenylmethylsulfonyl 
chloride (4 mg/ml in isopropanol). Samples could then be stored at -70 °C until 
analysis. Protein carbonyls were determined by Nestec Ltd. Research Centre,
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Lausanne, Switzerland. Protease inhibitors were obtained from Sigma Chemical Co. 
(Poole).
strand breaks
2.2.4. Lymphocyte DNA . Lymphocytes were separated from whole EDTA
treated blood using Lymphoprep (Nycomed Ltd., Birmingham). Blood (10 ml) was 
mixed with an equal volume of 0*9 % sodium chloride and layered over 10 ml 
Lymphoprep in centrifuge tubes such that the blood column was 4 cm high. Tubes 
were than centrifuged for 30 minutes at 800 x g using a swing out rotor. After 
centrifugation the lymphocytes appeared as a distinct band at the sample/medium 
interface and were removed using a Pasteur pipette. Following dilution with 0 9 % 
sodium chloride (1 in 8) they were centrifuged for 10 minutes at 250 x g. The pellet 
was resuspended in 1 ml each of cell freezing medium A and cell freezing medium B 
(Biofluids inc. Rockville, MD, USA) in Nunc cryotubes (Life Technologies Ltd, 
Paisley). Cryotubes were placed in an isopropanol bath at room temperature and 
transferred immediately to -70 °C. Lymphocytes were stored at this temperature until 
analysis. DNAstrand breaks wel2etermined using the COMET assay by Nestec Ltd. 
Research Centre, Lausanne, Switzerland.
2.2.5. Antioxidant nutrients. Plasma samples for a-tocopherol, y-tocopherol, retinol, 
a-carotene, p-carotene and lycopene analysis were stored in Nunc cryotubes (Life 
Technologies Ltd, Paisley) at -70 °C. For ascorbic acid analysis, 1 ml of plasma was 
mixed with an equal volume of cold 10 % (w/v) metaphosphoric acid (Fluka chemicals, 
Gillingham). Following centrifugation for 10 minutes at 776 x g the supernatant was 
separated and stored at -70 °C. Analysis was carried out by Nestec Ltd. Research 
Centre, Lausanne, Switzerland.
2.2.6. Creatinine analysis. Urinary creatinine was determined by reaction with picric 
acid in alkaline solution at 25 °C using the Cobas Mira Plus (Roche Products Ltd, 
Welwyn Garden City). To 100 pi of diluted urine (1 in 100 with distilled water) 1000 
pi of Unimate 5 creatinine reagent were added (Roche Products Ltd). Absorbance at 
500 nm was measured 30 seconds (A J and 2 minutes after mixing (A2). Urinary 
creatinine was determined by comparison of AA (A2-A 1) with that obtained from 
Roche human calibrator (Roche Products Ltd).
2.2.7. Plasma lipid analysis. Plasma triglycerides were determined through the 
oxidative coupling of 4-chlorophenol to 4-aminoantipyrine to form a quinone-imine
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derivative, a reaction effected through hydrogen peroxide in the presence of 
peroxidase. Hydrogen peroxide was generated from triglycerides as shown below.
[20] Triglyceride -» glycerol + fatty acids
[21] Glycerol + ATP -> glycerol-3-phosphate + ADP
[22] Glycerol-3-phosphate —> dihydroxyacetone phosphate +H2O2
Plasma samples (10 pi) were mixed with 1000 pi Unimate 5 triglyceride reagent 
(Roche Products Ltd) and absorbance at 500 nm measured using the Cobas Mira Plus 
after incubation for 5 minutes at 37 °C. Triglycerides were determine by comparison of 
absorbance with that obtained from Lipid Control Serum (Roche Products Ltd).
Plasma total cholesterol was measured after oxidation to cholesterol-3-one and 
hydrogen peroxide. The hydrogen peroxide produced was determined using the Cobas 
Mira Plus through the oxidative coupling of phenol and 4-aminoantipyrine to from a 
quinone-imine derivative. Plasma samples (10 pi) were mixed with 1000 pi Unimate 7 
cholesterol reagent (Roche products Ltd) and absorbance measured at 500 nm after 
incubation for 10 minutes at 37 °C. Cholesterol was determined by comparison of 
absorbance with that obtained from Lipid Control Serum (Roche Products Ltd).
HDL cholesterol was measured after precipitation of LDL and VLDL using HDL 
reagent (Roche Products Ltd). Plasma samples (200 pi) were mixed with HDL reagent 
(500 pi) and allowed to stand for 10 minutes at 20-25 °C. After centrifugation for 10 
minutes at 716 x g the supernatant was taken for analysis as described for total 
cholesterol. HDL cholesterol was determined by comparison of absorbance to that of 
Control Serum N (Roche Products Ltd) diluted with 0 9 % sodium chloride solution 
(200 pi Control Serum N to 500 pi 0-9 % sodium chloride).
2.2.8. Saccharin analysis. Urinary saccharin was analysed using a reverse phase 
HPLC procedure. Saccharin was separated from interfering UV-absorbing substances 
using a 25 cm Kromasil C18 column (Hichrom Ltd, Reading) connected to a Spectra- 
Physics P4000 pump and Spectra-Physics AS 3000 autosampler (Thermo Separation 
Products, Stone). Detection was carried at a wavelength of 225 nm using a Spectra- 
Physics forward optical scanning detector (Thermo Separation Products, Stone). 
Saccharin was eluted using the following solvent system:
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Solvent A: 96 % water containing 0-5 % formate adjusted to pH 4 with ethanolamine.
4 % acetonitrile 
Solvent B: 100 % acetonitrile
The solvent programme is shown in table 12
Table 12. Solvent programme for saccharin analysis
Time (minutes) 0 30 32 52 54 94
% A 100 100 0 0 100 100
% B 0 0 100 100 0 0
2.2.9. Statistical analysis. Parametric comparisons were performed using students t 
test and analysis of variance with Tukey-Kramer multiple comparison test as 
appropriate. Non-parametric analysis was performed using the Kruskal-Walhs 
nonp arametric AN OVA test.
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3. Results
3.1. Lipid peroxidation
Baseline levels of biomarkers of in vivo lipid peroxidation (baseline period 1) in 
smokers and non-smokers are shown in table 13. Ethane exhalation and urinary MDA 
excretion (expressed as pg MDA/mg creatinine) were significantly greater from 
smokers (P<0*05). There was no significant difference in plasma MDA between the 
two groups.
Table 13. Baseline levels of lipid peroxidation in smokers 
and non-smokers
Non-smokers Smokers
(n=9) (n=7)
Ethane exhalation 
pmol/1 44 ±24 100 ± 48$
Plasma MDA 
nmol/1
pmol/mmol TG
0-61 ±0-15 
0-27 ±0-10
0 58 ± 0 22 
037 ± 016
Urinary MDA 
pg/kg/24 hours 
pg/mg Ct
5-20 ± 0 8 9
0 21 ± 0 03
5-79 ± M 9 
0 26 ± 0*04$
Values are expressed as mean ± S.D.
Abbreviations: TG triglyceride, Ct creatinine. * indicates significant 
difference from non-smokers P<0-05.
The effects of fish oil supplementation and green tea on lipid peroxidation are 
described below.
3.1.1. Ethane exhalation. Fish oil supplementation had no significant effect on ethane 
exhalation from smokers and non-smokers and there was no significant difference 
between green tea and placebo periods after both 2 and 4 weeks of supplementation 
(figure 23). Ethane exhalation from smokers was, however, consistently greater than 
that from non-smokers. Due to the large degree of inter-individual variability this 
difference in mean values did not always reach statistical significance.
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3.1.2. Plasma MDA: nmol MDA/ml plasma. There was no significant change in non- 
smokers’ mean plasma MDA throughout the study (figure 24). Although the response 
(defined here as the difference between baseline and a measurement made after 2 or 4 
weeks supplementation) of non-smokers’ plasma MDA to 2 weeks of fish oil 
supplementation was greater during the placebo period the difference in response 
between the two treatment periods, green tea and placebo, was not statistically 
significant.
Fish oil supplementation resulted in a significant increase in smokers’ mean plasma 
MDA during the placebo period (P<0-001 and P<0-05 after 2 and 4 weeks 
respectively). The response of smokers’ plasma MDA to supplementation with fish oil 
and placebo for 2 weeks was significantly greater than that seen in the non-smokers 
(P<0‘05). There was, however, no significant difference in mean plasma MDA values 
between smokers and non-smokers at any stage during the study. During the green tea 
period smokers’ plasma MDA followed a similar trend to that seen during the placebo 
period; an increase after 2 weeks followed by a decrease at 4 weeks relative to the 2 
week value. The increase in smokers’ plasma MDA during the green tea period was 
smaller than that seen during the placebo period. Difference in the response between 
the green tea and placebo periods did not, however, reach statistical significance and 
there was no significant difference in smokers’ mean plasma MDA between the two 
periods. Similarly, difference in mean plasma MDA values and the response to fish oil 
supplementation between green tea and placebo periods did not reach statistical 
significance if data for smokers and non-smokers were combined.
The reduction in smokers’ mean plasma MDA between 2 and 4 weeks of 
supplementation did not reach statistical significance during either the green tea or 
placebo periods. When data for smokers and non-smokers were combined this 
reduction was statistically significant during the placebo period (P<0-05).
3.1.3. Plasma MDA: pmol MD A/mmol triglyceride. Plasma TBARS have been 
shown to correlate positively with the plasma concentration of triglycerides (Franke et 
al, 1994). After adjustment for the hyoptiiglyceiidemic effects of fish oil 
supplementation (figure 41) plasma MDA showed a similar trend to that seen before 
adjustment; an increase after 2 weeks of supplementation followed by a reduction 
between 2 and 4 weeks, except in the non-smokers during the green tea period (figure 
25). In this case the increase in plasma MDA also reached statistical significance in the 
non-smokers.
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Although the response of smokers’ plasma MDA to fish oil supplementation was 
greater than that of non-smokers during the placebo period the difference in response 
between the two groups did not reach statistical significance. Once again there was no 
significant difference in mean plasma MDA values between smokers and non-smokers 
at any stage during the study.
There was no significant difference in mean plasma MDA values and the response to 
fish oil supplementation between green tea and placebo periods in either group, 
smokers or non-smokers.
After adjustment for plasma triglyceride concentrations the reduction in mean plasma 
MDA between 2 and 4 weeks of supplementation with fish oil and placebo failed to 
reach statistical significance in either group individually or after the data were 
combined.
3.1.4. Urinary MDA: jag MD A/kg/24 hours. The effect offish oil supplementation 
on urinary MDA excretion was similar to its effect on plasma MDA; an increase after 2 
weeks followed by a decrease at 4 weeks relative to the 2 week value (figure 26). 
After 2 weeks of supplementation mean urinary MDA excretion from smokers was 
significantly greater than baseline during both the green tea and placebo periods. Non- 
smokers* mean urinary MDA was not significantly different from baseline at any stage 
during the supplementation periods.
The response of smokers’ urinary MDA excretion to supplementation with fish oil and 
placebo for 2 weeks was significantly greater than that seen in non-smokers (P<0-05). 
There was, however, no significant difference in mean urinary MDA excretion between 
smokers and non-smokers at any stage during the study.
Although the increase in smokers’ urinary MDA excretion was greatest during the 
placebo period there was no significant difference in the response to fish oil 
supplementation between green tea and placebo periods. At each time point during the 
study mean urinary MDA excretion was not significantly different between green tea 
and placebo periods in smokers and non-smokers.
The difference in smokers’ mean urinary MDA excretion between 2 and 4 weeks of 
supplementation reached statistical significance during the placebo period only 
(P<0-05).
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3.1.5. Urinary MDA: jig MD A/mmol creatinine. To allow for the possibility of 
incomplete collection of 24 hour urine samples, urinary MDA excretion has been 
expressed against urinary creatinine (figure 27). When expressed as such, MDA 
excretion followed a similar trend to that shown in figure 26. After 2 weeks it was 
significantly greater than baseline in non-smokers during the green tea period and in 
smokers during the placebo period. After 4 weeks of supplementation the only 
significant difference from baseline was seen in the smokers during the placebo period.
Although the response of smokers’ urinary MDA excretion to fish oil supplementation 
was greater during the placebo period the difference in response between the two 
periods, green tea and placebo, did not reach statistical significance. There was no 
significant difference in mean urinaiy MDA excretion between green tea and placebo 
periods in either smokers or non-smokers at any stage during the study.
The difference in mean urinary MDA excretion between 2 and 4 weeks of 
supplementation during the placebo period was not statistically significant in either 
group individually but was statistically significant if data for smokers and non-smokers 
were combined (P<0-05).
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Figure 23. Ethane exhalation from smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. Asterisks indicate significant difference 
from corresponding group of non-smokers * P<0*05, ** P<0*01. Ethane exhalation 
during the supplementation periods was not significantly different from baseline in 
smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, 
n=7 smokers).
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Figure 24. Plasma MDA in smokers and non-smokers expressed as nmol/ml; effect of 
fish oil supplementation with green tea and placebo. Letters indicate significant 
difference from corresponding baseline a P<0,05) b P<0*001. Values are expressed as 
mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 25. Plasma MDA in smokers and non-smokers expressed as pmol/mmol 
triglyceride; effect of fish oil supplementation with green tea and placebo. Letters 
indicate significant difference from corresponding baseline a P<0-05, b jP<0-01. There 
were no significant differences between smokers and non-smokers. Values are 
expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 26. Urinary MDA excretion from smokers and non-smokers expressed as 
pg/kg/24 hours; effect of fish oil supplementation with green tea and placebo. Letters 
indicate significant difference from baseline aP<0-05, b jP<0*001. Values are expressed 
as mean ± S.D. (n=9 non-smokers, n=7 smokers).
157
0.7 i
El Non-smokers: Fish 
oil/Placebo
H Non-smokers: Fish 
oil/Green tea
□ Smokers: Fish oil/Placebo
■ Smokers: Fish oil/Green 
tea
Baseline 2 weeks 4 weeks
Figure 27. Urinary MDA excretion from smokers and non-smokers expressed as 
pg/mg creatinine; effect of fish oil supplementation with green tea and placebo. Letters 
indicate significant difference from corresponding baseline a P<0-05, b P<0-01. There 
were no significant differences between smokers and non-smokers. Values are 
expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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3.2. Protein oxidation
There was no significant difference in plasma protein carbonyls between smokers and 
non-smokers at baseline (baseline period 1, table 14)
Table 14. Baseline plasma protein carbonyls in smokers and 
non-smokers
Non-smokers Smokers
(n=9) (n=7)
Protein carbonyls
nmol/mg protein 0-131 ±0-023 0-121 ± 0-036
Values are expressed as mean ± S.D.
Fish oil supplementation for 4 weeks resulted in a significant increase in non-smokers’ 
mean plasma protein carbonyls during both green tea and placebo periods (figure 28). 
The corresponding increase in smokers’ plasma protein carbonyls only reached 
statistical significance during the green tea period. Although the response of smokers’ 
plasma protein carbonyls to 2 weeks of fish oil supplementation was greater than that 
of non-smokers during both green tea and placebo periods, the difference in response 
between the two groups failed to reach statistical significance. There was no significant 
difference in mean values and the response to fish oil supplementation between green 
tea and placebo periods in both groups, smokers and non-smokers.
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Figure 28. Plasma protein carbonyls in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. Letters indicate significant difference 
from corresponding baseline a P<0-05. There were no significant differences between 
smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, 
n=7 smokers).
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3.3. DNA oxidation
strand breaks
Lymphocyte DNA , measured using the COMET assay, was similar in
smokers and non-smokers at baseline (baseline period 1, table 15)
Table 15. Baseline lymphocyte DNA oxidation
Non-smokers Smokers
(n=9) (n=7)
COMET migration
pm 112 ±44 92 ± 9
Values are mean ±  S.D.
Fish oil supplementation with either green tea or placebo had no significant effect on
lymphocyte DNA in smokers and non-smokers (figure 29).
strand breaks
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Figure 29. Lymphocyte DNA in smokers and non-smokers measured using
the COMET assay; effect of fish oil supplementation with green tea and placebo. There 
were no significant differences between smokers and non-smokers. Values measured 
during the supplementation periods were not significantly different from baseline in 
both groups, smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 
non-smokers, n=7 smokers).
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3.4. Antioxidant nutrients
Plasma levels of antioxidant nutrients measured prior to the study (baseline period 1) 
are shown in table 16. Plasma vitamin E values have been shown to correlate positively 
with plasma lipids. Thumhan et al (1986) found that the correlation with total 
cholesterol was stronger than that with other lipids. Accordingly plasma a- and y- 
tocopherol are expressed as mg/1 plasma and pmol/mmol cholesterol. Bolton-Smith et 
al (1991) suggested that associations between plasma lipids and P-carotene or retinol 
are not important determinants of plasma concentrations of these antioxidant nutrients. 
Accordingly no such corrections were carried out for these nutrients. With the 
exception of y-tocopherol, plasma antioxidant nutrients were consistently lower in 
smokers. There was, however, considerable inter-individual variability and the 
differences between smokers and non-smokers did not reach statistical significance.
Table 16. Baseline levels of antioxidant nutrients in smokers 
and non-smokers
Non-smokers
n=9
Smokers
n=7
a-Tocopherol
mg/1 16-5 ± 5-6 14-5 ±4-3
pmol/mmol Ch 7-30 ± 143 6-69 ±3-08
y-Tocopherol
mg/1 0-72 ±0-31 0-84 ±0-38
pmol/mmol Ch 0-34 ±0-14 0-43 ± 0-22
Retinol
Pg/1 633 ± 159 559 ±79
P-Carotene
ng/i 298-6 ± 143-6 219-8 ± 131-0
a-Carotene
Pg/1 67-0 ±33-7 49-4 ± 54-9
Lycopene
ng/l 475 ± 277 311 ±285
Ascorbic acid 
pmol/1 49-0 ± 16-4 36-6 ±21-0
Values are mean ± S.D. Abbreviations: Ch total cholesterol.
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The effects of fish oil supplementation and green tea on plasma antioxidant nutrients 
are described below.
3.4.1. a-tocopherol: mg/1. Plasma a-tocopherol was consistently lower in smokers 
throughout the study (figure 30). The difference between smokers and non-smokers 
did not, however, reach statistical significance at any of the time points studied. Fish 
oil supplementation along with either green tea or placebo had no significant effect on 
plasma a-tocopherol in smokers and non-smokers and there was no significant 
difference between green tea and placebo periods in either group.
3.4.2. a-tocopherol: jumol/mmol cholesterol. After adjustment for total cholesterol, 
plasma a-tocopherol was again consistently lower in smokers compared with non- 
smokers (figure 31). Once again fish oil supplementation with either green tea or 
placebo had no significant effect in either group and there was no significant difference 
between green tea and placebo periods.
3.4.3. y-tocopherol: mg/1. Although it was not significantly affected by smoking 
status, plasma y-tocopherol was consistently lower in non-smokers (figure 32). Fish oil 
supplementation along with placebo resulted in a significant reduction in non-smokers’ 
mean plasma y-tocopherol after 2 weeks (P<0-05) which was maintained after a further 
2 weeks of supplementation. There was no significant change in non-smokers’ mean y- 
tocopherol during the green tea period. There was, however, no significant difference 
in non-smokers’ mean plasma y-tocopherol values between green tea and placebo 
periods. Smokers’ plasma y-tocopherol did not change significantly at any stage during 
the study.
3.4.4. y-tocopherol: pmol/mmol cholesterol. After correction for plasma total 
cholesterol plasma y-tocopherol was similar to that shown in figure 32; consistently 
lower in non-smokers compared with smokers (figure 33). Once again the reduction in 
non-smokers’ mean y-tocopherol only reached statistical significance during the 
placebo period (P<0-05 andP<0*01 after 2 and 4 weeks respectively). The response of 
non-smokers’ plasma y-tocopherol to fish oil supplementation was not significantly 
different between green tea and placebo periods.
3.4.5. Retinol. There was no significant difference in plasma retinol between smokers 
and non-smokers at any stage during the study (figure 34). Fish oil supplementation for 
2 weeks resulted in a significant increase in smokers’ plasma retinol during the green
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tea period (P<0-01), but not the placebo period. After 4 weeks of supplementation 
values were no longer significantly different from baseline. Non-smokers plasma retinol 
was not significantly effected by fish oil supplementation along with either green tea or 
placebo.
3.4.6. P-carotene. Plasma p-carotene was consistently lower in smokers compared 
with non-smokers, although this difference did not reach statistical significance (figure 
35). Fish oil supplementation with either green tea or placebo had no significant effect 
on plasma p-carotene in smokers and non-smokers and there was no significant 
difference between green tea and placebo periods.
3.4.7. a-carotene. Similar to p-carotene, plasma a-carotene was consistently lower in 
smokers (figure 36). Again, fish oil supplementation with either green tea or placebo 
had no significant effect on plasma levels in smokers and non-smokers and there was 
no significant difference between placebo and green tea periods at any stage during the 
study.
3.4.8. Lycopene. Like the other carotenoids measured, lycopene was consistently 
lower in smokers compared with non-smokers and was not significantly affected by 
fish oil supplementation with either green tea or placebo (figure 37).
3.4.9. Ascorbic acid. Plasma ascorbic acid was consistently lower in smokers when 
compared with non-smokers (figure 38). Due to the large degree of inter-individual 
variability this difference in mean values did not reach statistical significance. Fish oil 
supplementation along with either green tea or placebo had no significant effect on 
plasma ascorbic acid in smokers and non-smokers and there was no significant 
difference between green tea and placebo periods at any point during the study.
165
25 i
20
15 i
10
□Non-smokers: Fish 
oil/Placebo
H Non-smokers: Fish 
oil/Green tea
□  Smokers: Fish oil/Placebo
■ Smokers: Fish oil/Green 
tea
Baseline 2 weeks 4 weeks
Figure 30. Plasma a-tocopherol in smokers and non-smokers expressed as mg/1; effect 
of fish oil supplementation with green tea and placebo. There were no significant 
differences between smokers and non-smokers. Values measured during the 
supplementation periods were not significantly different from baseline in both groups, 
smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, 
n=7 smokers).
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Figure 31. Plasma a-tocopherol in smokers and non-smokers expressed as pmol/mmol 
cholesterol; effect of fish oil supplementation with green tea and placebo. There were 
no significant differences between smokers and non-smokers. Values measured during 
the supplementation periods were not significantly different from baseline in both 
groups, smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 non- 
smokers, n=7 smokers).
167
1.6 -i
II Non-smokers: Fish 
oil/Placebo
H Non-smokers: Fish 
oil/Green tea
D Smokers: Fish oil/Placebo
■ Smokers: Fish oil/Green 
tea
Baseline 2 weeks 4 weeks
Figure 32. Plasma y-tocopherol in smokers and non-smokers expressed as mg/1; effect 
of fish oil supplementation with green tea and placebo. Letters indicate significant 
difference from corresponding baseline a P<0-05. There were no significant differences 
between smokers and non-smokers. Values are expressed as mean ± S.D. (n=9 non- 
smokers, n=7 smokers).
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Figure 33. Plasma y-tocopherol in smokers and non-smokers expressed as pmol/mmol 
total cholesterol; effect of fish oil supplementation with green tea and placebo. Letters 
indicate significant difference from corresponding baseline a P<0*01, b P<0-05. There 
were no significant differences between smokers and non-smokers. Values are 
expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 34. Plasma retinol in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. Letters indicate significant difference 
from baseline a P<0-0LThere were no significant differences between smokers and 
non-smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 35. Plasma (3-carotene in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
171
% 50 -
Il Non-smokers: Fish 
oil/Placebo
^  Non-smokers: Fish 
oil/Green tea
D Smokers: Fish oil/Placebo
■ Smokers: Fish oil/Green 
tea
Baseline 2 weeks 4 weeks
Figure 36. Plasma a-carotene in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 37. Plasma lycopene in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 38. Plasma ascorbic acid in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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3.5 Markers of compliance
3.5.1. Plasma lipids. To give an indication of compliance with the requested 
consumption of fish oil capsules, plasma lipids were monitored. Plasma total 
cholesterol did not change throughout the study (figure 39) while there was a trend 
towards higher HDL cholesterol in smokers and non-smokers during both 
supplementation periods (figure 40). Fish oil supplementation reduced plasma 
triglycerides in smokers and non-smokers (figure 41). This effect was consistently 
greater in the non-smokers and the response of non-smokers’ plasma triglycerides to 4 
weeks of supplementation with fish oil and green tea was significantly greater than that 
seen in the smokers (P<0-05). Triglycerides were not significantly affected by ingestion 
of green tea. Plasma triglycerides for each individual are shown in figure 42 for non- 
smokers and figure 43 for smokers. In the non-smokers there was a reduction in 
plasma triglycerides between baseline and 2 weeks in all volunteers during period 1. 
There was, however, an increase in plasma triglycerides between 2 and 4 weeks of 
supplementation in some volunteers during this period. During period 2 the effect of 
fish oil supplementation was similar, although the increase between 2 and 4 weeks of 
supplementation only occurred in one volunteer. Of particular note during period 2 are 
subjects C and J. In subject C there was an increase between baseline and 2 weeks of 
supplementation followed by a reduction between 2 and 4 weeks, while plasma 
triglycerides increased throughout this supplementation period in subject J. In 
individual smokers the trends in plasma triglycerides were similar to those seen in the 
non-smokers.
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Figure 39. Plasma total cholesterol in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 40. Plasma HDL cholesterol in smokers and non-smokers; effect of fish oil 
supplementation with green tea and placebo. There were no significant differences 
between smokers and non-smokers. Values measured during the supplementation 
periods were not significantly different from baseline in both groups, smokers and non- 
smokers. Values are mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 41. Plasma triglycerides (mmol/1) in smokers and non-smokers, effect offish oil 
supplementation with green tea and placebo. Letters indicate significant difference 
from corresponding baseline a P<0-05, b P<0-01. Values are expressed as mean ± S.D. 
(n=9 non-smokers, n=7 smokers).
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Figure 42. Changes with time in non-smokers’ plasma triglycerides during the study.
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Figure 43. Changes with time in smokers’ plasma triglycerides during the study.
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3.5.2. Urinary saccharin. An HPLC chromatogram showing saccharin as a distinct 
peak with a retention time of 22-85 minutes is shown in figure 44.
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Figure 44. HPLC chromatogram of a urine sample analysed using the conditions 
described in section 2.2.8. Saccharin eluted as a distinct peak with a retention time of 
22-85 minutes.
Saccharin excretion by smokers and non-smokers increased during both 
supplementation periods (figure 45). Due to the considerable inter-individual 
variability, mean values during the supplementation periods were not always 
significantly different from baseline.
Saccharin excretion from each volunteer is shown in figure 46 for the non-smokers and 
figure 47 for the smokers. As can be seen there were significant amounts of saccharin 
in baseline urine samples from some volunteers, notably subjects H (non-smoker) and 
E (smoker) during period 1. In the non-smokers there was, with the exception of 
subject H, an increase in saccharin excretion between baseline and 2 weeks of 
supplementation during period 1. As a group, the mean increase was 1-41 mg 
saccharin/mmol creatinine. This was reduced to 0-95 mg/mmol creatinine if subject F 
was excluded. These values are less than the baseline value for subject H (1-71
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mg/mmol creatinine). In the smokers the mean increase between baseline and 2 weeks 
of supplementation during period 2 was 044 mg/mmol creatinine while the mean 
baseline for this period was 0-77 mg/mmol creatinine. It therefore appears that 
saccharin excretion resulting from ingestion of the green tea/placebo capsules may 
have been subject to considerable interference from dietary sources. The potential 
problems of interpreting urinary saccharin as a marker of compliance are illustrated by 
subjects E and M (smokers) during period 2. In both these individuals, saccharin 
excretion after 2 weeks of supplementation was lower than that at baseline.
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Figure 45. Urinary saccharin excretion by smokers and non-smokers. Letters indicate 
significant difference from corresponding baseline a P<0-05, b P<0-001. Values are 
expressed as mean ± S.D. (n=9 non-smokers, n=7 smokers).
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Figure 46. Changes with time in non-smokers’ urinary saccharin excretion during the 
study.
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Figure 47. Changes with time in smokers’ urinary saccharin excretion during the 
study.
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In an attempt to gain an indication of compliance with the requested consumption of 
green tea/placebo capsules total saccharin excreted over a 24 hour period has been 
divided by that anticipated if the only source of urinary saccharin was the capsules and 
the volunteers were 100 % compliant (table 17). When expressed as such, saccharin 
excretion from some volunteers was considerably less than that anticipated if they were 
100 % compliant. It must be assumed that collection of 24 hour urine samples was 
complete when making this calculation. Lower than anticipated saccharin excretion 
may therefore be a reflection of incomplete collection of urine samples as well as non- 
compliance. Nevertheless data from subject C are suggestive of non-compliance. If this 
volunteer was 100 % compliant urine volumes would have had to average nearly 5 
litres to account for total urinary excretion.
Table 17. Saccharin excretion expressed as total saccharin collected in a 24 
hour urine sample divided by that expected for 100 % compliance and no 
other source of saccharin.
Subject Baseline 2 weeks 4 weeks Baseline 2 weeks 4 weeks
A 58 39 60 133
B 143 166 171 107
C 22 29 65 32
D 87 86 97 87
E 68 523 87 106
F 229 423 442 91
G 92 35 126 155
H 52 260 217 210
I 54 93 82 137
J 241 110 26 172
K 157 150 76 74
L 540 91 142 22
M 177 29 86 105
N 67 58 91 61
O Saccharin could not be determined due to co-eluting substances
P 40 94 59 58
Calculations made assuming 100 % collection of urine samples
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4. Discussion
For the reasons discussed in chapter 4 volunteers were instructed to refrain from 
vigorous physical exercise and alcohol consumption for at least 24 hours prior to 
sample collection. Chronic ethanol consumption has been shown to have no effect on 
alkane metabolism, at least in rats (Remmer et a l, 1984). Volunteers were therefore 
instructed to maintain their normal pattern of alcohol consumption throughout the 
remainder of the study, within the limits set out in the exclusion criteria (page 145). 
Given the acute effects of smoking on plasma lipid peroxidation and the relatively high 
level of ethane in cigarette smoke it was important that samples were collected from 
smokers after a standard period of abstention from smoking. Accordingly smokers 
were instructed to refrain from smoking from midnight on the day prior to sample 
collection. On one occasion a smoker had a cigarette approximately 60 minutes prior 
to sample collection. This was detected as abnormally high ethane exhalation and the 
volunteer gave a further set of samples on the following day.
Meydani et a l (1991) found that the increase in plasma EPA and DHA resulting from 
fish oil supplementation was greater in older (51-71 years) than younger (22-35 years) 
humans. This may be explained by the observation that intestinal fatty acid absorption 
increases with age (Hollander et a l, 1984). Meydani et al (1991) also found that the 
increase in plasma lipid peroxidation resulting from fish oil supplemetation was greater 
in the older subjects. The volunteers used by Meydani et a l (1991) were female and 
the older group were post-menopausal. Female hormones have been reported to have 
antioxidant activity (Meydani et a l, 1991). It is therefore possible that the hormonal 
status of the two study groups may have contributed to the age-related effect offish oil 
supplementation on plasma lipid peroxidation. Nevertheless older individuals may be 
more susceptible to fish oil-induced lipid peroxidation and the current study was 
conducted in men over 40 years.
Plasma MDA in smokers has been reported to be slightly, but not significantly, greater 
than that in non-smokers when samples are collected after abstention from smoking for 
24-40 hours (Harats et a l, 1989; Harats et a l, 1991) and from smokers in which the 
recent smoking history was not specified (Duthie et a l, 1991; Duthie et a l, 1993). 
Acute cigarette smoking, 4-7 cigarettes over a 90 minute period, has been shown to 
increase significantly plasma TEARS (Harats et a l, 1990; Harats et a l, 1991). From 
the results of the current study it cannot be determined if habitual smoking increased 
plasma MDA. If such an increase occurred it appears to have been washed-out during
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the 8-5 hours between smoking and collection of blood and breath samples. Ethane 
exhalation from smokers was, however, over 100 % greater than that from non- 
smokers after this period of abstention from smoking. A possible explanation for the 
dissimilar effect of smoking on these biomarkers lies in the nature of free radical 
exposure resulting from smoking. The lungs are the primary site of free radical 
exposure resulting from cigarette smoke and tar, and accumulate larger numbers of 
activated phagocytic cells. Oxidative damage resulting from smoking may therefore be 
much more extensive in the lungs compared with the rest of the body. If this is the case 
ethane exhalation may be a more sensitive biomarker of smoking-induced oxidative 
damage compared with other indices measured in bodily fluids such as plasma. During 
the act of smoking itself oxidation of lung tissue and blood perfusing the lungs may 
occur to such an extent that it is detectable as plasma MDA. After a period of 
abstention from smoking, lung cell lipid peroxidation is likely to be less extensive than 
that seen during smoking and may no longer be detectable in plasma. It may, however, 
still be detectable as ethane exhalation. It is of course also possible that the elevated 
ethane exhalation from smokers represents wash-out from body stores of ethane 
originating in the smoke. If this is the case, then it is also possible that ethane 
originating from in vivo lipid peroxidation induced by the act of smoking may 
penetrate body stores and appear in the breath after a period of abstention from 
smoking.
Urine samples were collected over the 24 hours prior to collection of blood and breath 
samples. During this time volunteers were instructed to maintain their normal smoking 
habits, with the exception of cessation from midnight on the night prior to collection of 
breath and blood samples. Urinary MDA excretion therefore encompassed the acute 
effects of smoking and may have been expected to be greater from smokers. This was 
indeed the case after correction for urinary creatinine excretion.
In vitro exposure of plasma to cigarette smoke has been shown to result in protein 
carbonyl formation (Reznick et a l, 1992; Cross et a l, 1993). In the current study 
cigarette smoking was not a determinant of in vivo plasma protein carbonyls. It has 
been suggested that oxidatively modified proteins are rapidly degraded (Davies 1987). 
Similar to changes in plasma MDA, any increase in plasma protein carbonyls resulting 
from the act of smoking may therefore have been washed-out during the 8-5 hours 
between smoking and sample collection.
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strand breaks
There was no significant difference in baseline lymphocyte DNA between
smokers and non-smokers in the current study. Kiyosawa et al. (1990) reported that 
the level of SOHdG in smokers’ lymphocyte DNA was only slightly greater than that in 
non-smokers DNA. They also found that SOHdG in smokers’ leukocyte DNA was 
significantly greater after smoking 2 cigarettes in a 10 minute period when compared 
with measurements made after overnight abstention ftom smoking. Once again it 
therefore appears that any effect of smoking in the current study may have been 
washed-out prior to sample collection.
Smokers have been reported to have lower plasma concentrations of ascorbic acid 
(Schectman et a l, 1991; Bolton-Smith 1993) and (3-carotene and a-carotene (Stryker 
et a l, 1988). Plasma lycopene (Stryker et a l, 1988) and serum retinol (Bolton-Smith 
et a l, 1991) have been reported to be uneffected by smoking status. Conflicting 
reports exist regarding the effect of smoking on cc-tocopherol (Bolton-Smith 1993; 
Van Antwerpen et a l, 1993). In agreement with the literature, baseline levels (baseline 
period 1) of plasma (3-carotene, a-carotene and ascorbic acid were lower in smokers. 
There was, however, considerable inter-individual variability in both groups and the 
differences in mean values did not reach statistical significance. Plasma retinol, and 
particularly lycopene, were also lower in smokers in the current study, at variance with 
the literature. Given the considerable inter-individual variability and the small numbers 
enrolled in the current study in relation to studies showing no effect of smoking status 
on these nutrients (n=T37 Stryker et a l, 1988; n=196 Bolton-Smith et a l, 1991) it 
cannot be concluded that they are affected by smoking status from the current results.
In agreement with Allard et a l (1994b), fish oil supplementation had no significant 
effect on ethane exhalation. It did, however, result in a significant increase in plasma 
and urinary MDA. This effect offish oil on plasma TEARS has been well documented 
in the literature (Brown and Whale, 1990; Haglund et a l, 1991; Meydani et a l, 1991). 
The increase in plasma and urinary MDA without any corresponding increase in ethane 
exhalation appears on first consideration to be inconsistent. A possible explanation for 
the differing responses of urinary MDA and ethane exhalation may lie in the 
mechanisms through which fish oil supplementation stimulates lipid peroxidation. As 
alluded to in chapter 4, the increase in lipid peroxidation resulting from fish oil 
supplementation may have two components: a chronic phase involving enrichment of 
cellular membranes with EPA and DHA and an acute phase representing oxidative 
metabolism of the fish oil fatty acids. Urine samples were collected over a 24 hour 
period during which volunteers took 10 g of fish oil. Urinary MDA would therefore
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have encompassed both phases. Breath samples were collected approximately 12 hours 
after the last dose offish oil and are therefore less likely to represent the acute phase. 
This does not explain the difference between plasma MDA and ethane exhalation since 
blood samples were collected at the same time as breath samples. The capacity offish 
oil supplementation to increase plasma MDA without affecting ethane exhalation has, 
however, also been observed by Allard et al (1994b). Possible explanations for the 
difference in the response of these biomarkers include:
(1) exhaled ethane may be largely of exogenous origin (chapter 5). Any change in 
ethane exhalation resulting fiom in vivo lipid peroxidation may therefore have been 
masked;
(2) ethane exhalation represents a terminal end product of lipid peroxidation. Plasma 
MDA encompasses lipid hydroperoxides as well as any MDA within the sample and 
may therefore represent more oxidative events;
(3) fish oil supplementation increases plasma EPA and DHA (Meydani et a l, 1991). 
Despite the fact that BET was added to plasma samples prior to reaction with DETBA 
peroxidation of these fatty acids during the assay procedure cannot be unequivocally 
ruled out.
During the placebo period plasma and urinary MDA from smokers and non-smokers 
decreased between 2 and 4 weeks of supplementation. When data for smokers and 
non-smokers were combined, the reduction in plasma MDA was statistically significant 
when expressed as nmol/ml while the reduction in urinary MDA was statistically 
significant after correction for urinary creatinine. A similar effect has been observed by 
Meydani et al (1991) and Brown and Whale (1990). hi both these studies the fish oil- 
induced increase in plasma MDA was transient. Fish oil supplementation has been 
shown to increase erythrocyte and platelet glutathione peroxidase activity in humans 
(Bellisola et a l, 1992) and catalase and ghitathione-S-transferase in rat liver 
(Yamazaki et a l, 1987). The recovery in plasma and urinary MDA seen in this and 
other studies as the duration of fish oil supplementation continues may therefore be 
due to induction of antioxidant enzymes. It may, however, also be a reflection of a 
reduction in compliance with time (discussed below).
Green tea had no significant effect on ethane exhalation from smokers and non- 
smokers. Fish oil supplementation did not, however, affect ethane exhalation in either
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group. In the absence of any obvious oxidative stress it is, therefore, perhaps not 
surprising that the relatively low dose of green tea had no significant effect on ethane 
exhalation from non-smokers. Ethane exhalation from smokers was consistently 
greater than that from the non-smokers, which may be an indication of elevated 
oxidative damage. With reference to chapter 1 section 6 it can be seen that it is under 
conditions such as these that green tea has the greatest opportunity to show an effect. 
It has, however, been reported previously that ethane exhalation from smokers is 
unaffected by antioxidant supplementation (Allard et al, 1994b; Hoshino et al, 1990)
The increase in smokers’ plasma and urinary MDA resulting from supplementation 
with fish oil and placebo for 2 weeks was significantly greater than that in non- 
smokers. Harats et a l (1989) found that LDL isolated from smokers was more 
susceptible to lipid peroxidation induced by incubation with smooth muscle cells than 
that from non-smokers. As might be expected, it therefore appears that smoking 
increases susceptibility to oxidative damage.
It can be suggested from these data that the endogenous antioxidant defence systems 
were unable to protect against the fish oil-induced increase in plasma and urinary 
MDA, particularly in smokers. Similar to ethane exhalation in smokers, it is under 
conditions such as these that green tea has the greatest opportunity to demonstrate an 
effect. There was, however, no evidence to suggest that green tea affected plasma and 
urinary MDA in either the smokers or non-smokers. It therefore appears that, at the 
dose given, green tea did not protect against the increase in lipid peroxidation resulting 
from fish oil supplementation. Orally administered (+)-catechin has, however, been 
shown to protect against ethanol-induced lipid peroxidation in rats (Édes et a l, 1986) 
and to lower serum MDA in humans with chronic hepatitis (Par et a l, 1985). Green 
tea catechins have been shown to reduce plasma TEARS in rats fed a diet containing 
30 % peiilla oil (Nanjo et a l, 1993). The apparent non-effect of green tea in this study 
may therefore be a reflection of the study design. Steps which may have increased the 
opportunity for green tea to show an effect will be discussed later.
At this point it is worth remembering that the effect of vitamin E on fish oil-induced 
lipid peroxidation is by no means consistent. While Harats et al (1991) and Nair et al
(1993) found that additional vitamin E was successful in counteracting the fish oil- 
induced increase in plasma TEARS, Brown and Whale (1990) and Allard et a l 
(1994b) found that it was unsuccessful. Differences between these studies do not 
appear to be due to the fish oil used or the ratio of vitamin E to fish oil. The capacity
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of vitamin E, a lipid-soluble antioxidant, to attenuate the in vivo increase in plasma 
MDA resulting from fish oil supplementation can therefore be questioned. In light of 
this, the lack of an effect of green tea is perhaps not surprising.
With the exception of -/-tocopherol, fish oil supplementation had no significant effect 
on non-smokers’ plasma antioxidant nutrients during the placebo period. The reason 
for this depression in y-tocopherol without any change in cc-tocopherol is unclear. 
Given that the biological activity of y-tocopherol is approximately 10 % that of cc- 
tocopherol (Hunt and Groff 1990) the significance of this in relation to antioxidant 
defence mechanisms is likely to be minimal. The effect of fish oil supplementation on 
plasma antioxidant nutrients in smokers was also minimal. If plasma concentrations are 
taken as a reflection of whole body status it therefore appears that fish oil 
supplementation did not significantly compromise antioxidant nutrients. Such an 
assumption may, however, be questioned for vitamin E since it has been reported that 
vitamin E is mobilised from body stores at times of oxidative stress (Van Antwerpen et 
al, 1993). Nevertheless, if this is the case, the increase in plasma and urinary MDA 
resulting from fish oil supplementation is perhaps surprising. The capacity of fish oil 
supplementation to increase lipid peroxidation without affecting plasma vitamin E  has, 
however, been reported previously (Brown and Whale 1990; Harats et a l, 1991; 
Allard et a l, 1994b). The observation that antioxidant nutrients may not have been 
compromised by fish oil supplementation in the current study offers a further 
explanation for the apparent non-effect of green tea against biomarkers of lipid 
peroxidation.
As alluded to previously, smoking has been well documented to increase in vivo 
ascorbic acid consumption. Although there was no significant change in plasma 
ascorbic acid at any point during the current study the trend in smokers ascorbic acid is 
suggestive of a sparing effect of green tea against this antioxidant nutrient. Roger
(1988) has reviewed several mechanisms through which flavonoids may pare  ascorbic 
acid. These include:
(1) inhibition of enzymes which bring about ascorbic acid oxidation;
(2) catalysing the reduction of dehydroascorbate by glutathione,
(3) stimulating dehydroascorbate resorption.
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The effects of fish oil supplements on plasma lipids have been reviewed by Harris
(1989). In a total of 31 publications investigating the effects of varying doses offish oil 
for varying durations in a total of 596 volunteers with normal plasma lipids the average 
effects offish oil were: essentially no change in total cholesterol, a 25 % reduction in 
triglycerides and a 3 % rise in HDL cholesterol. Mean plasma triglycerides were 
reduced during the supplementation periods in the current study, an observation 
suggestive of compliance with the requested consumption of fish oil capsules. When 
looked at individually it can be seen that there is a slight increase in plasma 
triglycerides between 2 and 4 weeks of supplementation in some volunteers. The 
reason for this is unknown, although it may indicate a drop off in compliance as the 
duration of supplementation increased. In some volunteers, notably A and G (smokers) 
and J (non-smoker) there was an increase in plasma triglycerides during one of the 
supplementation periods which may be indicative of non-compliance. When 
interpreting these results it must be remembered that the volunteers were instructed to 
present themselves for sample collection in the fasted state. Failure to do so may have 
resulted in elevated triglycerides and confounded the results obtained. Alcohol 
consumption may also have confounded plasma triglycerides. Analysis of plasma EPA 
and DHA may therefore have given a better indication of compliance with the 
requested consumption of fish oil capsules.
Green tea consumption has been associated with reduced serum total cholesterol and 
triglycerides and increased serum HDL cholesterol (Imai and Nakachi. 1995). In the 
current study any effect of green tea would have been superimposed on that of the fish 
oil. It is therefore not surprising that there was no obvious hypotriglyceridemic effect 
of green tea.
Haglund et a l (1991) found that supplementation with a fish oil containing 0 2 mg/g 
a-tocopherol increased plasma MDA and reduced plasma triglycerides. Increasing the 
cc-tocopherol content of the oil to 1-0 mg/g prevented the increase in plasma MDA and 
increased the reduction in triglycerides. It was suggested that vitamin E prevented in 
vivo oxidation of the fish oil, leading to more active n-3 fatty acids in the liver, which 
resulted in a more pronounced reduction in plasma triglycerides. In the current study 
the fish oil-induced reduction in plasma triglycerides was greater in the non-smokers 
while its effect on plasma MDA was greater in the smokers. This may also be 
explained by the interpretation offered by Haglund et a l (1991) for their findings. It 
must, however, be remembered that non-smokers’ plasma triglycerides were, on
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average, greater than those of smokers prior to the supplementation periods and may 
therefore have been more responsive to fish oil supplementation.
The HPLC method described in section 2.2.8 successfully isolated saccharin fiom 
other UV-absorbing substances present in urine samples from all volunteers except 
subject O. The identity of saccharin was confirmed on the basis of retention time and 
spectral data. In the case of subject O a broad peak with spectral properties dissimilar 
to saccharin eluted at the expected retention time. Saccharin excretion fiom smokers 
and non-smokers increased during the supplementation periods. It does, however, 
appear that saccharin excretion resulting from the green tea/placebo capsules was 
subject to considerable interference fiom dietary sources of saccharin. In this regard 
Wilson and Crews (1995) found that 24 hour urine samples collected after 
consumption of a saccharin-free diet for 7 days contained up to 2-4 mg 
saccharin sample. In the current study, volunteers were on a free choice diet 
throughout. Interference fiom dietary sources may therefore have been considerable. 
For example, the green tea/placebo capsules provided a total of 18 mg saccharin/day 
while Boots saccharin tablets contain 12-5 mg saccharin/tablet. The data obtained for 
urinary saccharin therefore appear to be, at best, a general indication of compliance for 
the groups as a whole. A different marker of compliance such as jy-aminobenzoic acid 
may therefore have been more appropriate (Bingham and Cummings, 1983). 
Nev ertheless for some individuals, notably some of the non-smokers, there was a 
reduction in saccharin excretion between 2 and 4 weeks of supplementation. Similar to 
plasma triglycerides, this may be indicative of a drop off in compliance as the duration 
of supplementation increased.
In the study conducted by Haglund et al (1991) volunteers were given fish oil for two 
periods of 3 weeks with a 2 week wash-out between supplementation periods. While 
Haglund et a l (1991) state that the levels of fatty acids and vitamin E in some cells 
such as platelets and leukocytes have not returned to baseline after a 2 week wash-out 
they also state that the 2 week wash-out period they used did not have any major 
influence on their results. In the current study a 3 week wash-out period was 
employed. Baseline levels of plasma and urinary MDA, plasma triglycerides and plasma 
protein carbonyls prior to period 1 and period 2 are shown in table 18.
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Table 18. Baseline levels (prior to period 1 and period 2) of plasma and urinary 
MDA, plasma triglycerides and plasma protein carbonyls .
Non-smokers (n=9) Smokers (n=7)
Period 1 Period 2 Period 1 Period 2
Plasma MDA 
nmol/1
pmol/mmol TG
0-61 ±0-15 
0-27 ±0-10
074 ± 0  14 
0 43 ± 0  21
0-58 ± 0-22 
0-37 ±0-16
0-47 ±0-16 
0-30 ±0-13
Urinary MDA 
pg/kg/24 hours 
pg/mg Ct
5-20 ±0-89 
0 21 ± 0 04
6-20 ± 1-87 
0-28 ± 0 08
5-79 ± 1-19 
0-26 ± 0-04
6-30 ± 2-39 
0-32 ± 0-07
Plasma TG 
mmol/1 2-64 ± 1-37 2-27 ± l -48 1-63 ± 0-45 1-62 ±0-41
Plasma PC 
pmol/mg protein 131 ±23 241±61§ 121 ±36 311± 51§
Values are expressed as mean ± S.D. Abbreviations: TG triglyceride, Ct creatinine, PC protein 
carbonyls. § indicate significant different between periods 1 and 2 P<0001.
There was no significant difference in plasma and urinary MDA measured prior to 
period 1 and period 2. It therefore appears that a 3 week wash-out period was 
adequate to flush-out the effects of fish oil supplementation on lipid peroxidation. 
Plasma protein carbonyls prior to period 2 were, however, significantly greater than 
measurements made prior to period 1. The 3 week wash-out period may not, therefore, 
have been adequate to remove the effects of the first supplementation period on this 
biomarker. Half of each group, smokers and non-smokers, received green tea during 
the first period while the remainder received placebo. During the second period the 
treatment, green tea or placebo, was reversed. Differences in subject characteristics 
between the 2 supplementation periods should not, therefore, invalidate comparisons 
between green tea and placebo.
In conclusion, the results of this study reaffirm that fish oil supplementation lowers 
plasma triglycerides and increases lipid peroxidation in humans. They also illustrate the 
potential for fish oil supplementation to increase protein oxidation. This is an 
interesting observation since it suggests that, in addition to providing an increase in
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peroxidizable substrate, fish oil supplementation actually stimulates in vivo oxidative 
damage. There is no evidence to suggest that these effects were attenuated by green 
tea, which may be either an indication of its inability to do so or a reflection of the 
study design. From the results of the current investigation the following suggestions 
can be made for fixture studies:
(1) increasing the number of smokers used may increase the opportunity for green tea 
to show an effect. From the results of the current study it has been calculated that there 
would be a 90 % chance of the difference in urinary MDA excretion between green tea 
and placebo periods after 2 weeks (expressed as creatinine) reaching statistical 
significance (P<0-05) if the current study was repeated with 65 volunteers. The 
difference in plasma MDA (nmol/ml) between green tea and placebo periods may have 
reached statistical significance (90 % probability) at this level if 58 volunteers had been 
used. Analysis of cotinine may also have proved usefixl as an indication of tobacco 
consumption.
(2) providing the volunteers with a controlled diet throughout the study might reduce 
inter- and intra-individual variability. This would, however, considerably add to the 
cost and complexity of the project.
(3) a larger dose of fish oil might result in a greater increase in the biomarkers 
monitored. Under such conditions a larger dose of green tea may shown an effect. The 
aim of this study was, however, to investigate the in vivo antioxidant activity of a dose 
of green tea which could realistically be achieved by habitual consumption of green tea 
beverage.
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Chapter 7
General discussion
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The aim of this thesis was to investigate the in vivo antioxidant activity of a moderate, 
and in dietary terms realistic, dose of green tea in animals and humans. Initially 
methods for the analysis of ethane exhalation and plasma and urinary MDA in animals 
were set up and validated. There was no significant difference in ethane production 
between conventional and germ-free Lister Hooded rats fed either an irradiated GR3 
diet or an irradiated semi-synthetic diet containing 5 % fish oil as the lipid source. 
Ethane production from germ-free animals fed an irradiated semi-synthetic diet 
containing 5 % maize oil was significantly greater than that from conventional animals 
fed the same diet. On the basis of these observations the gastrointestinal flora can be 
discounted as a significant source of ethane production in animals fed such diets. The 
validity of ethane exhalation as a biomarker of in vivo lipid peroxidation in animals fed 
diets rich in PUFA may, however, still be questioned since these studies do not rule out 
the possibility that a portion of the ethane in samples of total body gas may originate 
from the faeces.
The method developed for MDA analysis successfully isolated the MDA-DETBA 
adduct derived from plasma and urine samples from other compounds with significant 
absorption at 540 nm Within the limits describe in chapter 2, this method can therefore 
be considered as a valid measure of plasma and urinary MDA. Addition of green tea 
extract to plasma and urine samples immediately before reaction with DETBA did not 
affect their MDA content. Die method was therefore considered suitable for the 
current investigations.
In agreement with the literature, results from the current animal studies demonstrate 
the relationship between biomarkers of in vivo lipid peroxidation and dietary fatty acid 
composition. Replacing the LAD 1 animal diet with a semi-synthetic diet containing 5 
% fish oil resulted in a statistically significant increase in ethane exhalation and urinary 
MDA excretion from vitamin E-normal Lister Hooded rats. When the semi-synthetic 
diet contained maize oil as the lipid source the opposite effect was seen. Ethane 
exhalation and urinary MDA excretion from vitamin E-deficient animals fed the vitamin 
E-deficient fish oil diet were significantly greater than that from vitamin E-normal 
animals fed a similar diet containing vitamin E. Urinary MDA excretion is a reflection 
of MDA ingested from the diet as well as in vivo lipid peroxidation. The peroxidation 
status of the diet also appears to be an important determinant of ethane exhalation. The 
MDA content of the vitamin E-deficient fish oil diet was approximately twice that of 
the fish oil diet containing vitamin E. The difference in ethane exhalation and urinary 
MDA excretion between vitamin E-normal and vitamin E-deficient animals may
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therefore have been largely due to the peroxidation status of the diets rather than the 
status of the animais themselves. The fact that ethane exhalation and urinary MDA 
excretion may have been a reflection of dietary peroxidation as well as events initiated 
in vivo also means that the antioxidant activity of green tea may have been effective 
against only a component of these biomarkers and may have been partially masked. 
The opportunity for green tea to display in vivo antioxidant activity may therefore have 
been increased by feeding a PUFA-free diet prior to sample collection. As alluded to in 
chapter 4 this step would also have reduced any in vivo lipid peroxidation associated 
with metabolism of the fish oil and is perhaps worthy of further investigation.
Green tea catechins have been well documented to possess in vitro radical scavenging 
activity (Zhao et a l, 1989; Ho et a l, 1992). Their in vivo antioxidant activity depends 
on absorption from the gastrointestinal tract in a biologically active form That green 
tea catechins are absorbed from the gastrointestinal tract has been demonstrated in 
animals and humans (Lee et a l, 1995). Indeed absorption and metabolism of (+)- 
catechin appear similar in humans and rats (Hackett et a l, 1982; Hackett et a l, 1983). 
Green tea catechins are, however, predominantly in the conjugated form in plasma and 
may therefore have reduced antioxidant activity in vivo compared with that measured 
in vitro. Nevertheless, the capacity of orally administered catechins to reduce in vivo 
oxidative damage has been demonstrated in animals (Édes et a i, 1986) and humans 
(Par et a l, 1985). In the current study plasma MDA in conventional animals provided 
with green tea beverage was significantly lower than that in animals maintained on 
normal drinking water, regardless of diet. Urinary MDA excretion from animals 
provided with the fish oil diet and green tea beverage was also consistently lower than 
that from atiimals maintained on this diet and normal drinking water, although this 
effect did not reach statistical significance. Given the fact that green tea was found to 
have no effect on the MDA assay these observations therefore appear to be indicative 
of in vivo antioxidant activity.
There was no evidence to suggest that green tea had antioxidant activity in animals fed 
the tocopherol-stripped diets. Replacing the drinking water of rats maintained on the 
tocopherol-stripped maize oil diet with green tea beverage had no significant effect on 
plasma MDA. One might speculate that the antioxidant activity of green tea was 
overwhelmed by the oxidative damage resulting from vitamin E deficiency in these 
animals. There was, however, no significant difference in plasma MDA between 
animals fed the tocopherol-stripped maize oil diet from weaning and corresponding 
animals fed a similar diet containing vitamin E. Plasma MDA in animals fed the vitamin
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E-deficient fish oil diet and green tea beverage was significantly greater than that in 
corresponding animals provided with normal drinking water. Although it is difficult to 
explain why green tea might actually increase plasma MDA this observation is again 
inconsistent with in vivo antioxidant activity. Given the effect of green tea on plasma 
MDA in conventional animals, it therefore appears that the capacity of green tea to 
attenuate in vivo lipid peroxidation may have been diminished in the vitamin E- 
deficient animals. Accordingly the in vivo antioxidant activity of green tea in animals 
fed the maize oil and fish oil diets may have involved an interaction with vitamin E. 
Possible mechanisms through which green tea may interact with vitamin E include:
(1) it has been shown that vitamin E is regenerated by ascorbic acid in vitro (Chan. 
1993), an interaction which may also occur in vivo (Igarashi et a l, 1991). Roger 
(1988) has reviewed several mechanisms through which fiavan-3-ols may spare or 
regenerate ascorbic acid. These include catalysing the reduction of dehydroascorbate 
by glutathione and stimulating dehydroascorbic acid resorption;
(2) it has been shown that quercetin and rutin bind to erythrocyte membranes (Sorata 
et a l, 1984). Quercetin has also been shown to interact with dipalmitoyl- 
phosphatidylcholine vesicles (Saija et a l, 1995), while it has been shown that catechin 
is present in the lipid fraction of cytoplasmic membranes (Roger, 1988). Green tea 
catechins may therefore be in a position to interact with vitamin E and regenerate a- 
tocopherol from the a-tocopheroxy radical. Flavonoids containing the B ring catechol 
group and the 2,3-double bond have been shown to have a redox potential greater than 
that of ascorbic acid (Bors et a l, 1995). Such flavonoids may therefore be regenerated 
by ascorbic acid and may have the potential to act as an interface between aqueous 
antioxidants and vitamin E. Unfortunately Bors et a l (1995) did not investigate the 
redox potential of flavanols, which have the B ring catechol group, but not the 2,3- 
double bond.
The results of the human study show that biomarkers of lipid, DNA and protein 
oxidation in blood are not significantly different between smokers and non-smokers 
when samples are collected from smokers after 8 5 hours abstention from smoking. 
Ethane exhalation from smokers was, however, significantly greater than that from 
non-smokers after this time. The reason for this observation is unclear although it may 
be a reflection of enhanced lung cell lipid peroxidation, stimulated by smoking, or 
ethane absorbed from the cigarette smoke itself.
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Fish oil supplementation resulted in a significant increase in plasma and urinary MDA 
fiom smokers and non-smokers. The magnitude of this effect was greater in smokers, 
suggesting that they may be a group particularly vulnerable to oxidative damage 
stimulated by fish oil supplementation. This maybe a reflection of the fact that smokers 
have been well documented to have low plasma concentrations of antioxidant nutrients 
compared with non-smokers. In this regard smokers appear to be an ideal study group 
for investigations into the in vivo antioxidant activity of a substance. They are, 
however, a heterogeneous group with regard to cigarettes consumption and smoking 
history and in this respect can be criticised.
The fish oil-induced increase in plasma and urinary MDA in the human study was 
significantly greater after 2 weeks of supplementation compared with that measured 
after 4 weeks. This observation may be an indication of either adaptaion to the 
increased oxidative load associated with fish oil supplementation or a drop off in 
compliance as the duration of supplementation continued, or both. Although plasma 
lipid levels and urinary saccharin were monitored as markers of compliance with the 
requested consumption of fish oil and green tea/placebo capsules respectively neither 
appear to have been ideal for this purpose. Saccharin excretion resulting from ingestion 
of the green tea/placebo capsules appears to have been subject to considerable 
interference from other dietary sources of saccharin while the use of plasma 
triglycerides may have been confounded by food consumption prior to sample 
collection. The use of/7-aminobenzoic acid and plasma EPA and DHA enrichment may 
therefore have been more appropriate as markers of compliance with the requested 
consumption of green tea/placebo capsules and fish oil capsules respectively.
Unlike plasma and urinary MDA, there was no indication of a recovery in plasma 
protein carbonyls between 2 and 4 weeks of supplementation. Indeed plasma protein 
carbonyls measured prior to the second supplementation period were significantly 
greater than measurements made prior to period 1. It therefore appears that the 
response of protein and lipid oxidation to fish oil supplemetation was dissimilar.
Although fish oil supplementation resulted in a significant increase in plasma and 
urinary MDA in the human study it did not affect ethane exhalation. The reason why 
fish oil supplementation increased urinary MDA excretion from humans and vitamin E 
normal animals while the fish oil-induced increase in ethane exhalation was seen only in 
animals is unknown. There are several possible explanations for this:
201
(1) the apparatus used to measure ethane exhalation from animals collected total body 
gas and therefore encompassed the flatus and any gases released from the faeces. It is 
possible that the fish oil-induced increase in ethane production originated from these 
sources in addition to in vivo lipid peroxidation, particularly since animals were not 
fasted prior to sample collection. In the human studies analysis was performed 
exclusively on breath samples;
(2) the fish oil-induced increase in ethane exhalation may have two components: an 
acute phase associated with metabolism of the oil and a chronic phase associated with 
enrichment of cellular membranes with EPA and DHA. Human breath samples were 
collected after an overnight fast and approximately 12 hours after the last dose of fish 
oil capsules. Animals were allowed to feed ad libitum until the time of sample 
collection. Ethane exhalation from animals may, therefore, have encompassed both 
phases while that from humans may have encompassed the chronic phase only;
(3) the peroxidation status of the diet may be an important determinant of ethane 
exhalation. Although precautions were taken to minimise peroxidation of the fish oil 
diet given to animals it is highly likely that it was peroxidized to a greater extent than 
the fish oil capsules given to humans;
(4) in relation to their body weight animals received a much greater dose of fish oil 
than humans. The fish oil-induced increase in urinary MDA excretion from animals was 
much greater than that from humans. After 1 week on the fish oil diet urinary MDA 
excretion from vitamin E-normal animals maintained on normal drinking water 
increased by 262 %. Urinary MDA excretion from non-smokers was 36 % greater than 
baseline (when expressed against urinary creatinine) after 2 weeks of fish oil 
supplementation. Urinary MDA excretion appears to have been more sensitive than 
ethane exhalation to fish oil supplementation in the animal studies; ethane exhalation 
from vitamin E-normal rats increased by 37 % after 1 week offish oil supplementation. 
Given that the increase in urinary MDA excretion from humans was approximately 14 
% of that in animals and ethane exhalation from humans was subject to a greater 
degree of inter-individual variability than that from animals the non-effect of fish oil 
supplementation on ethane exhalation from humans is, therefore, perhaps not 
surprising. The difference in the dose given to animals and humans may have been 
further exacerbated by the possibility of non-compliance in the human study;
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(5) animals were maintained in a constant environment throughout the study period 
while humans were allowed to maintain their normal lifestyle, with the exception of the 
restrictions listed in chapter 6. Ethane exhalation from humans may therefore have 
been more variable due to exogenous exposure compared with that from animals. 
Accordingly small differences in ethane exhalation may have been more difficult to 
demonstrate in humans.
There was no evidence to suggest that green tea had antioxidant activity in the human 
study. It is unclear why green tea reduced plasma MDA in vitamin E-normal animals 
but not humans. The dose of green tea given was similar in animals and humans, when 
expressed on a body weight basis, and plasma MDA was determined using a similar 
procedure in these studies. Animals were, however, given a much greater dose of fish 
oil than humans, on a body weight basis. Fish oil supplementation may therefore have 
compromised antioxidant nutrient status in animals to a much greater extent than 
occurred in humans. Although the unsaturation index of the maize oil diet was less 
than that of the fish oil diet, the maize oil diet was also rich in PUFA and may also 
have compromised antioxidant status. An alternative explanation may lie in the 
endogenous level of oxidative damage in animals and humans. It has been estimated 
that the number of oxidative hits to DNA per cell per day is about 100,000 in the rat 
and about 10,000 in the human (Ames et a l, 1993). Plasma MDA in animals 
maintained on LAD1 diet was approximately 10 times greater than that in free living 
humans. Oxidative damage may therefore have been considerably more extensive in 
rats compared with humans. Accordingly green tea may have had a greater opportunity 
to show an effect in the rats.
In conclusion, the results of the current studies suggest that orally administered green 
tea has in vivo antioxidant activity in vitamin E-normal rats, in agreement with the 
literature. There is no evidence to suggest that green tea reduced oxidative damage, 
stimulated by smoking or fish oil supplementation, in humans. As discussed in chapter 
6, this may be a reflection of the study design rather than a lack of activity. Steps 
which may have increased the opportunity for green tea to show an effect are 
discussed in chapter 6. With regard to future studies into the in vivo antioxidant 
activity of dietary flavonoids in humans, green tea still appears to be an ideal dietary 
source. Not only is it rich a rich source of catechins, which are biologically available 
and have been shown to possess antioxidant activity without being mutagenic, but it is 
also ideally suited for use in supplementation studies.
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